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 Abstract 
 
The pulmonary surfactant is a mixture of surface active substances, which are present at 
the air/water interface of the mammalian lung. The surfactant proteins, SP-B and SP-C, 
are important for the dynamic adaptation of the surface tension of the alveoli during the 
breathing cycle. SP-C facilitates the respreading of films from multilayers that have 
been formed during the compression [1-2]. It has been reported that insertion of the 
α-helical (C-terminal) part of SP-C into a lipid bilayers occurs when protrusions are 
formed at high surface pressures [3]. The aim of this study was to investigate the role of 
the S-palmitoyl chains and the α-helical part for the formation of lipid/protein 
surface-confined reservoirs, as well as the influence of the N-terminal part on 
lipid/protein interactions.  
In this study the film balance (FM) technique, fluorescence light microscopy 
(FLM) and scanning force microscopy (SFM) was used to investigate the biophysical 
properties and the topography of lipid/peptide monolayers. The experimental model 
systems were composed of the major surfactant phospholipids (DPPC:DPPG with a 
molar ratio of 80:20) and SP-C or SP-C analogues. Therefore truncated and/or 
depalmitoylated of SP-Cs were used as surfactant model systems. The different SP-C 
forms that are used in this experiment were human and porcine native SP-Cs (SP-C35+pp 
and pSP-C35+pp), non-palmitoylated native SP-C (SP-C34-pp), palmitoylated SP-C with 25 
residues (SP-C25+pp), palmitoylated and unpalmitoylated SP-C with 17 residues 
(pSP-C17± pp) or with 13 residues (pSP-C13± pp) and a substituted palmitoylated SP-C 
with13 residues (pSP-C13L1W).   
The native SP-C exhibited the same phase behavior and displayed the same 
topography characteristics as described in previous reports especially concerning the 
identified protrusions.  In contrast, the non-palmitoylated SP-C34-pp showed a different 
behavior in terms of fluidizing the lipid monolayer and forming filamentous structures 
instead of multi-steps of flat stacks at the plateau pressure.  Palmitoylated SP-C with 25 
residues (SP-C25+pp) produced similar protrusions as native SP-C but with a different 
topography (smaller and less steps of flat stacks). Moreover, the truncated SP-Cs 
(pSP-C17± pp, pSP-C13± pp, pSP-C13L1W) did not show any plateau in the isotherms at high 
surface pressures, and no characteristic SP-C protrusions were formed, which could be 
 detected with SFM. Instead, an aggregation of the peptide and material loss of peptides 
and/or lipids into subphase was found in these peptide-containing films. This clearly 
shows that the shorter N-terminal part of SP-C is not able to retain the peptide inside the 
monolayer at higher surface pressure.  
As a consequence, the palmitoylated part of SP-C exhibits an important role 
anchoring SP-C to the membrane and induces the respreading of lipid bilayers during 
expansion cycles.  The palmitoyl chains probably also function as adhesive moieties 
mediating the interactions between the α-helix of the peptide, on the one hand, and the 
acyl chains of the lipids, on the other hand, leading to more stable monolayers. 
The α-helix, however, seems to be important for the effective formation of 
multilayers beneath the surface-spread surfactant monolayer.  If it is too short and 
contains 17 residues or less the protrusions are not formed probably because the helix 
cannot span a lipid bilayer. 
 
A synthetic 21 residues long peptide called KL4 consists of hydrophobic (leu) 
and cationic (lys) amino acids and was used to mimic SP-B. KL4 has been considered as 
a therapeutic agent in RDS and ARDS patients.  The biophysical properties by using the 
three techniques as described before in the SP-C approaches are investigated in lipid 
monolayers supplemented with different KL4 contents.  
The phase behavior of KL4 is indeed similar to that of native SP-B. It is shown 
that KL4 in lipid films increases the fluidity of the system when the films contain high 
KL4 concentrations. The squeezing out of KL4 at high surface pressure (more than 30 
mN m-1) is demonstrated. Moreover, KL4 seems to be more potent in inducing a phase 
separation of the main surfactant lipids DPPC and DPPG. The protrusions, however, are 
not found in this peptide/lipid system and no refined structure could be observed in the 
SFM images as were found with the native SP-B.  
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Chapter 1 
 
 
Introduction 
 
 
 
All living matter is made up of cells.  Plasma membranes give cells their individuality 
by separating them from their environment.  They also separate compartments inside the 
cell to protect important metabolic processes and to direct material transport.  All cell 
membranes mainly contain proteins and lipids (most are phospholipids). The cell 
membrane components are varied depending on each cell type e.g. Myelin, which 
insulates nerve fibers, contains only 18% protein and 76% lipid or plasma membranes 
of human red blood cells and mouse liver contain nearly equal amounts of proteins (44, 
49% respectively) and lipids (43, 52% respectively).  There are several membrane 
proteins, which perform various functions such as enzyme activity, cell attachment, 
cell-cell communication and transport manifold substances into and out of the cell [4].  
Because of the different function of each cell type a differentiation of membrane 
proteins is cell type specific and particularly in organelles it is required to achieve 
particular function for life. 
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1.1 Membrane and proteins 
 
The membrane proteins that are shown in figure 1.1 carry out most of the specialized 
functions of the cell membrane.  There are many types of membrane proteins that vary 
from cell type to cell type. Membrane proteins can be  
• Integral proteins: these are fully incorporated into the membrane and are in 
contact with both the inside and the outside of the cell.  
• Surface membrane proteins: these are only associated with the exterior of the 
lipid bilayers and establish a contact with the extracellular space.  
• Inner membrane proteins: these are only associated with the interior of the lipid 
bilayers and get into contact with the cytoplasm (cytosol).  
• Peripheral membrane proteins: these proteins bind to the surface of integral 
membrane proteins. 
• Transmembrane channel proteins: these are similar to integral proteins but 
appear to possess a channel connecting the extracellular space to the cytoplasm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1  Schematic diagram of a biological cell membrane. 
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All of these proteins have specific functions in cell membrane like:  
• to attach parts of the cytoskeleton to the cell membrane in order to stabilize cell 
shape,  
• to attach cells at an extracellular matrix to enable an organization of connected 
tissues, 
• to transport molecules into and out of cells by passive transport (ion pumps, 
channel proteins) and active transport (carrier proteins),  
• to act as receptors for the signal transduction (hormones, neurotransmission), 
• to take part as enzymes in metabolism or as a part of the immuno response 
mechanisms.   
 
 
1.1.1 Membrane lipid/protein interaction 
 
Membrane proteins are surrounded by a shell or annulus of ‘solvent’ lipid molecules in 
a biological membrane. These lipid molecules interact rather non-specifically with the 
protein molecules in general, although a few ‘hot-spots’ may be present on the proteins 
where anionic lipids can bind with high affinity. The composition of the lipid annulus 
will be rather similar to the bulk lipid composition of the membrane for lack of 
specificity. The structures of the solvent lipid molecules are important to determine the 
conformational state activity of a membrane protein as well as charge and hydrogen 
bonding interactions between the lipid headgroups and residues in the protein. Also 
hydrophobic matching between the protein and the surrounding lipid bilayer plays an 
important role. Furthermore, the presence of ‘co-factor’ lipid molecules that bind with 
high specificity to membrane proteins and are located between transmembrane 
α-helices, seem to be often essential for activity [5].  The antibiotic polymyxin is one 
example of lipid/protein interaction with respect to penetration of protein into bacteria 
cell membranes [6]. 
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Mechanism of fusogenic and lytic peptides 
 
Many fusion peptides undergo a conformational change when interacting with the target 
membrane. The transition from a random coil to an ordered secondary structure like 
α-helix or β-sheet are the initial reactions of fusion peptides at the target membrane. The 
energy derived from this process is used for the membrane apposition and water 
exclusion from the fusion site [7]. The most important and efficient properties of 
fusogenic peptides are their length and hydrophobicity [8].   
In contrast to fusogenic peptides antimicrobial peptides often show lytic activity 
of the target membrane. Gram-negative microbial membranes are composed of a large 
amount of negatively charged lipids. Therefore one of the most important properties of 
antimicrobial peptides is their positive charge [9-11].    
A good example is Polymyxin B (PxB).  This amphiphilic cationic antibiotic 
peptide consists of one fatty acid residue attached via a linear tripeptide to a cyclic 
heptapeptide [12-13]. Due to the presence of six 1,3-diaminobutyric acid residues 
(DAB), the molecule has a net positive charge and therefore a strong preference for 
interaction with acidic phospholipids [6, 14-18]. 
PxB binds to the anionic lipid A of the lipopolysaccharide (LPS) that forms the 
outer membrane of Gram-negative bacteria, displacing divalent cations and the outer 
membrane to self-promote uptake into the periplasmic space [19-20]. It creates a contact 
with the outer leaflet of the cytoplasmic membrane inducing phospholipid transfer. 
Thereby the observed metabolic changes that result in stasis and cell death can be 
triggered. Other cationic peptide antibiotics are cecropins [21-22] gramicidin S, 
bactenecin, and indolicidin [23-24]. This novel antibacterial mechanism has major 
implications in bacterial resistance, since it would not be susceptible to generate stable 
genetic resistance.   
These mentioned peptides are specifically designed for specific interactions with 
lipid membranes. The mechanism does not depend on genetic preferences, but on the 
interaction force with suitable molecules in the membrane. The same matching between 
lipid and protein can be observed on the surface of alveoli. These globular 
compartments of the lung are covered by a lipid-protein monolayer, the so called lung 
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surfactant.  It prevents the collapses of the alveoli during breathing cycle due to specific 
interaction of the lung specific proteins with the phospholipid monolayer. 
 
 
1.2 Lung surfactant 
 
The lung is a major organ (6% of the body volume, irrespective of the body weight) 
with a large inner surface, which is continuously in contact with the environment. 
Mammalian lungs are membranous sacs, divided into alveoli, that vastly increase the 
surface area available for gas exchange (figure 1.2). Because warm blooded animals 
require a high rate of oxygen uptake, the large surface is essential as the transferring 
area of oxygen [25]. 
Due to different surface pressures in each alveolus during inhalation and 
exhalation smaller alveoli would collapse into bigger ones according to the Laplace law. 
 
Laplace law 
 
P   =   2γ/r                                                        (1.1) 
 
where   P is the air pressure in the alveolus  
γ is the surface tension  
r is the radius of the alveolus   
  
However, the lung contains diverse substances such as phospholipids and 
surfactant-associated proteins to reduce the surface tension of the alveolar air/liquid 
interface in an alveolus to nearly zero from normally 72 mN m-1 [26].  This was 
confirmed by in vivo measurements in rat lungs [27] where low values of surface 
tension were found at the end of expiration.  In order to avoid a lung collapse the 
complete air/liquid interface of the alveoli has to be covered with these surface active 
substances forming the so-called lung surfactant. They play an important role in the 
mechanism of reducing the surface tension at the alveolar air/liquid interface by 
promoting rapid insertion and spreading of lipids and proteins into the alveolar surface 
monolayer [1].   
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Figure 1.2  Diagram of the lung (left), which consists of many alveoli (right) in order to 
enhance the surface area for gas exchange. 
 
 
1.2.1 Physiological role of lung surfactant 
 
The alveoli are lined by a mainly phospholipids containing surfactant layer as shown in 
figure 1.3. The hydrophobic acyl chains of the lipids are oriented towards the air, and 
the polar head groups interact with the liquid surface.  
During surface compression, this monolayer forms distinct protrusions. 
Dipalmitoylphosphatidylcholine (DPPC) can pack into a gel phase [28] that can reduce 
the surface tension to nearly zero [29]. However, the exact mechanism by which this 
enrichment in DPPC occurs is still unknown [30].  
  
 
 
 
 
 
 
 
 
 
 
Figure 1.3  Alveolar cross-section [31] . 
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The lung surfactant is produced by the alveolar type II cells [32-33], as 
originally suggested more than 30 years ago [34]. Figure 1.4 shows the schematic 
diagram of lung surfactant secretion from pneumocytes or type II cells into the alveolar 
space. The surfactant components are stored in dense, multilayered membrane 
structures, the lamellar bodies [32]. After being secreted into the hypophase, the matrix 
of the lamella body is converted [35-37] to a lattice-like structure of tubular lipid double 
layers, called tubular myelin [38-39]. Tubular myelin is the main intra-alveolar reservoir 
of surfactant [40], which eventually forms the monolayer at the air/liquid interface [41]. 
But it is also thought that the surface film is build up by other intra-alveolar membrane 
structures such as monolayer-bilayer complexes. For the formation of this surface 
associated structures nonlipid surfactant components, especially the surfactant proteins, 
are essential [42-43]. Surfactant components are constantly removed from the surface 
film and recycled by the type II cells [44], or degraded by alveolar macrophages [45-
46]. 
 
 
Figure 1.4  Transference of surfactant material to the surface [28]. 
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 In biophysical studies lung surfactant model systems are investigated by the film 
balance to imitate the lipid/protein monolayer at the air/liquid interface in the alveoli. 
The lipid/protein mixture solution is spread on the subphase from organic solvent. 
Thereby a monomolecular film is formed at the surface. Mimicking the mechanistically 
properties of the lung surfactant during in- and exhalation, the model monolayer is 
compressed or expanded by a barrier. 
 
 
1.2.2 Composition of lung surfactant  
 
The lung surfactant is composed of 85% phospholipids, 50% saturated 
phosphatidylcholines (PC), 18% unsaturated phosphatidylcholines, 7% 
phosphatidylglycerols (PG), 4% phosphatidylethanolamines (PE), 2% 
phosphatidylinositols (PI), 2% sphingomyelins and 5% other phospholipids.  
Cholesterol is the dominating uncharged lipid and constitutes 6–8% of the total lipids as 
shown in the diagram of figure 1.5.  
The lipid composition of isolated lamellar bodies is very similar to that of the 
alveolar surfactant [47], but definitely different from that of plasma membranes [48]. 
Nearly half of the PC content is DPPC [49]. Only a minor part of the surfactant 
composition is build up by proteins.  Although surfactant-associated proteins account 
only for 2% of the whole surfactant material they are necessary for the breathing 
mechanism of the lung. There are four surfactant-associated proteins, which can be 
divided into two groups. The first group contains small and hydrophobic proteins, 
which are named surfactant protein B (SP-B) and surfactant protein C (SP-C).  Whereas 
the so called surfactant protein A (SP-A) and surfactant protein D (SP-D) compose the 
second group of large and hydrophilic proteins. The latter two are believed to be related 
to the storage and transport of lung surfactant material as well as the response of the 
immune system. They can also be found in other areas of the body. The following 
section will give more specific details of these surfactant proteins. 
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Figure 1.5  Diagram of lung surfactant compositions corresponding to [50]. 
 
 
1.2.3 Surfactant associated proteins (SP) 
 
In the last fifteen years the four surfactant-associated proteins have been purified and 
partially characterized. These proteins appear to influence many aspects of surfactant 
structure, function, and metabolism [51]. However their functions are still not known in 
detail. Figure 1.6 shows the molecular model of each surfactant protein and its location 
at the air/liquid interface. 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Molecular model of four surfactant proteins and location of each protein in the 
air/liquid interface (www.mpibpc.gwdg.de.html). 
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1.2.3.1 Hydrophilic surfactant proteins 
 
The two hydrophilic surfactant proteins in the lung surfactant are SP-A and SP-D. 
These two proteins are related and belong to a subgroup of mammalian lectins called 
collectins (or C-type lectins, group III). These proteins consist of oligomers with 
C-terminal carbohydrate recognition domains in association with the N-terminal 
collagen-like domains. The collectins can be divided into a group with a bouquet form 
(mannan-binding protein for SP-A) and a group with a cruciform shape (conglutinin for 
SP-D) [52-53]. SP-A and SP-D may be involved in the first-line defense system of the 
lung [54]. 
 
 
SP-A 
SP-A was the first surfactant protein that has been identified, and is also the most 
abundant [55]. Its molecular mass varies from 26-38 kDa [28]. The protein has a 
"bouquet" structure of six trimers as shown in figure 1.7.  It can be found in an open or 
closed form depending on the other substances present in the system. Calcium ions 
produce the closed-bouquet form [56]. 
 
Roles of SP-A 
SP-A is supposed to be involved in the formation of tubular myelin, the regulation of 
phospholipid insertion into the monolayer, the modulation of uptake and secretion of 
phospholipids by type II cells, the activation of alveolar macrophages, binding and 
clearance of bacteria or viruses and a chemotactic stimulation of alveolar macrophages 
[57].  The formation of tubular myelin by SP-A is shown in figure 1.7. 
SP-A is not directly responsible for the surface tension lowering properties of 
pulmonary surfactant, but maybe has a regulating role [58-59]. The fact that excess SP-
A could be detected in tracheal and bronchial glands and in the epithelium of 
conducting airways [60] also suggests the importance of non-surfactant-associated 
functions of SP-A and contributes to the proposed role of SP-A in the host defense. SP-
A (and SP-D) may even have a function in the amniotic fluid in the antibody-
independent recognition and clearance of pathogens [61]. 
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Figure 1.7  The tubular myelin formation by SP-A [62] 
 
SP-D 
The other hydrophilic collagenous glycoprotein found in bronchoalveolar lavage is 
SP-D [63]. It may be argued that SP-D is not a true surfactant protein. Only a small part 
of SP-D (less than 10%) is associated with surfactant phospholipids [64] and the 
production of SP-D is not exclusively in the lung.  Moreover, SP-D mRNA is also 
found in gastric tissue [65]. The mature human SP-D polypeptide chain contains 355 
amino acid residues, and the molecular mass of this protein is 43 kDa [66]. SP-D has 
many structural characteristics in common with other C-type lectins such as SP-A and 
conglutinin. 
 
Roles of SP-D 
SP-D does not seem to have a role in the classical function of surfactant. Most putative 
functions are related to immuno defense e.g. the activation of alveolar macrophages, the 
agglutination of bacteria, the protection against nonbacterial microorganisms and 
viruses and also play a role in phosphatidylinositol metabolism [57]. 
 
 
1.2.3.2  Hydrophobic surfactant proteins 
 
Phizackerley and co-workers were the first to describe the presence of hydrophobic 
surfactant proteins [67], namely SP-B and SP-C. These proteins are soluble in organic 
solvents such as chloroform/methanol or acetonitrile/water mixtures [68]. Both proteins 
are secreted by the alveolar type II cells and require specialized intracellular processing 
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events to produce their mature forms [69-71] because of the extremely hydrophobic 
nature of these proteins. 
 
SP-B 
SP-B is a small protein of 79 amino acid residues and has been known for its high 
cysteine content [72]. The primary structure (and especially the positions of the cysteine 
residues) is conserved in the species for which the sequence has been described (±80% 
of the mature protein). The cysteine residues form a unique disulfide pattern of three 
intramolecular bonds and one intermolecular disulfide bond, which stabilize the protein 
and produce a dimeric form of SP-B [73]. Mature SP-B contains a small disulfide loop 
within a larger loop. The secondary structure of SP-B is mainly α-helical [74-76]. The 
helices have an amphipathic character. 
 
Roles of SP-B 
Newborn babies with genetical SP-B dysfunction die soon just as genetically engineered 
SP-B null mice. The lack of SP-B is linked to improper processing of SP-C, so its effect 
cannot be entirely isolated [77]. 
Putative functions of SP-B in lung surfactant are reported as a promotion of 
rapid phospholipid insertion into the air/liquid interface, a formation of tubular myelin 
and an the influence on the molecular ordering of phospholipid layers [57]. SP-B can 
fluidize a monolayer by preventing lipid packing. This leads to smaller domains in a 
liquid-condensed state, and makes the formation of collapse structures at exhalation 
more difficult [78]. SP-B may also promote buckling and the formation of other 
reversible collapse structures. Figure 1.8 shows the orientation of SP-B in a lipid 
bilayer. It is assumed that it is localized at the membrane/water interface and interacts 
with charged phospholipids (represented in blue in the figure). 
 
 
 
 
 
Figure 1.8  Scheme of SP-B in a lipid bilayer (www.mpibpc.gwdg.de.html). 
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SP-C 
The second member of the group of hydrophobic surfactant proteins is SP-C. The 
unique properties and metabolism of this protein have previously been reviewed [79]. 
This smallest surfactant protein of 35 amino acid residues is only soluble in organic 
compounds such as chloroform or 80% acetonitrile in water [68]. The protein is 
extremely hydrophobic and is characterized by a high content of valine residues. Two 
thirds of the protein consists of a continuous hydrophobic stretch, and the secondary 
structure of this part of the protein is a regular α-helix [80-82], which is able to span a 
DPPC bilayer [83]. It has been shown that the long axis of the α-helix is oriented 
parallel to the lipid acyl chains [84] as depicted in figure 1.9.  
 
 
 
 
 
 
Figure 1.9  Scheme of SP-C spanning a lipid bilayer with the α-helix parallel to the lipid acyl 
chains (www.mpibpc.gwdg.de.html). 
 
 
Roles of SP-C 
The most important function of SP-C is to enhance the rate of lipid adsorption to the 
lung surfactant monolayer. In vitro, SP-C promotes the formation of multi-layered, 
stacked structures [85]. It has been suggested that SP-C induces a reversible formation 
of protrusions directed toward either the subphase or air, leading to fully reversible 
compression and expansion cycles [78, 85-88]. In vivo, lack of SP-C may cause 
problems at low lung volumes, which occur during exhalation. SP-C null mice 
demonstrate some abnormalities in breathing at these volumes, and bubbles of their 
surfactant are unstable when compressed in the captive bubble surfactometer. Thus, SP-
C may have a stabilizing effect on highly compressed surfactant [89]. 
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1.3 Lung surfactant model for the breathing cycle 
 
The material in the monolayer must sustain very high surface pressures over a 
moderately long time range [90] during breathing cycle to prevent a collapse of the 
alveoli. As DPPC is mainly capable of reducing the surface tension, it is enriched in the 
monolayer during the breathing cycle. Therefore, two different mechanisms are 
conceivable for the selective exclusion of non-DPPC material or selective insertion of 
new DPPC molecules (see figure 1.10). There is evidence for the existence of both 
mechanisms and, in both cases, surfactant-associated proteins are thought to play an 
important role in defining the phospholipid species destined to remain in the interface at 
the highest pressure. 
 
Figure 1.10 Model of squeeze-out of lung surfactant at high surface pressure i.e. during 
inhalation [28]. 
 
Surfactant in the hypophase contains much more non-DPPC components than 
the monolayer at the alveolar interface. It is assumed that these components help to 
increase the fluidity of monolayers and lead to collapse at lower surface pressure [91]. 
Assuming that the initial composition of the surface film reflects that of surfactant in the 
hypophase, it has been considered that the surface film must undergo selective squeeze-
out of non-DPPC components during compression to achieve the necessary DPPC-rich 
state capable of sustaining high pressure [92]. 
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 Physical studies on model lipid mixtures with film balances have shown that at 
least part of the interfacial refining via squeeze-out is likely associated with intrinsic 
properties of the lipids and their surface distribution [93]. While DPPC-rich domains 
remain at the interface, other components which collapse at lower pressure leave the 
surface. Surfactant proteins may optimize the process.  
Hydrophobic proteins SP-B and SP-C are strongly associated with surfactant 
lipids in bilayers and they are also capable of being transferred to the interface. 
Isotherms of lipid/protein monolayers containing SP-B and SP-C show discontinuities 
and plateaus consistent with the exclusion of proteins and lipids under compression [94-
96].  
SP-B is partially excluded from monolayers containing either DPPC or DPPG at 
pressures of around 40-45 mN m-1, without carrying away significant amounts of lipids 
out of the monolayer [95, 97]. At low pressures, SP-B may modify lipid packing in the 
monolayer, but at higher pressures some of it remains associated with the monolayer. 
However it seems that it does not interact with the lipid surrounding or perturb the 
monolayer [95-96]. SP-B can interact with PC bilayers in two ways with different 
effects on surface activity and lipid acyl chain packing and mobility [98]. Selective 
interaction of SP-B with certain lipid species such as PG [99-100] might cause lipid 
segregation. The removal of SP-B during compression is not accompanied by either 
anionic or zwitterionic lipid. No SP-B induced removal of lipid is likely to occur at high 
pressures [95]. This mechanism would lead to an enrichment of saturated lipids at the 
surface. 
Compression isotherms of monolayers containing SP-C and DPPC or DPPG or 
both phospholipids show that there is a partial exclusion of SP-C at a higher pressure 
than that necessary for the exclusion of SP-B [95]. In contrast to SP-B, every excluded 
SP-C molecule is accompanied by about 7-10 lipid molecules [95,101]. Exclusion of 
SP-C during compression would then trigger the expulsion of lipids. In the case studied 
there was no difference in amount of lipid excluded from either DPPC or DPPG 
monolayers, so that selective exclusion cannot be implied from these data [95,101]. The 
time-of-flight secondary ion mass spectrometry (TOF-SIMS) images also show the 
visualization of enriched SP-C area surrounding pure lipid areas at high surface pressure 
[102]. However this does not mean that only non-DPPC components are squeezed-out 
but that DPPC with considerable may remain amount in the protrusion [102].  
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Additional studies with unsaturated lipids would be worthwhile to test for its 
potential to promote their selective exclusion. Under some conditions SP-C as well as 
SP-B have shown certain inclination for interaction with acidic phospholipids in 
bilayers and monolayers [99,103]. Also, SP-C resides in fluid domains of bilayers [104] 
and monolayers [105] whenever there is a coexistence of fluid and rigid regions.  
In case of SP-A, it preferentially interacts with DPPC in comparison to other 
lipids [106-107]. SP-A interacts with the boundaries between condensed and fluid 
regions in DPPC monolayers [108] and it binds best to bilayers containing high amounts 
of gel/fluid boundaries [109]. It has been suggested that SP-A can also form bridges 
between the interfacial monolayer and subphase bilayers, contributing to the 
establishment of a surfactant surface reservoir [110]. This reservoir possibly is a ‘DPPC 
reservoir’ because of the preferable interaction between SP-A and DPPC-rich domains 
in the bilayers and monolayers. This leads to poise the system for concerted transfer of 
DPPC [28]. The final transfer of DPPC molecules could require the cooperation of other 
surfactant proteins. This would also explain why SP-A by itself does not enhance the 
adsorptive properties of phospholipids but further improves adsorption in samples 
containing surfactant hydrophobic proteins [111]. 
 
 
1.4 Surfactant deficiency illnesses 
 
In 1959, Avery and Mead [112] showed that respiratory failure in premature infants is 
due to the lack of surfactant. The corresponding disease, which is a major cause of 
neonatal morbidity and mortality [113], was initially referred to as hyaline membrane 
disease, from the appearance of dense membranous structures in the collapsed alveoli 
[114]. Today, this disease is called respiratory distress syndrome (RDS) [50]. Examples 
of this illness caused from deficient lung surfactant are mentioned in the next section.  
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1.4.1 Respiratory distress syndrome (RDS) 
 
Respiratory distress syndrome, RDS, is a multifactorial lung disease of premature 
infants. The main cause of RDS is a deficiency of pulmonary surfactant, which leads to 
a lack of surface tension reduction at the air/liquid interface but also to generalized 
atelectasis of the alveolar ducts and alveoli [112,115]. Prematurity is the most important 
factor predisposing to RDS. During the past decade the number of multiple pregnancies 
has increased significantly as a result of diversified infertility treatments and advanced 
maternal age [116]. Due to the considerably higher rate of preterm births of multiples 
compared to singletons, RDS is one of the major causes of morbidity among them. 
 
 
1.4.2 Adult Respiratory Distress syndrome (ARDS) 
 
ARDS is a life threatening disorder characterized by noncardiogenic pulmonary edema 
and refractory hypoxemia, with a case fatality rate as high as 40–60% [117-122]. The 
pathophysiology of ARDS involves injury to the alveolar-capillary barrier, lung 
inflammation, atelectasis, surfactant dysfunction, and intrapulmonary shunting.  
Poor oxygenation and proteins in any exudates will adversely affect surfactant 
activity. Any mechanical disadvantage in ventilation will increase, if the reduction of 
the surface tension does not exist in alveoli of all sizes. The surfactant response to 
overinflation is not predictable, but must rely upon lung elasticity in the stretched 
alveoli and a normal film of surfactant (folding) in the smaller alveoli. If there is 
insufficient surfactant to cover the stretched alveoli, presumably the secondary effects 
on protein accumulation, and immune cells might also be altered [123].  
The disorder typically appears within 12 to 24 hours of an identifiable clinical 
event and may be due to direct lung injury, such as with gastric content aspiration, 
pneumonia, neardrowning, toxic gas inhalation, or chest/lung trauma. In addition, 
ARDS may be associated with systemic processes such as sepsis, nonthoracic trauma, 
acute pancreatitis, major surgery, multiple blood transfusions, fat embolism, or shock 
[124].  
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No specific therapy for ARDS currently exists. To date, the numerous treatment 
strategies for the disorder that have been studied have not reduced associated morbidity 
or mortality.  
 
 
1.4.3 Treatment of RDS  
 
Specific treatment of surfactant deficiency goes back to the report of Fujiwara et 
al.1980 [125], who showed that babies suffering from RDS can be effectively treated by 
instillation of heterologous surfactant preparations in the airways. Since then, 
replacement therapy has been widely used in RDS [126]. Phospholipids and 
hydrophobic proteins are common components of all surfactant preparations from 
mammalian sources [125,127-128], indicating that these specific surfactant proteins, 
present in low amounts and initially considered as merely contaminants [129] are 
essential components of surfactant preparations for replacement therapy.  
 
Surfaxin® is one of the synthetics produced by Discovery Co and composed of 
KL4, the lipids DPPC and palmitoyl-oleoyl phosphatidylglycerol (POPG), plus palmitic 
acid (PA) which is well known in the treatment of many lung surfactant deficiency 
illnesses, especially ARDS. It is a humanized surfactant product candidate that is based 
on the proprietary peptide KL4 (also known as sinapultide) designed to precisely mimic 
the essential attributes of human surfactant protein B (SP-B)  
(http://www.discoverylabs.com/abt-disc-stp.htm). 
 
 Table 1.1 shows some examples of surfactant substances from either purified 
natural or synthesis surfactant, which are used in treatment of surfactant deficiency in 
RDS and ARDS. 
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Table 1.1  Surfactants currently undergoing evaluation as therapy for RDS/ARDS [130] 
 
Surfactant Source/ 
composition 
Method of delivery Dosage reported Reference 
Venticute® rSP-C; PL Intratracheal 
instillation 
1 mg rSP-C/kg, 50 
mg PL/kg up to 4 
times 
[131] 
Surfaxin® KL4; PL Airway lavage 10 mg/ml via 
lavage 
[124] 
HL 10 Porcine lung; 
SP-B, SP-C; 
PL 
Intratracheal 
instillation 
100–200 mg PL/kg 
up to 4 times 
[132] 
rSP-C = Recombinant SP-C; PL = phospholipids.  
 
 
 
1.5 Aim of this study 
 
Both SP-C and SP-B play an important role in the physiological function of the lung 
surfactant. They do not only influence the monolayer properties of the film covering the 
liquid interface but also the dynamic qualities, i.e. the reversible insertion and exclusion 
of surfactant material during the breathing process.  
For possible therapeutic administration of synthetic lung surfactants, it is 
important to elucidate the structure-function relationship of these proteins. Therefore 
one aim of this work is to establish the relationship between the structural features of 
SP-B and SP-C, on the one hand, and the biophysical properties of lung surfactant 
model systems containing these peptides, on the other hand. Especially the mechanisms 
of multilayer formation during compression and the relation to intrinsic structural 
attributes of the peptides are to be elucidated.  
To study the role of SP-C, different analogues will be used for the investigation 
of their biophysical properties and of their influence on lipid mixtures consisting of 
1,2-dipalmitoylphosphatidylcholine (DPPC) and 1,2-dipalmitoylphosphatidylglycerol 
(DPPG), the major surfactant phospholipids. Short SP-C fragments with and without 
palmitoyl chains at the cysteine residues are utilized to investigate the role of 
palmitoylation and the influence of the α-helical length on the phase behaviour of 
surfactant monolayers.  
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One of the most interesting SP-B analogues is a short peptide called KL4 which 
will be analysed and compared to its native analogue. Various techniques such as film 
balance, fluorescence light microscopy and scanning force microscopy will be applied 
to elucidate the structure-function relationship addressed in this work. 
In the long term, the findings of this work shall contribute to the understanding 
of the protein induced mechanisms which are pivotal for the functioning of the lung 
surfactant. The results might help developing new potent surfactant mimics, which can 
be used to improve the treatment of lung surfactant deficiency illnesses.  
 
  
 
 
 
Chapter 2 
 
 
Hydrophobic surfactant proteins 
 
 
 
The two hydrophobic surfactant proteins, SP-B and SP-C, are both responsible for the 
rapid adsorption and spreading of vesicular material from the hypophase to the 
monolayer [133-135]. Moreover they influence the order and the phase behavior of 
phospholipids in mono- and bilayers [68,82,136,137].  
 
 In this study several modified peptides of SP-C as well as SP-B have been 
investigated to elucidate the their influences on the biophysical properties of lipid 
monolayers.  
 
 
2.1    Surfactant proteins C 
 
2.1.1 Structure of SP-C 
 
The mature SP-C peptide is a 35–amino acid peptide composed of 69% hydrophobic 
amino acids (ala, ile, leu, phe, trp, val). This could be shown by the analysis of the SP-C 
consensus sequence, derived from the alignment of amino acid sequences from 10 
different mammal species.  
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Figure 2.1 shows the consensus sequences determined by alignment of SP-C 
proproteins from ten mammal species (only bovine, canine, and porcine SP-C mature 
peptide sequences are available). The SP-C proprotein contains a single membrane-
spanning domain (black box). The N-terminal and C-terminal peptides (blue bars) are 
proteolytically cleaved to generate the 35 amino acid, mature, transmembrane peptide 
(yellow bar). Palmitoylation of cysteine residues (red box) occurs in all species [138]. 
 
Figure 2.1  Alignment of SP-C proprotein of different mammal species [138].  
 
The overall hydrophobicity of the peptide is increased by palmitoylation of the 
cysteines at positions 5 and 6 in most species except for canine and mink SP-C, which 
contain a single palmitoylated cysteine at position 6 (figure 2.1, the red box). 
Some SP-C variants (less than 5%) are also palmitoylated on lysine 11 [139]. 
Nonpalmitoylated or deacylated forms of SP-C can form sulfhydryl-dependent dimers 
and amyloid fibrils [140-142]. Therefore, variable palmitoylation (non-, mono-, di and 
tripalmitoylated isoforms) in combination with N-terminal truncation leads to 
considerable microheterogeneity of SP-C [143]. The functional consequences of this 
heterogeneity are not known.  
One of the most remarkable features of SP-C is an extremely hydrophobic 
domain (residues 13–28) in which valine is the predominant amino acid (69%) (figure 
2.1, black box). This domain accounts for one of the original names for this peptide 
part, surfactant proteolipid polyvaline [144].  
The NMR structure of porcine SP-C is consistent with a transmembrane peptide 
in which residues 9–34 form a rigid-helix (figure 2.2) [80]. This structure can span a 
fluid DPPC bilayer in the way that the polyvaline domain is perfectly accommodated in 
the interior acyl chain region of the membrane. The helical nature of the membrane-
spanning domain is promoted by the palmitate moieties on the extramembrane 
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N-terminal region of SP-C, which may interact with an adjacent membrane or, more 
likely, with the same bilayer in which the peptide resides [145]. The transmembrane 
orientation of SP-C is further stabilized by invariant lys-arg residues at positions 11 and 
12 that interact with negatively charged phospholipid headgroups [83].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 a) The sequence of the porcine lipopolypeptide SP-C, with the palmitoylcysteinyl 
residues in positions 5 and 6.  b) The NMR solution structure in a mixed solvent 
of CDCl3/CD3OH/0.1 M HCl 32:64:5 (v/v) at 10 °C [146]. 
 
 
2.1.2  Role of SP-C in surface film formation 
 
Both hydrophobic proteins, SP-B and SP-C, are involved in reducing the surface tension 
as they support a rapid adsorption of phospholipids into the monolayer [133].  This 
leads to the stabilization of the surfactant film [147] and the squeeze-out of fluid 
components [147-148].   
SP-C also aids in the respreading of films from a collapsed phase [149] and in 
the formation of a surface-associated surfactant reservoir (consisting of a region of 
multilamellar stacks attached to the monolayer).   
 
 
a 
b 
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2.1.2.1 Role of the SP-C α-helical part 
 
The α-helical transmembrane domain of SP-C is thought to play an important role in the 
surfactant function [1]. As already mentioned, the α-helix is able to span a lipid bilayer 
with the helical part oriented parallel to the acyl chains [146]. Such an orientation is 
assumed to exist in the multilayer stacks of the surfactant reservoir.  However, in a 
monolayer the tilt angle of the helix is considerably higher (~24˚) allowing a maximum 
contact area with the surrounding lipids. These peptide-lipid interactions could facilitate 
the spreading of lipids over the surface and provide the potential to reach very low 
surface tension [138].   
Furthermore, the relative mobility of the C-terminal region of SP-C may play a 
role in disrupting the packing of acyl chains in a bilayer leading to membrane 
destabilization [146,150]; however, unlike SP-B, SP-C does not appear to promote lipid 
mixing (fusion) [151-152].  
 
 
2.1.2.2  Role of the SP-C palmitoylated part  
 
The palmitoyl chains of SP-C seem to play an important role to assure surfactant 
function during the breathing cycle.  It is assumed that the acyl chains possibly act as an 
anchor for the peptide linking it to the monolayer during the formation of the surfactant 
reservoir.  
Palmitoylation in SP-C may also play an important role in the stabilization of the 
α-helical structure [1]. From a structural point of view it has been reported that the 
palmitoyl groups both increase [84,153-154] and decrease [82,155] the helical content 
of the peptide. This discrepancy was independent of the environment used for analysis 
and might be attributed to the ability of the peptide to undergo a conversion from helical 
to β-sheet conformation [154]. Also differences in the method of depalmitoylation, in 
the SP-C sources (animal species, synthetic SP-Cs) and method of analysis [1] are 
conceivable.  However, the lack of covalently bound palmitoyl groups reduces the 
mechanical stability of the surface film, the spreading of phospholipids from the 
reservoir to the air/liquid interface upon expansion, the compressibility of dynamically 
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cycled films and the surface tension lowering properties [147, 156-158]. This indicates 
that palmitoylation is required for optimal surface activity of SP-C. 
Therefore, different analogues of SP-C with varying length of the α-helix are 
synthesized in order to investigate the effect of the α-helix. A SP-C analogue with the 
first 25 residues (SP-C25+pp) is used and compared with native SP-C. The molecular 
model is shown in figure 2.3b, which was prepared using Hyper-Chem.   
Moreover, non-palmitoylated native SP-C and shorter peptides are used to 
investigate the role of palmitoylation for SP-C function. Therefore, native SP-C without 
acyl chains at both cysteins is synthesized, SP-C34-pp (figure 2.3a). In addition, synthetic 
porcine SP-C with 17 and 13 amino acid residues with and without palmitoylation 
(pSP-C17±pp and pSP-C13±pp) were investigated. To round of this study, a peptide with 13 
residues and a substitution of leucine against tryptophan (pSP-C13L1W) is synthesized 
(figure 2.3c-d). These short peptides of SP-C are suitable to investigate mainly the 
function of palmitoylation and the interaction of the N-terminal part of SP-C with lipid 
monolayers.   
Table 2.1 shows the details of SP-C sequences that will be used in this study. 
Molecular model images prepared by Hyper-Chem of each peptide are shown in figure 
2.3. 
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Figure 2.3  Molecular models of SP-C analogues prepared by Hyper-Chem. (a) Human SP-C 
with 34 residues, (b) human SP-C with 25 residues, (c) porcine SP-C with 17 residues, (d) 
porcine SP-C with 13 residues and (e) the first residue substituted porcine SP-C with 13 
residues. All peptides are shown without palmitoylation at positions 4 and 5 for human and 
positions 5 and 6 for porcine SP-C.  The numbers represent the residue position with the side 
chain structures. The green ribbon shows the backbone structure. The dotted white line in (a) 
represents the hydrogen bond between the residue chains. 
 
a 
b c 
d e 
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Table 2.1  Sequence of SP-Cs that are used in this study.  
Source Name 
Mw. (with/without 
palmitoylation) 
Sequence 
rHuman SP-C35+pp 4172.35 
F-G-I-P-C-C-P-V-H-L-K-R-L-L-I-V-V-V-V-V-V-
L-I-V-V-V-I-V-G-A-L-L-M-G-L 
Pig pSP-C35+pp 4186.37 
L-R-I-P-C-C-P-V-N-L-K-R-L-L-V-V-V-V-V-V-V-
L-V-V-V-V-I-V-G-A-L-L-M-G-L 
rHuman SP-C34-pp 3548.67 
G-I-P-C-C-P-V-H-L-K-R-L-L-I-V-V-V-V-V-V-L-I-
V-V-V-I-V-G-A-L-L-M-G-L 
rHuman SP-C25+pp 3157.02 
G-I-P-C-C-P-V-H-L-K-R-L-L-I-V-V-V-V-V-V-L-I-
V-V-V 
Pig pSP-C17± pp 2412.0/1935.5 L-R-I-P-C-C-P-V-N-L-K-R-L-L-V-V-V 
Pig pSP-C13± pp 2001.4/1524.9 L-R-I-P-C-C-P-V-N-L-K-R-L 
Pig pSP-C13L1W 1598.0 W-R-I-P-C-C-P-V-N-L-K-R-L 
   F-G: The underline emphasizes the amino acids that are different for each species.  
   C-C: Bold letters show the palmitoylated residues. 
     r /p: The indexes “r ” or “p ” are used for either recombinant or porcine SP-C. 
   
± pp: The indexes  “+pp” or “– pp ” are used for dipalmitoylated or nonpalmitoylated peptides, respectively. 
 
 
2.2   Surfactant protein B 
 
 SP-B is a peripheral homodimer of approximately 17 kDa.  Secondary structure 
analysis and homology modelling with related proteins, especially members of the 
saposin-like family predict an SP-B structure, which contains four amphipathic 
α-helices (figure 2.4).  These helices are thought to interact with the surfactant lipids 
with a specific interaction between anionic lipids and the positive charges of SP-B 
[159]. 
 
 
 
 
 
Figure 2.4    Model of the SP-B structure [78]. 
a-helix 
b-sheet 
positively charged residue 
negatively charged residue
aromatic residue 
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 2.2.1  Role of SP-B in surface film formation 
 
The most important property of SP-B is to modulate the biophysical properties of 
surfactant lipids. A rapid insertion of phospholipids into the air/liquid interface is 
obligatory for the maintenance of alveoli integrity. SP-B greatly enhances the formation 
of a stable surface film by inducing the insertion of phospholipids into the monolayer 
[58,133-134,160] -especially that of DPPC [133,147].  
Although the orientation of SP-B within a lipid membrane is not clear, today 
most evidence supports a model in which the polar parts of the amphipathic helices 
interact with phospholipid head groups. The highly conserved positively charged amino 
acids interact specifically with the anionic phospholipids such as phosphatidylglycerol 
[100,151] in order to enhance phospholipid adsorption [161-162]. 
Furthermore, SP-B may play a role in the intracellular assembly of surfactant, 
namely in lamellar body organogenesis, the structural rearrangement of secreted 
surfactant lipids into tubular myelin, and the subsequent rapid insertion of secreted 
surfactant phospholipids into the surface film itself [77]. 
Experiments with positively charged peptides resembling fragments of SP-B 
showed an increase of collapse pressure of palmitic acid up to 70 mN m-1 [163]. At a 
surface pressure higher than 40-45 mN m-1, SP-B is squeezed out of the monolayer, 
together with two or three phospholipid molecules per SP-B dimer [94]. Later, during 
expansion, a new cycle is started by SP-B-catalyzed insertion of phospholipids into the 
monolayer. During this process, part of the SP-B may be degraded as was shown in 
vitro by continuous alteration of the surface area [164]. 
  In addition, SP-B is the only surfactant-associated protein absolutely required 
for postnatal lung function survival.  A study by Weaver and Conkright (2001) [138] 
shows that complete deficiency of SP-B in mice and humans results in lethal respiratory 
distress syndrome.   
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2.2.2 KL4 as a mimic of SP-B  
 
Materials reconstituted with synthetic phospholipids and the hydrophobic protein SP-B 
appear to impart full biophysical properties akin to those of lung surfactant [165]. 
Studies of different fragments and mutants of SP-B suggest its positive charges with 
intermittent hydrophobic domains as the function-related structural and compositional 
characteristics in SP-B [163].  
Therefore a synthetic 21 amino acid peptide containing the hydrophobic amino 
acids leucine (L) and lysine (K), in the sequence (KL4)4K is an ideal mimic of SP-B. 
Figure 2.5 shows the molecular model of KL4 prepared by Hyper-Chem. The top view 
of KL4 depicts the α-helix with five lysines pointing into the environment whereas the 
side view displays the location of 5 positive charges belonging to the lysine residues. 
There are some studies concerning KL4 investigating its function in lipid 
bilayers [166]. KL4 also modulates monolayer properties of DPPC:PG systems, similar 
to the effect of SP-B [3].   
Cochrane et al., 1996 [167] and Revak et al., 1996 [115] reported that this 
peptide, when mixed with 1,2-dipalmitoylphosphatidylcholine:1-palmitoyl-2-
oleoylphosphatidyl –glycerol:palmitic acid (DPPC:POPG:PA), acts as an artificial lung 
surfactant.  It was proven to be effective in the clinical treatment of animal and human 
RDS.  Obviously this peptide behaves very similarly to SP-B in providing a simple 
substitute for SP-B in reconstituted surfactant systems [3]. 
The study of the surface properties of a pure peptide and a mixture of peptide 
with major surfactant lipids should facilitate our understanding of the role of the peptide 
in this system and provide a better mechanistic model of lung surfactant structure and 
function in general. The previous studies [168-169] proposed that KL4 mimics the 
actions of SP-B where the lysine residues are suggested to interact with the polar 
headgroups [168].  The infrared reflection-absorption spectroscopy (IRRAS) showed 
that the peptide is oriented preferentially parallel to the aqueous surface [169]. In 
contrast, Gustafsson et al.,1996  [166] evaluated both secondary structure and peptide 
orientation in bulk phase with circular dichroism spectroscopy (CD) and attenuated total 
reflection fourier transform infrared spectroscopy (ATR-FTIR) measurements and 
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suggested that KL4 forms a helix oriented parallel to the lipid acyl chains.  
Therefore the question of molecular orientation of KL4 still remains to be elucidated.  
 
 
 
 
 
 
  
 
 
 
 
Figure 2.5   KL4 molecule, in top- and side-view (prepared using HyperChem).  
 
 
2.3 Protein isolation and peptide synthesis  
 
The native peptide used in this study originates from pig lung lavage. All modified 
SP-C peptides are obtained synthetically and vary in the N-terminal palmitoylation. KL4 
was also prepared by solid phase peptide synthesis. 
 
 
2.3.1 The isolation of native hydrophobic surfactants 
 
This method is a modified form of the butanol-extraction from Haagsman et al., [170] 
combined with Fast Performance Liquid Chromatography (FPLC). All details are 
published in the work of Breitenstein, D., 2004 [171]. In brief the processes are  
 
1) 150 mM NaCl was used to extract the lung surfactant from fresh pig lung. The 
lung lavage was obtained using a vacuum pump.  
+ 
+ 
+ 
+ 
+ 
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2) The lavage was centrifuged at 500 x g, 4 ºC for 5 min. At this step the red pellet 
of erythrocytes and other cell materials was separated. The centrifugation step 
was repeated three times with the supernatant under the same conditions. 
3) The last supernatant was centrifuged at a higher speed (17000 x g, 4 ºC) for 90 
min. The lamellar bodies, tubular myelin and surfactant proteins (SP-A, SP-B, 
SP-C) as well as lipids were precipitated in this step.  
4) The pellet from the previous step was suspended with a little amount of pure 
water and kept at -20 ºC. 
5) For the extraction of surfactant protein, the pellet suspension was mixed with 
butanol (30 x of the suspension volume) and stirred slowly for 90 min. 
6) The butanol extraction was centrifuged at 17000 x g, 4 ºC for 90 min in order to 
remove SP-A from this extraction.  After that the supernatant contained only 
hydrophobic surfactant constituents. This supernatant is also called 
“hydrophobic extract”. 
7) The hydrophobic extract was dried in a rotating evaporator at maximum 40 ºC 
and 35 mbar. 
8) To extract the hydrophobic surfactant proteins, SP-B and SP-C, gel filtration 
chromatography was used with Sephadex LH-60 as a stationary phase and 
chloroform:methanol: 0.1 N HCl  with a ratio of 1:1:0.05 (v/v/v) as a mobile 
phase. 
9) The different fractions were eluted. The first fraction contained SP-B, the second 
a dimeric form of SP-C, the third the monomeric form of SP-C and the last is the 
lipid fraction (~9 hours after running the elute solution). 
10) The solvent was evaporated by using a rotating evaporator and then the dry 
fraction was dissolved in chloroform/methanol (50:50, v/v).  
 
The fractions were analyzed qualitatively by using sodiumdodecylsulfate 
polyacrylamide gelelectrophoresis (SDS-PAGE), matrix assisted laser 
desorption/ionization mass spectrometry (MALDI-MS), electrospray ionization 
mass spectrometry (ESI-MS) and Edman amino acid sequencing.  
 
 
 
Peptide synthesis 32
2.3.2 Peptide synthesis  
 
For this study SP-C34-pp and SP-C25+pp were kindly provided by Byk-Gulden 
Pharmaceuticals (Konstanz, Germany). pSP-C17+pp, pSP-C17-pp and KL4 are a generous 
gift from Prof. R. Mendelsohn, Rutgers University, New Jersey, USA. pSP-C13+pp, 
pSP-C13-pp and pSP-C13L1W were kindly provided by Prof. J. Perez-Gil, Madrid, Spain. 
The synthesis of the peptides is based on the solid phase peptide synthesis. 
 
Fmoc chemical-solid phase peptide synthesis 
Peptides are synthesized utilizing 9-fluorenylmethoxycarbonyl (Fmoc) as a C-terminal 
carboxamide and using an automated multiple peptide synthesizer AMS 422 (Abimed, 
Langelfeld, Switzerland) [172]. 
 
General method: The peptide synthesizer combines the Fmoc chemistry with PyBop as 
an activating agent to perform solid-phase peptide synthesis. The synthesis starts with 
the C-terminal amino acid. Amino acids are then added one at a time until the 
N-terminus is reached. Three steps are repeated each time by adding a different amino 
acid: 
(1) Deprotection of the N-terminal amino acid of the peptide bound to the resin. 
(2) Activation and addition of the next amino acid.  
(3) Deprotection of the new N-terminal amino acid.  
A diagram of these basic steps of solid phase peptide synthesis using Fmoc 
Chemistry is shown in figure 2.6. 
There are wash steps between each process. The synthesizer is capable of 
monitoring the deprotection and coupling steps.  
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Figure 2.6  Diagram of the basic steps in solid phase peptide synthesis using Fmoc Chemistry. 
The number indicates each step during the synthesis process as described in detail in the text. 
(http://www.biochem.mcw.edu/protein_facility/peptide_synthesis.html) 
 
(1) (2) 
(3) 
(4) 
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2.3.2.1 Synthesis of SP-C peptides 
 
The synthesized SP-C peptides used in this study were synthesized as described in 
Plasencia et al., 2001 [172]. Rink amide-methylbenzhydrylamine (MBHA) resin was 
used as polymeric support (0.4 mmol x g-1). Fivefold excess of amino acid derivatives 
were added at the coupling steps. The side chain protecting groups were tert-
butyloxycarbonyl (BOC) for Trp, 2,2,5,7,8-penthamethyl chroman-6 sulfonyl (PMC) 
for Arg and acetamidomethyl (ACM) and trityl (TRT) for protected and free cysteines, 
respectively.  
 
Post-synthesis procedures and quality control: At the end of the synthesis the 
protected peptides and the resin are collected. The next step is to cleave the peptide 
from the resin and to remove the side-chain protection groups from the peptide as 
defined in figure 2.6 at step (4). Both cleavage and deprotection are carried out in the 
mixture trifluoroacetic acid (TFA)/ H2O/ thioanisole/ phenol/ ethanedithiol (EDT) with 
a ratio of  
82.5:5:5:5:2.5. Afterwards, they were precipitated and washed by cold ether, and 
lyophilized.  
 
Peptide modifications (acylation) [173]: In order to add palmitic acid chains at 
cysteine residues, the cysteine side chains were originally protected with ACM groups. 
After chain assembly, the ACM groups were selectively released from the peptide resin 
by treatment with 0.1 M mercuric acetate in dimethyl formamide (DMF) for 3 hours; 
the peptide resin was treated with 10% (by volume) 2-mercaptoethanol in DMF 
overnight and thoroughly washed with DMF. Palmitic acid (16 equiv, 8 per thiol group) 
was dissolved in methylene chloride (+ca. 1% DMF) to give a buttery foam that reacted 
with the peptide resin in the presence of O-(benzotriazol-1-yl)-N,N,N´-tert-
tetramethyluronium tetrafluoroborate (TBTU) (16 equiv) and diisopropylethylamine 
(DIEA) (32 equiv) for 4 hours at 25 °C, after which an Ellman test of a resin aliquot was 
negative. The bis-palmitoylated peptide resin was next treated with a mixture of TFA/ 
H2O/ thioanisole/ phenol/ EDT as mentioned before in cleavage and deprotection steps. 
The purity of the peptide is further monitored by MALDI-TOF mass 
spectrometry analysis and N-terminal Edman amino acid sequencing. Quantitation of 
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free thiol groups in the peptides was achieved by reaction with dithio-bis-nitrobenzoic 
acid (DTNB) [174]. 
 
 
2.3.2.2 Synthesis and purification of KL4 
 
A prederivatized Fmoc-Wang resin (Applied Biosystems-Perkin Elmer) was used for 
KL4 synthesis [175]. After cleavage from the resin and single-pass purification with 
reverse-phase HPLC, the molecular mass of the reduced monomer was confirmed by 
electrospray mass spectrometry (UCLA Center for Molecular and Medical Sciences). 
The product was twice lyophilized from acetonitrile: 10 mM HCl (1:1, v/v) to remove 
acetate counter ions. The peptide was then oxidized with EKATHOX resin (Ekagen, 
Palo Alto, CA) through the addition of a 10-fold molar excess of resin-active groups to 
1 mM B-peptide thiol in trifluoroethanol: water (8:2, v/v) for 6 hours, followed by 
removal of the resin from the peptide solution by centrifugation (1,000 × g for 10 min) 
and the mass of monomeric oxidized peptide was confirmed by matrix-assisted laser 
desorption-ionization time-of-flight (MALDI-TOF) mass spectrometry (UCLA Center 
for Molecular and Medical Sciences) [176]. 
 
 
2.4 Determination of concentration of peptide using the fluorescamine 
test  
Total protein content determination is a measurement common to many applications in 
basic science and clinical research. Several fluorescent assays for protein quantification 
have been developed in an attempt to alleviate the difficulties presented when using 
absorbance based assays. One such fluorescence-based assay, first described by 
Udenfriend [177], is based on the rapid reaction of fluorescamine (4-phenyl-spiro 
[furan-2(3H),1'-phthalan]-3,3'-dione) with proteins. The non-fluorescent compound, 
fluorescamine, reacts rapidly and stoichiometrically with amino acids, peptides, and 
proteins to yield highly fluorescent derivatives (Figure 2.6). 
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Figure 2.6  Reaction of fluorescamine and primary amino groups. Fluorescamine reacts with 
the primary amino groups found in terminal amino acids and the ε-amine of lysine to form 
fluorescent pyrrolinone type moieties. 
 
Materials and Methods 
Fluorescamine, Bovine Serum Albumin (BSA) protein standard, phosphate buffered 
saline (PBS) and acetone (HPLC grade) were obtained from Sigma Chemical Company 
(St. Louis,MO).  
The protein assay was performed according to Udenfriend et al., 1972 [177]. A 
standard series of dilutions of BSA from 0, 0.1, 0.2 and 0.4 mg BSA/ml were made 
using 0.05 M PBS pH 8.9 as the diluent. After dilution, 50 µl aliquots of standards were 
pipetted into reagent glass tubes in replicates of three. Samples with a concentration of 
approximately 5-10 µg/ml were pipetted into reagent glass tubes and afterwards, all 
solvents were evaporated with N2 gas (~15-30 min). After that, sample and standard 
tubes were added with 100 µl of 10 % (w/v) SDS and boiled in a water bath for 5 min.  
After cooling down, 1.5 ml of 0.05 M PBS pH 8.9 and 1.45 ml of the same PBS were 
pipetted in the standard tubes.  Each tube was supplied by fresh prepared fluorescamine 
solution (3 mg of fluorescamine solutes in 10 ml of Acetone) for 0.5 ml and well mixed 
for 1 min. The fluorescence was then determined using a LS 2b Perkin Elmer 
fluorescence spectrometer (Wellesley, Ma, USA) with a wavelength of 366 nm, 2.5 nm 
bandwidth excitation filter and a wavelength of 475 nm, 10 nm bandwidth emission 
filter.  
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Biophysical properties study of 
SP-C variants 
 
 
 
The effects of truncated SP-C peptides in a phospholipid mixture, which mimics the 
native lung surfactant composition, were investigated by various in vitro techniques 
such as film balance, fluorescence microscopy and scanning force microscopy.  These 
techniques, which are commonly used in surface science, are modified to suit them for 
application to the lung surfactant system [178] in order to study the biophysical surface 
properties of surfactants also under dynamic conditions. The in vitro measurements will 
be used to understand the in vivo pulmonary system. 
 
 
3.1   Phase behavior of truncated SP-C at the air/water interface 
 
To determine the thermodynamic phase behavior of phospholipids and truncated 
peptides at the air/water interface film balance measurements were performed.  This 
technique has proven to be of large value to characterize lipid monolayer properties and 
has extensively been used to study lung surfactant films at the air/water interface. 
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3.1.1 The Wilhelmy film balance  
 
An approach to measure the surface tension is the determination of the force on a plate 
that is partially immersed in the subphase. This technique is based on the work of 
Ludwig Ferdinand Wilhelmy in 1863 on fluid-covered solids [179].  Later, in 1891, 
Agnes Pockels published the first pressure–area isotherm [180] and in the second 
decade of the last century Irving Langmuir improved this technique [181] [182]. 
Together with Katharine Blodgett, Langmuir further developed a technique for 
transferring a monolayer film on a solid support [183] (for details see section 3.3.2).  
The application of a Langmuir-Wilhelmy film balance for the investigation of lung 
surfactant films was first introduced by the pioneering work of Clements in 1957 [184].   
 
The advantage of the Wilhelmy method is the absolute measurement of the 
surface tension whereas the original film balance developed by Langmuir is a 
differential one. The physical principles of a Wilhelmy system are shown in figure 
3.1.1. 
 
 
 
 
 
 
 
Figure 3.1.1  Schemes showing forces acting on a Wilhelmy plate: a front view, b side 
view [185]. 
 
The overall forces acting on the plate consist of differently directed forces. The 
downward forces are the gravity of the plate and the surface tension of the liquid. The 
buoyancy due to displaced water leads to an upward oriented force. For a rectangular 
plate of dimensions l, w and t and a material of density ρp, immersed to a depth h in a 
liquid of density ρl, the net downward force F is given by 
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F = ρp glwt + 2γ (t + w) cos θ − ρl gtwh,                                 (3.1) 
 
where γ is the surface tension of the liquid, θ is the contact angle of the solid plate and g 
is the gravitational constant. During the usual procedure for the use of a Wilhelmy 
balance the plate has to be kept completely wetted by the liquid.  Either the change in h 
for a constant applied force or the change in F for a stationary plate, when the surface 
tension is altered, is measured.  In this work the latter method was used. The change in 
force ∆F is related to the change in surface tension ∆γ by the equation 
 
 w)+ 2(t
F∆
=∆γ                                                      (3.2) 
 
The Wilhelmy film balance allows the compression of monolayers under 
constant speed to a target surface pressure and also allows the monolayer film to be held 
at constant surface pressure, while the area is adjusted. 
Here, the area of the surface film is changed by mechanically moving the 
barriers and the surface pressure is monitored.  The surface pressure (π) is defined  by  
γ0 – γ, where γ0 is the surface tension of the clean surface and γ is the surface tension of 
a surface with a surfactant. π is thus the amount by which the surfactant lowers surface 
tension.  This instrument is based on the principle of Rayleigh’s equation: 
 
π A = constant                                                     (3.3) 
 
where A is the area of the film. Thus, as the area is decreased the film pressure rises and 
these changes are noted on compression of the monolayer. 
The main disadvantage of the Wilhelmy balance concerns the contact angle of 
the liquid and the plate. This angle has to be known and to remain constant during an 
experiment, which might not be easy to ensure while monolayers can deposit onto the 
plate under increasing surface pressure. This may cause a change in the value of θ. 
 In this work a Wilhelmy system with filter papers was used. The film balance 
consists of a Teflon trough, which was filled with a subphase, a moveable Teflon barrier 
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and a sensor with a Wilhelmy plate to determine the surface pressure. Figure 3.1.2 
shows a schematic draw of the film balance. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.2  Schematic draw of a Langmuir film balance with a Wilhelmy plate as 
pressure sensor, which was used in this work [185]. 
 
 
3.1.2 Isotherm 
 
Physical properties of gases can be described by isotherms. The pressure inside a 
specific volume of gas depends on the amount of gaseous molecules, the temperature 
and the size of the volume. This behavior is given by the equation of an ideal gas 
 
pVm = RT                                                      (3.4) 
 
where p is the pressure, Vm the molecular volume, R the gas constant and T the absolute 
temperature. Real gases have a slightly different behavior because of intermolecular 
forces described by 2mVa and the eigenvolume of the molecules b. This is described by 
the van-der-Waals equation 
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In a two-dimensional system surface active substances at the air/water interface 
behave like a real gas. The lateral pressure can be identified as the two-dimensional 
pressure of a gas-like substance and the area per molecule corresponds to the 
eigenvolume of gas molecules. Therefore pressure–area isotherms describe the physical 
behavior of surface active substances and give information about the lateral pressure at 
a specific area per molecule and temperature.  
 
 
Figure 3.1.3   Compression isotherm of dipalmitoyl-sn-glycero-phosphatidylcholine 
(DPPC) at 20°C.  The insets show the orientation of the acyl chains at different lateral 
pressures. 
 
The lung surfactant contains a large amount of lipids especially phospholipids 
that have been extensively studied in the past with the film balance technique. These 
phospholipids are surface active molecules and automatically form monolayers at the 
air/water interface if the lipids are dissolved in a volatile organic solvent and spread 
onto a water surface. The organic solvent evaporates and the headgroups of the lipids 
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orient to the water subphase due to their hydrophilicity, whereas the apolar fatty acid 
chains orient to the air due to their hydrophobicity. An isotherm for dipalmitoyl-sn-
glycero-phosphatidylcholine (DPPC) is presented in figure 3.1.3. 
 
Compression and expansion of a spread monolayer are different processes. 
During compression the molecules start to interact and undergo a phase transition from 
a gas-like to a liquid expanded or fluid phase (le phase). In the gas-like phase there is no 
lateral adhesion and some of the hydrocarbon chains lay on the water subphase with the 
phase transition to the le phase (fluid phase see figure 3.1.3) the unoriented hydrophobic 
tails begin to orient completely to the air. Upon further compression the area per 
molecule is reduced and the molecules get in contact with each other. This leads to an 
increase of the lateral surface pressure. The molecules loose degrees of freedom and not 
all possible gauche-conformations in the alkyl chains are occupied. Compression to 
smaller molecular areas causes the carbon chains to orient in a nearly parallel manner, 
which is called liquid crystalline or gel phase (lc phase, see figure 3.1.3).  
 
In phospholipid isotherms, the le-lc transition region (plateau region between le 
phase and lc phase as shown in figure 3.1.3) is called main transition [186].  Further 
compression leads to a phase transition into a solid or crystalline phase (s phase, see 
figure 3.1.3), in which the molecules are closely packed and uniformly oriented. The 
hydrophobic cores of the molecules interact by hydrophobic and van-der-Waals forces, 
whereas hydrogen bonds and Coulomb forces occur between the hydrophilic 
headgroups. If further pressure is applied to the monolayer, it collapses due to 
mechanical instability. 
 
During expansion of a monolayer from a given physical state the forces acting 
inside the monolayer (binding and repulsing forces) do not appear consequently in the 
reverse order of their appearance during compression. This leads to a different isotherm, 
which shows an equal or lower surface pressure at a given area per molecule. A cycle of 
compression and expansion, however, starts and ends at the same surface pressure of 0 
mN m−1 in the gas-like phase of the monolayer. Along an isotherm the integral of the 
surface pressure π over the area determines the work that has to be performed, whereas 
the integral of π over the area during an expansion determines the energy that becomes 
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∆πp 
∂A 
∂π 
available from the system. If the energy during compression is higher than that during 
expansion, the difference between compression and expansion isotherms can be 
explained by loosing material to the subphase or with strong interactions of amphiphilic 
molecules in the solid state.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.4  Compression isotherm of pSP-C35+pp on water, pH 5.6 at 20°C.  Tangential method 
to determine limiting area (A0), at the beginning molecular area (Ap1) and the end of the first 
plateau (Ap2), length of the plateau region (Lp) and differential surface pressure (Pp2-Pp1) of the 
first plateau region (∆πp). ∂A and ∂π are according to equation 3.6. 
 
 
Limiting area per residue (A0) 
 
Each phase transition is generally characterized by a plateau region and a pressure 
increase when the phase transition in the monolayer is completed. In the case of the g/le 
phase transition that occurs at a surface pressure of 0 mN m-1 only the pressure increase 
is discernible in the isotherm. The molecular area characterizing this “lift-off” of the 
isotherm is termed limiting area per residue (A0) and describes the characteristic area for 
a given molecule at which intermolecular interactions leading to a pressure increase 
occur.   
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The interception of a tangential to the isotherm at the point of highest curvature 
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, point of inflection) with the x-axis gives the onset area A0 of a lipid or 
peptide monolayer as shown in figure 3.1.4. 
 
 
Plateau length (Lp) 
 
The co-existence of two phases (e.g. le and lc phase) or conformational changes in a 
peptide monolayer appear as a plateau region in the isotherm. These two different 
phases exist at the same lateral pressure below the critical point of the surface active 
material. Two different onset areas can be determined. The beginning of the “plateau” is 
given by the molecular area Ap1 and the end point molecular area by Ap2.  The “length” 
(Lp) of the plateau region can be defined as the difference in molecular area between Ap1 
and Ap2. The method of using tangents at the point of inflection at the beginning and at 
the end of a plateau region allows to determine the onset and the offset area as 
interception with the abscissa as well as ∆πp in the case of a non-horizontal plateau (see 
figure 3.1.4). 
 
 
Compressibility 
 
The film compressibility (β) is a property, which denotes the inverse of the slope of an 
isotherm. The isothermal compressibility shows the change in area with the lateral 
pressure at a constant temperature.  β0 can be calculated by 
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                                              (3.6) 
 
On the other hand compression isotherms to describe a behavior of peptide and 
phospholipid monolayers can also be fitted following Fukushima et al. [187] by using 
the semi-empirical equation  
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π (A − A0)(1 − kπ) = kT                                            (3.7) 
 
where k is the compressibility, which describes the behavior of peptide and 
phospholipid monolayers in a compressed state [188]. 
The compressibility is a useful parameter to describe the elastic properties of 
surface active agents such as the lung surfactant system and is used in this work as a 
qualitative parameter to compare the influence of different peptides on the phase 
behavior of phospholipid mixtures.  
 
 
Hysteresis effects 
 
Hysteresis is a property of systems (usually physical systems) that do not instantly 
follow the forces applied to them, but react slowly, or do not return completely to their 
original state, that is systems whose states depend on their immediate history [website: 
Wikipedia].  Therefore when the film is compressed, energy is applied to and, stored in 
the system.  Due to a continuous movement of the barrier the monolayers are usually 
not in thermal equilibrium and undesirable effects on the lateral pressure can occur. One 
of these effects is the discrepancy between compression and expansion isotherms of the 
same monolayer. These effects are described as hysteresis effects [185]. 
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3.1.3 Preparation of monolayers at the air/water interface 
 
Concentration of lipid solutions 
i. Phosphate test 
A standard technique to quantify the concentration of lipid solutions is the 
determination of the amount of phosphorus in phospholipid samples by using a reaction 
of ammoniummolydate producing phosphomolybdate, a blue colored-compound [189].  
The error of this method is approximately 5%.  All samples are triple trials. 
 
Procedure (related to Chen et al. 1956 [190] and Rouser et al. 1966 [189]):  
 
1. The samples are filled in new clean reagent tubes. The amount of phosphorous 
should be approximately 1 µg or 33 nmol. The organic solvent is evaporated 
with N2 gas and heating at 50°C. 
2. A calibration curve is pipetted in a range of 0 to 65 nmol of phosphorus by using 
a 1M sodium dihydrogen phosphate solution.  
3. To all samples (including calibration samples) 300 µl of concentrated perchloric 
acid (70% HClO4) are added 
4. The samples are incinerated at 200°C in a heating block for 2 hours. 
5. After the samples are cooled down to room temperature, each sample is 
provided with 700 µl of reagent A (containing 2.232 g ammonium molybdate 
(VI) ⋅ 4 H2O in 89 ml HClO4 (70%) and 411 ml H2O) and 700 µl of reagent B 
(containing 8.929 g ascorbic acid in 500 ml H2O) and carefully vortexed. 
6. The samples are incubated in a water bath at 95 °C for 5 min. 
7. After cooling down to room temperature, the samples are measured in a 
photometer at wavelength of 820 nm. 
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ii. Controlling the concentration of lipid solutions by Langmuir film 
balance measurements 
 
The concentration of lipid solutions is regularly verified on a Langmuir film balance. In 
the solid phase the shape of lipids can be approximated as rod-like with the diameter of 
the headgroup as the rod’s diameter. Therefore every headgroup has an area demand in 
a monolayer, which is given by the base of a rod. The area of the headgroup is a specific 
parameter depending on the lateral surface pressure of a monolayer and can be used to 
determine the amount of lipids in a monolayer if the total area covered by a lipid film is 
known. 
The molecular area of dipalmitoyl-sn-glycero-phosphatidylcholine (DPPC) at a 
lateral pressure of 20 mNm−1 is about 46 Å2 (on a water subphase1), whereas the 
headgroups of dipalmitoyl-sn-glycero-phosphatidylglycerol (DPPG) occupy an area of 
about 42 Å2. The concentrations of lipid solutions can be calculated from pressure–area 
isotherms and are compared with standard isotherms of well-defined lipid solutions. 
These standard isotherms were measured at 20 °C on pure water (MilliQ quality) as 
subphase to avoid the influence of subphase ions.  
 
 
Preparation of lipid/peptide solutions 
All lipid and peptides were dissolved in chloroform/methanol mixtures in a 1:1 ratio 
(v/v).  The lipid/peptide mixtures were prepared by using HamiltonTM syringes to get 
well-defined volumes of the pure lipid/peptide solutions and mixing them to a defined 
molar ratio. In this work the molar ratio of the lipid mixture was 4:1 for DPPC:DPPG. 
The lipid solutions were stored at −20 °C and were stable for months. 
 
 
 
 
 
                                                
1
The subphase influences the area of a headgroup because different ions interact with the headgroups to 
form a closer or a less closer package of lipids at the air/water interface. 
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Cleaning the film balance 
 
Lipids and lung surfactant peptides have a high surface activity. Therefore the trough 
has to be thoroughly cleaned. To remove surface active substances the detergent 
MucasolTM was used in a 0.5% aqueous solution (v/v). The trough was incubated with 
MucasolTM for 15 minutes, afterwards the detergent was removed by using a vacuum 
pump. Three times washing with pure water was followed by removing all residues of 
MucasolTM with filter paper. Subsequently the trough was rinsed twice with water. A 
kimwipe, saturated with dichloromethane, was used to wipe out the trough before it was 
purged five times with pure water. The trough was then filled with a selected subphase, 
in this case pure water. 
 
 
Isotherm measuring 
 
The isotherms were measured on a Langmuir film balance developed by Riegler & 
Kirstein, Berlin. A filter paper was cut to a length of nearly 1 cm and a width of 
approximately 2 mm. The trough with an area of 144 cm2 was filled with 75 ml pure 
water (Milli-Q quality, pH 5.6) and the filter paper was equilibrated in water for half an 
hour. The lipid solution was spread onto the surface in a way that the pressure was less 
than 0.5 mN m-1. This gave the certainty that the lipids were in the liquid expanded 
phase. After ten minutes the solvent was evaporated completely and the measurement 
was started. The barrier was moved with a speed of 5.81 cm2min−1.  The lipid films 
were compressed until a surface pressure of 50-55 mN m-1 was reached or the barrier 
came nearest to the filter paper and immediately expanded to get the expansion 
isotherm. These cycles of compression and expansion were repeated three times without 
any time to equilibrate between compression and expansion and vice versa. 
Lipid/peptide mixtures were measured with different types and increasing amount of 
peptides. 
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3.1.4 Film balance measurements of pure peptides 
 
The compression and expansion isotherm cycles of pure surfactant protein and the 
truncated peptides were investigated on a pure water subphase (Milli-Q quality) pH 5.6 
at 20°C.  The preparation of those monolayers was described in section 3.1.3.  The 
direction of the film balance barrier was immediately inverted when the monolayer 
reached the highest surface pressure of each peptide film. The barrier was operated with 
constant velocity (5.98 cm2/min).  
 
 
3.1.4.1  Isotherm of SP-C native  
 
The compression and expansion isotherms of human recombinant SP-C (SP-C35+pp) have 
been investigated before in a previous PhD-thesis [191] as shown in figure 3.1.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.5  Compression and expansion isotherms of the recombinant human SP-C 
(SP-C35+pp) on pure water (pH 5.6) at 20°C. The compression and expansion cycles were 
repeated three times.  There was no time lag between a compression and an expansion isotherm. 
The 1st, 2nd and 3rd compression/expansion cycles are shown in solid, dashed and dotted lines, 
respectively (modified from [191]). 
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The SP-C35+pp isotherm shows a limiting area A0 of 800 Å2 and displays a 
plateau region between 400 and 600 Å2 with a surface pressure of ~ 26 mN m-1.  In 
addition, a slight shoulder appears in the isotherm at a surface pressure of 35 mN m-1.  
The monolayer was compressed up to a surface pressure of 40 mNm-1 and then 
immediately expanded by inverting the direction of the barrier. As can be seen in figure 
3.1.5, the compression and expansion isotherms are not superimposable.  During 
expansion a second plateau region appears at ~26 mNm-1 and the limiting area A0 is 780 
Å2.  The 2nd and 3rd cycles of compression and expansion are nearly the same as the first 
cycle. They show the same plateau regions as well as identical surface pressures.  It can 
be concluded that there is no substantial material loss into the subphase.  The 
compressibility of the 2nd and 3rd cycle in the region between 600 and 800 Å2 is a little 
lower than in the first one; 2nd and 3rd 
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.  The onset points of the 
pressure increase of these two cycles are also displaced to lower molecular areas.  This 
might be due to a better arrangement of peptide molecules after the first cycle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.6  Compression isotherm of the porcine SP-C (pSP-C35+pp) on pure water (pH 5.6) at 
20°C (modified from [192-193]). 
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Human recombinant SP-C shows a similar phase behavior as the corresponding 
protein from porcine lung (pSP-C35+pp).  The compression isotherm of pSP-C35+pp is 
shown in figure 3.1.6.  
The isotherm shows a plateau region with the same length (~200 Å2) and the 
same surface pressure (~28 mNm-1) but with a slight shoulder appearing at a surface 
pressure of 38 mNm-1. The limiting area A0, however, is shifted to a larger molecular 
area of 1000 Å2 compared to SP-C35+pp (800 Å2). This might be due to the difference in 
the amino acid sequence of the two peptides. The sequence of pSP-C35+pp with 35 amino 
acids is LRIPCCPVNLKRLLVVVVVVVLVVVVIVGALLMGL whereas the one for 
SP-C35+pp is GIPCCPVHLKRLLIVVVVVVLIVVVIVGALLMGL (differences are 
underlined).  Even though the molecular area is different they show identical phase 
behavior and therefore display the same monolayer characteristics. pSP-C35+pp can hence 
be used as reference for the native peptide in further experiments. 
 
 
3.1.4.2 Isotherm of SP-C 34-pp  
 
Recombinant human SP-C has been modified to be non-palmitoylated at the cysteines 
in position 3 and 4 (SP-C34-pp).  Its compression-expansion isotherm with 2 cycles is 
shown in figure 3.1.7. 
SP-C34-pp has a limiting area, which is significantly lower than the one for 
SP-C35+pp (720 Å2 instead of 800 Å2).  It also has a plateau at a surface pressure of 24 
mN m-1 and a shoulder at 36 mN m-1.  The length of the plateau region is also shorter by 
around 100 Å2 (from ~520-420 Å2). Since SP-C34-pp has no palmitoylated residues its 
molecular weight is less.  This might explain the slightly lower phase transition pressure 
and the shorter plateau region.  Due to the lack of two palmitic acid chains the peptide 
itself needs less space. Therefore the onset point of the pressure increase is shifted to 
significantly lower areas and shows a lower compressibility in this region than 
SP-C35+pp.  
The hysteresis of this peptide is small. The second cycle of compression and 
expansion isotherm is almost identical to the 1st cycle.  Only the limiting area is a bit 
smaller (700 Å2 in the 2nd cycle instead of 730 Å2 in the 1st cycle) because of a slightly 
better arrangement of the peptide in the following cycle. 
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Figure 3.1.7  Compression and expansion isotherms of the recombinant human non-
palmitoylated SP-C (SP-C34-pp) on pure water (pH 5.6) at 20°C. The compression and expansion 
cycles were repeated two times.  There was no time lag between a compression and an 
expansion isotherm. The 1st and 2nd compression/expansion cycles are shown in solid and 
dashed lines, respectively (modified from [191]). 
 
 
Likewise, further analogues of SP-C with variations in length in the C-terminal 
part of SP-C were investigated with respect to their phase behavior. Recombinant 
human SP-C was truncated to 25 residues.  The palmitoyl residues were left at the 
cysteines in position 3 and 4 (SP-C25+pp).  Porcine SP-C was truncated to 17 and 13 
residues with or without palmitoylation at the cysteines in position 4 and 5 (pSP-C17± pp, 
pSP-C13± pp).   The results for pure peptide monolayers will be given in the following 
chapters. 
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3.1.4.3 Isotherm of SP-C 25+pp   
 
The truncated recombinant human SP-C (SP-C25+pp) with the sequence 
GIPCCPVHLKRLLIVVVVVVLIVVV has also been investigated in the previous work 
from Wintergalen, 1999 [191] as shown in figure 3.1.8. 
This figure represents compression and expansion isotherms, which are different 
from the previous ones. The isotherm of the first cycle has a limiting area at 330 Å2 and 
does not display any plateau. Only a shoulder is observable at 35 mNm-1.  The 
isotherms exhibit a strong hysteresis as can be seen in the successive compression and 
expansion isotherms which are not superimposable. This behavior was not observed in 
the former isotherms.  In addition, the shoulder at 35 mNm-1 of the 1st cycle vanishes 
with renewed compression during the 2nd and 3rd cycles. Comparing the isotherms of 
pure SP-Cnative monolayers with the ones of the truncated SP-C peptide, one states that 
the isotherm of the SP-C25-pp is shifted to smaller surface area.  At a surface pressure of 
20 mN m-1 the molecular area is about 210 Å2 whereas the previous variants have the 
corresponding surface areas at 540 Å2 (SP-C34-pp) and 630 Å2 (SP-C35+pp).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.8  Compression and expansion isotherms of the truncated recombinant human SP-C 
(SP-C25+pp) on pure water (pH 5.6) at 20°C. The compression and expansion cycles were 
repeated three times.  There was no time lag between a compression and an expansion isotherm. 
The 1st , 2nd and 3rd compression/expansion cycles are shown in solid, dashed and dotted lines, 
respectively (modified from [191]). 
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In order to investigate the functional relevance of the N-terminal part of SP-C in 
more detail SP-C peptides which where significantly truncated and only possessed 17 or 
13 amino acids (pSP-C17±pp, pSP-C13±pp) were analyzed. 
 
 
3.1.4.4 Isotherm of pSP-C 17±  pp   
 
The phase behavior of shorter porcine SP-C peptides containing only 17 amino acids of 
the N-terminal part with and without palmitoylation (pSP-C17+pp and pSP-C17-pp, 
respectively) were investigated.  Their isotherms are shown in figure 3.1.9. 
One of the most prominent changes compared to the isotherms of the longer 
SP-C peptides is the shift to significantly smaller molecular areas for both peptides  
(limiting area A0 area is 160 Å2 for pSP-C17+pp and 90 Å2 for pSP-C17-pp instead of 800 
Å2 for SP-Cnative or 330 Å2 for SP-C25+pp).   
Furthermore, palmitoylated pSP-C17+pp only shows one plateau at a significantly 
lower surface pressure of 20 mNm-1 compared to 30 mNm-1 for pSP-C35+pp and no 
shoulder at higher surface pressures. When successive compression/expansion cycles 
are performed, the isotherm of the shorter palmitoylated peptide reveals a clearly 
reduced hysteresis compared to the native protein. However, no material loss was 
observed during these cycles since the compression isotherms for the 2nd and 3rd cycle 
are almost identical.  
Although the first compression isotherm of pSP-C17-pp has a similar appearance 
as the one of the palmitoylated peptide and displays a limiting area of 90 Å2 and a 
plateau at 15 mNm-1 it shows a totally different behavior when performing 
compression/expansion cycles.  At the first cycle a small plateau between 56-43Å2 is 
visible (∆πp = 15-18 mN m-1). This plateau disappears when the monolayer is 
compressed for a 2nd or 3rd time.  Successive compressions also lead to an irreversible 
material loss, as can be seen from the area offset after each cycle. 
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                       a 
 
 
 
 
 
 
 
 
 
 
                            b 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.9  Compression and expansion isotherms of the truncated porcine SP-Cs, pSP-C17+pp 
(a) and pSP-C17-pp (b) on pure water (pH 5.6) at 20°C. The compression and expansion cycles 
were repeated three times. There was no time lag between a compression and an expansion 
isotherm. The 1st compression/expansion cycle, 2nd and 3rd cycle are shown in solid, dashed and 
dotted lines, respectively. 
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3.1.4.5 Isotherm of pSP-C 13±  pp   
 
The shortest SP-C peptides (13 amino acids, with or without palmitoylation) have been 
investigated as previously mentioned (see figure 3.1.10). 
In contrast to pSP-C17+pp the isotherm of palmitoylated SP-C with 13 residues is 
shifted to smaller molecular areas and is characterized by a limiting area of 125 Å2. It 
further does not show a significant plateau region but displays a kink at a pressure of 35 
mNm-1. Interestingly, this truncated peptide does not form any stable monolayers 
anymore, which is in contrast to the palmitoylated peptides with 17 residues. A 
continuous material loss is observable upon successive compression/expansion cycles as 
becomes clear from the area offset of each new beginning compression cycle. 
The non-palmitoylated truncated pSP-C13-pp shows a similar behavior to the 
palmitoylated one, only at smaller molecular areas (limiting area 15 Å2). Only a small 
shoulder at 10 mNm-1 is discernible in the first compression isotherm and vanishes upon 
subsequent compression. Since the monolayer was not stable and protein was squeezed 
out into the subphase, the barrier was expanded when reaching a molecular area of 5 Å2. 
Repeated compression/expansion cycles also evidenced a significant material loss, 
which was largest during the first compression cycle. This behavior indicates that the 
unpalmitoylated peptide formed even less stable monolayers than pSP-C13+pp. 
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                                a 
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Figure 3.1.10  Compression and expansion isotherms of the truncated porcine SP-Cs, pSP-C13+pp    
(a) and  pSP-C13-pp (b) on pure water (pH 5.6) at 20°C. The compression and expansion cycles 
were repeated three times. There was no time lag between a compression and an expansion 
isotherm. The 1st compression/expansion cycle, 2nd and 3rd cycle are shown in solid, dashed and 
dotted lines, respectively. 
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3.1.4.6 Isotherm of SP-C 13L1W 
 
Another truncated peptide was now used for the investigation of the influence of amino 
acid polarity.  We exchanged the first amino acid leucine in porcine SP-C to tryptophan. 
This peptide has the same phase behavior as SP-C13-pp but the isotherm is shifted 
to larger molecular areas. No plateau region or significant shoulder can be found in the 
isotherms of this type of peptide.  In addition, pSP-C13L1W has a higher compressibility 
in the first cycle than pSP-C13-pp, which might be due to the area demanding ring of the 
tryptophan. Upon successive compression/expansion cycles a material loss from the 
monolayer is discernible, which also is largest during the first compression. Repeated 
compressions lead to only a little material loss compared to the first compression 
probably because not much peptide is left over in the monolayer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.11  Compression and expansion isotherms of the substituted truncated porcine 
SP-C13L1W on pure water (pH 5.6) at 20°C. The compression and expansion cycles were repeated 
three times.  There was no time lag between a compression and an expansion isotherm. The 1st, 
2nd and 3rd compression/expansion cycle are shown in solid, dashed and dotted line, 
respectively. 
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In the following, the most relevant data characterizing the compression-
expansion isotherms of different SP-C peptides are summarized in table 3.1.1  
 
Table 3.1.1  Data from the first compression isotherm of different types of pure SP-C peptides 
on a pure water subphase (pH 5.6) at 20 °C with A0 = limiting molecular area, Ap1 = beginning 
molecular area of the first plateau, Lp = length of the plateau region, Pp1 = beginning surface 
pressure of the plateau region and ∆πp = differential surface pressure at the plateau region, 
which were calculated by the tangential method as seen in figure 3.1.4. 
 
Type of SP-C A0 [Å2] Ap1 [Å2] Lp [Å2] Pp1 [mN m-1] ∆πp  [mN m-1] 
SP-C35+pp  800  600  163 26 3 
pSP-C35+pp  1000  750  192 28 3 
SP-C34-pp  720  520  55 24 3 
SP-C25+pp  330  - - - - 
pSP-C17+pp  160  100  30 20 7 
pSP-C17-pp  90 60  15 15 6 
pSP-C13+pp  125  - - - - 
pSP-C13-pp  15  - - - - 
pSP-C13L1W 30  - - - - 
 
 
 
3.1.4.7 Discussion 
 
The presented results in this chapter document the overall ability of native SP-C 
and its truncated analogues to form monolayers at the air/water interface. However, the 
stability of a given peptide monolayers as well as their explicit phase behavior strongly 
depend on the length of the α-helical part and the degree of palmitoylation.   
The isotherms of native SP-C (human and porcine) exhibit similar features, 
especially a pronounced plateau at a surface pressure of 26 and 28 mNm-1, respectively. 
However, the isotherm of porcine SP-C is shifted by 200 Å2 to larger molecular areas 
compared to the one of human SP-C whereas the plateau length and the plateau pressure 
remain quite similar. This area shift might be due to discrepancies in the amino acid 
sequence and therefore differences in the area requirement of the substituted residues. 
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Generally, it is assumed that amino acids in α-helical homopolypeptides spread 
onto a water subphase assume areas of 13-19 Å2 per residue at the beginning of the 
plateau region [194].  The variation in area depends upon the length of the amino acid 
side chain, with larger groups causing greater separation of the α-helical peptides lying 
on the surface.  
Calculating the molecular areas per residue for the native SP-C peptides with 35 
amino acid residues analyzed in this work yields values of 17.1 Å2 for human SP-C and 
21.4 Å2 for the porcine analogue. These results are in line with the predicted areas per 
residue of an α-helical peptide and are consistent with the notion that hardly any 
segments of the protein molecules are squeezed out of the interface at this surface 
pressure. 
However, it is possible that the secondary structure of SP-C is not fully α-helical 
but also contains β-sheet components [195]. According to Malcolm the area per residue 
for β-sheet structures is 16-33 Å2 [194].  Assuming that human and porcine SP-C also 
differ in their α-helical portions this would explain the shift in molecular areas and the 
differences in the molecular areas per residues calculated for the two peptides. 
The isotherms for human and porcine native SP-C presented in this work are 
somewhat different from those already published in the literature probably due to 
differences in subphase composition or temperature as well as possible differences in 
the purification procedure of SP-C. Isotherms obtained at a temperature of 37 °C on a 
buffered subphase (pH 7.0) displayed larger molecular areas (limiting area ∼2800 Å2) 
than the ones documented in this work (e.g. 1000 Å2 for pSP-C35+pp) and no plateau was 
observable [133]. When a saline subphase was used (150 mN NaCl, 20 °C) the limiting 
area was 900 Å2 and a plateau at 18 mN m-1 was discernible [101]. Monolayer studies 
performed at 20 °C on a pure water subphase with a Langmuir film balance lead to 
isotherms exhibiting three plateau regions at 21.7, 29.9 and 56.6 mN m-1 [196]. The 
reason that the isotherms presented in this study do not show as many plateaus is the 
Wilhelmy system used for the analysis of SP-C monolayers. When compressing peptide 
monolayers to surface pressures higher than 40-50 mN m-1 (the limiting pressure 
depends on the type of peptide) the contact angle of the Wilhelmy plate changes and the 
measured pressure values are not correct anymore. However, the results obtained for 
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lower surface pressures are reliable which is supported by the isotherm course of Post et 
al. which is in line with our results [196]. 
Since not many studies on pure SP-C monolayers exist the processes at the 
air/water interface occurring during compression mainly remain unclear. Ellipsometric 
measurements performed by Post et al. revealed that the thickness of the layer almost 
doubles from the beginning to the end of the first plateau from 17.5 Å to 32.5 Å [196].  
When the surface pressure was further increased a continuous increase in layer 
thickness was observed. This behavior is explicable by the formation of multiple layers 
as has already been described for α-helical peptides [194] and/or by changes in protein 
conformation e.g. by increasing the amount of α-helical structures leading to a change 
of the molecular shape. Considering the mainly helical SP-C as a cylinder being 
oriented with its long axis parallel to the surface, it is also conceivable that an 
orientation of the molecules perpendicular to the surface during compression would 
partially explain the thickness increase observed in ellipsometric measurements. Finally, 
it has to be taken into account that the analyzed peptide is palmitoylated at two cysteine 
residues. It is to be expected that such a molecule displays a complex phase behavior at 
the air/water interface and that it cannot be easily compared to a cylinder, which 
reorientates during compression. The covalently bound fatty acids will contribute in a 
more or less subtle way to the overall phase behavior of the peptide. The exact 
processes taking place in pure SP-C monolayers at the air/water interface, however, are 
still not identified and remain to be elucidated. 
 
Performing consecutive compression/expansion measurements with peptide 
monolayers shed some light on the reversibility of the processes occurring at the 
air/water interface. As was shown in this work, no monolayer collapse was observed 
when the SP-C films were compressed up to a surface pressure of 40 mN m-1. This is 
consistent with the results from Post et al. who also documented a high reversibility of 
successive compression/expansion cycles [196]. However, when the SP-C monolayers 
were compressed above 40 mN m-1 a film collapse with irreversible material loss was 
discernible [196]. It can be therefore concluded that the processes occurring at the 
air/water interface at lower surface pressures (multilayer formation, conformational 
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changes and/or straightening up of the α-helices accompanied by rotational changes of 
the palmitoyl chains) seems to be a highly reversible process in the case of native SP-C. 
When the palmitoyl chains are removed from SP-C significant changes can be 
observed in the isotherms of pure peptide monolayers. The most noticeable difference is 
the considerable shortening of the plateau at 24 mN m-1 whereas the shift of the limiting 
area to smaller areas is comparably small. The hysteresis effect, that is the difference 
between compression and expansion isotherms, is also extremely small, which leads to 
the conclusion that the palmitoyl chains are responsible for the observed phase behavior 
at lower surface pressures.  
It is possible that the hydrophobic acyl chains in the palmitoylated SP-C are in a 
fluid state that is characterized by frequent rotational changes and show only little 
interactions with the helical part of the protein. However, since the plateau found at 25 
mN m-1 is temperature independent it is assumed that it is not caused by liquid to gel 
state transitions of the palmitoyl chains [155]. Other processes, on the other hand, are 
possible. During compression of the monolayer the fatty acid chains could get in direct 
contact with each other, reorientate and furthermore interact with the hydrophobic part 
of the protein a process that is not comparable to a le/lc phase transition. Such a 
behavior of the palmitoyl chains would mediate intermolecular interactions and lead to 
stable structures that withstand the disrupting force applied during the expansion of the 
monolayer. It would also explain the large hysteresis observed in the 
compression/expansion isotherms of native SP-C. Removing the acyl chains and thus 
the adhesive module of the peptide would lead to a less compressible monolayer that 
does not show any hystersis effect any more. These assumptions would fit with the 
observed isotherm for SP-C34-pp. 
However, other aspects have to be considered when trying to explain the 
observed differences in the phase behavior of palmitoylated and unpalmitoylated SP-C. 
Considering the information available in the literature on the influence of the two 
palmitoyl chains on the structure of SP-C it becomes clear that the fatty acyl moieties 
are required for the peptide to be functionally fully active [153,155-156].  From a 
structural point of view it has been reported that the palmitoyl groups both increase 
[84,153-154] and decrease [82,155] the helical content of the peptide. This discrepancy 
was independent of the environment used for analysis and might be attributed to 
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different procedures employed to deacylate native SP-C and the fact that the peptide can 
undergo a conversion from helical to β-sheet conformation [154]. It can therefore not be 
excluded that the palmitoyl chains additionally influence the phase behavior of SP-C by 
modulating the secondary structure of the peptide. 
 
When a SP-C analogue was analyzed that contained 10 amino acids less in the 
C-terminal part but still contained the two palmitoyl residues a significant change in the 
biophysical properties was observed. First, a large shift of the isotherm to smaller 
molecular areas was observed for SP-C25+pp. This can be attributed to the loss of amino 
acids which occupy a defined molecular area. Second, no plateau region was discernible 
at 25 mN m-1 and a significant material loss was detected upon consecutive 
compression/expansion cycles. This behavior is rather surprising taking into account the 
assumptions made on the influence of the palmitoyl chains acting as adhesive moieties 
in the molecule and the results obtained for shorter palmitoylated peptides (details see 
below). If the acyl chains were present in the peptide one would expect a slight plateau 
as well as high reversibility and a large hysteresis effect. It is possible that other 
processes occurring between the peptides have to be considered and remain to be 
elucidated. 
 
When the phase behavior of SP-C analogues was verified containing only 17 
amino acids, again a shift of the isotherms to smaller molecular areas was observed. It 
can be attributed to the shortening of the helix and the reduction of the area requirement 
of the peptide. In addition, palmitoylated SP-C17 displayed a plateau in the isotherm at 
20 mN m-1 and showed high reversibility during successive compression/expansion 
cycles. These findings confirm the assumption that the palmitoyl chains act as adhesive 
modules in the peptide stabilizing the monolayer. Most important, the acyl moieties 
were in this case pivotal for the prevention of an irreversible squeeze-out of the peptide. 
Depalmitoylated SP-C17 was not able to form stable monolayers. This is also the reason 
why no reversibility was observed when compression/expansion isotherms were 
recorded and a significant material loss was detected.  
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 Interestingly, when the SP-C peptide was extremely shortened to the amino acid 
residues 1-13, palmitoylation could not completely prevent irreversible loss of material 
into the subphase. Upon consecutive compression/expansion cycles SP-C13+pp was 
successively squeezed out. However, the SP-C13+pp monolayer was clearly more stable 
than the one formed by the depalmitoylated peptide where almost 70 % of the material 
was irreversibly squeezed out during the first compression cycle. The same behavior 
was observed for the equally depalmitoylated variant SP-C13L1W.  
It becomes apparent from these sets of experiments that the α-helical part of the 
peptide has to comprise more than 13 amino acid residues for the palmitoyl chains to 
properly function as stabilizing moieties and that hydrophobic interactions between the 
acyl chains and the α-helix are essential. It is possible that the palmitoyl residues orient 
parallel to the helical part of the peptide. In the case of native SP-C the length of the 
α−helix from residues 9-34 and that of its pronouncedly hydrophobic part from residues 
13-28 was determined to be 37 Å and 23 Å, respectively [80].  These values are 
remarkably close to the experimentally determined overall thickness of a DPPC 
phospholipid bilayer (37 Å) and its interior acyl chain part (26 Å) in the liquid-
crystalline phase [197]. Reducing the length of the helical part therefore strongly 
influences the hydrophobic interactions with the palmitoyl chains. Apparently, in SP-
C17+pp the length of the α-helix and its hydrophobicity are sufficient to permit stabilizing 
interactions between the helical part and the acyl chains. NMR data and CD spectra of 
depalmitoylated SP-C1-17 in lipid micelles reveal an α-helix content of approximately  
40 % and indicate that the onset of helical structure is at a nearly identical sequence 
location as in native SP-C [146]. A peptide containing only 13 amino acid residues, 
however, would not be able to form an α-helix and does not possess enough 
hydrophobic amino acid residues which could properly interact with the palmitoyl 
chains. These peptides therefore do not form stable monolayers at the air/water 
interface. 
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3.1.5 The effect of peptides in lipid/peptide systems 
 
Three-component systems with varying amount of different SP-C derivatives were 
investigated in order to characterize the influence of the peptides on the phase behavior 
of mixed phospholipids. Film balance experiments were performed using a mixture of 
the neutral phospholipid DPPC and the charged DPPG in a 4:1 molar ratio. This 
composition corresponds to the ratio of neutral and negatively charged lipids found in 
human lung lavages [198]. 
 
 
3.1.5.1 Isotherms of DPPC:DPPG (4:1) mixtures with SP-Cnative (pSP-C35+pp) 
 
The ternary mixture of DPPC: DPPG: pSP-C35+pp was investigated with various amounts 
of peptide (0.4, 0.8, 1.5, 5.0 and 10.0 mol%). The corresponding compression isotherms 
are depicted in figure 3.1.12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.12  Compression isotherms of DPPC:DPPG (80:20, mol/mol) with and without 
different amounts of pSP-C35+pp as shown in the inset. The measurement were performed on a 
pure water subphase (pH 5.6) at 20°C. 
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In the case of native SP-C/lipid films, a concentration of 0.4 mol% 
pSP-C35+ppwas used as a standard model system of the lung surfactant in accordance 
with earlier investigations [196] and with the fact that in lung lavages the content of 
hydrophobic proteins was found to be less than 1% [199]. Upon compression, the 
spread lipid/SP-C mixture showed, in the region of low surface pressures, a similar 
behavior as in the pure lipid monolayer after reaching a limiting molecular area of about 
90 Å2.  The surface pressure increases continuously to a value of around 54 to 58 mNm-
1
 (figure 3.1.12 black line; 0.4 mol% pSP-C35+pp). At such pressures, the mean molecular 
area is about 42 Å2, which corresponds to the molecular area of a pure DPPC:DPPG 
monolayer in the solid state (as can be seen from the black dash-dotted line).  Upon 
further compression, the compressibility of the lipid/peptide film increases abruptly. 
This becomes apparent in the surface pressure area diagram as a distinct plateau region 
with a length of 14 Å2. The end of the plateau region is characterized by a further 
increase of film pressure at a molecular area of about 28 Å2.  
At 0.8 mol% of pSP-C35+pp (red line) the isotherm is similar to the one of 
DPPC:DPPG films with 0.4 mol% SP-C.  Only slight shifts to larger molecular areas 
due to increasing amount of protein in the system were discernible.  
Increasing the amount of pSP-C35+pp further, naturally, the isotherms are shifted 
to larger molecular areas if either an ideal mixing or complete phase separation is 
expected. However, the plateau region changes significantly when higher amounts of 
peptide are inserted into the monolayer.  At a concentration of 1.5 mol% pSP-C35+pp the 
limiting molecular area is 100 Å2 and the lipid plateau visible between 2 and 4 mN m-1 
in lipid mixtures with lower peptide contents vanishes. In addition, the plateau length 
increases by 23 Å2. The end of the plateau region, moreover, becomes much less 
sharply defined than the ones at lower peptide amounts.  
Increasing the concentration of pSP-C35+pp to 5 mol% leads to an increase of the 
limiting molecular area to 144 Å2. Furthermore, the compressibility of the lipid/peptide 
monolayer significantly increases and a little shoulder between 18 and 25 mN m-1 and a 
molecular area of 95 and 80 Å2 appears. Interestingly, the characteristic SP-C plateau 
observed in monolayers containing smaller peptide amounts at a surface pressure of 54 
mN m-1 changes abruptly: The plateau height decreases by 4 mN m-1 leading to a 
plateau at 50 mN m-1. Moreover, the plateau length increases to a value of 30 Å2. Since 
the monolayer was highly compressible in the plateau region, compression of the 
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monolayer had to be stopped manually because the barrier had almost reached the 
measuring system. Therefore no plateau end is discernible in this isotherm.  
Lipid monolayers containing 10 mol% pSP-C35+pp are also shifted to larger 
molecular areas (limiting area A0 = 198 Å2) and display a high compressibility. The 
shoulder that had already appeared at 20-25 mN m-1 in mixtures containing 5 mol% 
peptide becomes more pronounced. It begins at a surface pressure of 22 mN m-1 and 
ends at 25 mN m-1. As before, the SP-C plateau is shifted to smaller surface pressures 
and displayes a plateau height of 48 mN m-1. Also the plateau length increases to a 
value of 45 Å2.  
The various constants describing the characteristics of the lipid/peptide 
isotherms depicted in figure 3.1.12 are summarized in table 3.1.2. 
 
Table 3.1.2  Data from the compression isotherms of DPPC:DPPG (80:20, mol/mol) displayed 
in figure 3.1.12 with various concentrations of pSP-C35+pp on pure water (pH 5.6) at 20 °C where 
A0= limiting molecular area, Ap1 = molecular area of the beginning plateau region, πp1 = 
beginning surface pressure at plateau region and Lp = length of plateau region. 
 
Concentration of pSP-C35+pp A0 [Å2] Ap1 [Å2] πp1  [mN m-1] Lp [Å2] 
0.0 mol% 80 - - - 
0.4 mol% 90 42 54 14 
0.8 mol% 100 44 55 16 
1.5 mol% 100 42 54 23 
5.0 mol% 144 58 50 30 
10.0 mol% 198 73 47 45 
 
 
3.1.5.2 Isotherms of DPPC:DPPG (4:1) mixtures with non-palmitoylated SP-C 
(SP-C34-pp) 
 
The influence of the modified human recombinant non-palmitoylated peptide SP-C34-pp 
on a DPPC:DPPG mixture was investigated with the film balance technique. Figure 
3.2.13 shows compression isotherms of DPPC:DPPG mixtures (80:20, mol/mol) with 
various concentrations of SP-C34-pp ranging from 0.4 to 5.0 mol%.   
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In contrast to the lipid/peptide systems containing native SP-C, adding 0.4 mol% 
SP-C34-pp to the DPPC/DPPG mixture surprisingly lead to a lower limiting molecular 
area of 70 Å2 compared to the one of the pure lipid monolayer (80 Å2) and of the native 
SP-C system (90 Å2). At the same time the compressibility of the lipid/SP-C34-pp 
mixture decreased indicating a more rigid and more densely packed monolayer.  
Stepwise increasing the amount of peptide from 0.4 to 5.0 mol% then lead to a 
successive increase of the limiting molecular A0 from 80 to 105 Å2. Furthermore, the 
compressibility of the lipid/peptide monolayers increased consecutively. Compared to 
the native SP-C system, the limiting areas were shifted to smaller values at equal 
peptide concentrations (e.g. 105 Å2 for 5 mol% SP-C34-pp compared to 144 Å2 for 5 
mol% pSP-C35+pp). This behavior can be attributed to the missing acyl chains and 
reflects the tendencies already observed for pure peptide systems. 
Interestingly, SP-C34-pp monolayers behaved differently than the ones containing 
native SP-C at surface pressures above 50 mN m-1. Whereas in the native system a 
characteristic plateau was already observed at a peptide concentration of 0.4 mol% in 
the mixtures containing depalmitoylated SP-C no plateau was discernible at 0.4 and 0.8 
mol%. Instead, a monolayer collapse at 68 mN m-1 was visible. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.13  Compression isotherms of DPPC:DPPG  (80:20, mol/mol) with and without 
different amounts of SP-C34-pp as shown in the inset.  The measurements were performed on a 
pure water subphase (pH 5.6) at 20°C. 
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Only at peptide concentrations of 2.5 mol% and higher, the distinct plateau at a 
surface pressure of ~50 mN m-1appeared.  The plateau length of a mixture with 2.5 
mol% SP-C34-pp is 6 Å2 and begins at a smaller molecular area than the native system 
(36 Å2 instead of 42 Å2). However, increasing the amount of SP-C34-pp the plateau 
length also increases while the plateau end becomes less pronounced. Meanwhile, the 
slope of the subsequent pressure increase at areas below 30 Å2 gradually decreases. 
Finally, at peptide concentrations of 5 mol% no plateau end is detectable anymore 
because the compression of the monolayer had to be stopped for technical reasons. 
Interestingly, upon increasing the peptide amount the plateau height did not 
decrease as strongly as was the case in the native systems. The plateau height only 
ranged from 50-52 mN m-1 compared to 50-55 mN m-1 when increasing the peptide 
concentration from 0.4 to 5 mol%. 
Table 3.1.3 summarizes the constants describing the distinct features of the 
isotherms displayed in figure 3.1.13. 
 
Table 3.1.3  Data from the compression isotherms of DPPC: DPPG (80:20, mol/mol) with and 
without various concentrations of SP-C34-pp (figure 3.1.13) on pure water (pH 5.6) at 20 °C 
where A0= limiting molecular area, Ap1 = molecular area of the beginning plateau region, πp1 = 
beginning surface pressure at plateau region and Lp = length of plateau region. 
 
Concentration of SP-C34-pp A0 [Å2] Ap1 [Å2] πp1  [mN m-1] Lp [Å2] 
0.0 mol% 80 - - - 
0.4 mol% 70 36 67 (collapse) - 
0.8 mol% 75 38 68 (collapse) - 
2.5 mol% 90 38 52 6 
3.0 mol% 95 39 51 7 
4.0 mol% 95 38 51 10 
5.0 mol% 105 39 50 n.e.* 
* n.e. means no end of plateau could be determined, therefore, no length of plateau can be calculated. 
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3.1.5.3 Isotherms of DPPC:DPPG (4:1)  mixtures with truncated palmitoylated 
SP-C (SP-C25+pp) 
 
In order to investigate the effect of the α-helical part of SP-C on the surface active 
peptide properties a shorter human recombinant SP-C with only 25 residues has been 
synthesized.  Phospholipid mixtures containing different peptide concentrations were 
analyzed with a film balance (see figure 3.1.14).  
The lipid mixtures containing 0.4 mol% SP-C25+pp display a similar phase 
behavior as the ones containing the depalmitoylated full-length peptide SP-C34-pp: The 
limiting area is shifted to a smaller value compared to the one for the pure lipid film (70 
Å2 instead of 80 Å2) and the compressibility in the range of 0-10 mN m-1 is smaller.  
Increasing the amount of peptide then results, as before, in a typical isotherm 
displacement to larger molecular areas. This shift is similar to the one observed for 
SP-C35-pp, the non-palmitoylated full-length peptide (e.g. the limiting area for 2.5 mol% 
SP-C25+pp is 89 Å2 compared to 90 Å2 for 2.5 mol% pSP-C34-pp).   
Although both modified peptides, the non-palmitoylated SP-C34-pp and the 
truncated SP-C25+pp, seem to have the same effect at lower surface pressures they 
display a different behaviour in the plateau region. The truncated peptide SP-C25+pp 
already induces plateau formation at concentrations of 0.4 mol%. This plateau, 
however, is significantly different from the one observed in mixtures containing full-
length peptides (either palmitoylated or not). The plateau region is characterized by a 
considerable pressure increase indicating a significantly lower compressibility. Upon 
increasing the amount of SP-C25+pp, the slope of the plateau decreases until, at a peptide 
concentration of 2 mol% and higher, the plateau is entirely horizontal again. Again, for 
technical reasons no plateau end could be determined and therefore no plateau length is 
calculated. Increasing the peptide concentration results, as before, in a gradual decrease 
of the plateau height (53 mN m-1 at 2.0 mol% and 50 mN -1 at 2.5 mol%).  
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Figure 3.1.14  Compression isotherms of DPPC:DPPG  (80:20, mol/mol) with and without 
different amounts of SP-C25+pp  as shown in the inset.  The measurements were performed on a 
pure water (pH 5.6) at 20°C. 
 
 Table 3.1.4 contains the characteristic constants describing the features of the 
isotherms shown in figure 3.1.14. 
 
Table 3.1.4  Data from the compression isotherms of DPPC:DPPG (80:20, mol/mol) with and 
without various concentrations of SP-C25+pp (figure 3.1.14) on pure water (pH 5.6) at 20 °C 
where A0= limiting molecular area, Ap1 = molecular area of the beginning plateau region, πp1 = 
beginning surface pressure at plateau region and Lp = length of plateau region.  
 
Concentration of SP-C25+pp A0 [Å2] Ap1 [Å2] πp1  [mN m-1] Lp [Å2] 
0.0 mol% 80 - - - 
0.4 mol% 70 39 - n.e.* 
0.8 mol% 75 41 - n.e. 
1.0 mol% 77 40 54 n.e. 
1.5 mol% 80 42 53 n.e. 
2.0 mol% 89 43 52 n.e. 
2.5 mol% 89 42 53 n.e. 
* n.e. means no end of plateau could be determined, therefore, no length of plateau can be calculated. 
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3.1.5.4 Isotherms of DPPC:DPPG (4:1)  mixtures with pSP-C17 ± pp  
 
Short peptides with 17 residues with and without palmitoylation were investigated to 
study the influence of palmitoylation in considerably truncated SP-C molecules.  The 
isotherms obtained for DPPC:DPPG 4:1 with different concentrations of pSP-C17± pp are 
shown in figure 3.1.15. 
At low surface pressures up to a value of 25 mN m-1 the isotherms of 
palmitoylated pSP-C17+pp show a similar behavior as the so far analyzed modified 
peptides: Upon addition of 0.4 mol% pSP-C17+pp the limiting area slightly decreased 
under simultaneous decrease of compressibility. Increasing the peptide concentration 
leads to a shift of the isotherms to larger molecular areas and an increase of the limiting 
molecular area A0 from 75 Å2 (0.4 mol% pSP-C17+pp) to 90 Å2 (10 mol% pSP-C17+pp). 
Due to the shortened α-helical part and the reduced dimensions of the protein the area 
shift is smaller than the one observed for the longer SP-C peptides (e.g. limiting area of 
77 Å2 for 2.5 mol% pSP-C17+pp and 89 Å2 for 2.5 mol% pSP-C25+pp).  
However, at surface pressures above 25 mN m-1 a completely different phase 
behavior for the pSP-C17+pp systems compared to the previous lipid/peptide monolayers 
was detected. First, increasing the peptide concentration to a value of 5 and 10 mol% 
leads to the appearance of a distinctive shoulder at 29 mN m-1 indicating the squeeze-
out of peptide and/or lipids. 
Second, the compressibility of the lipid/peptide systems is higher than the one of 
pure lipid films also indicating a loss of lipid material and not only a squeeze-out of 
pSP-C17+pp. Since the compressibility only increases vaguely with the amount of 
pSP-C17+pp it can be assumed that the material loss is almost independent of the peptide 
concentration (insert in figure 3.1.15).  
In order to further analyze this appearance of material loss, consecutive 
compression/expansion isotherms were recorded (data not shown). From these 
measurements it was obvious that the observed material loss was reversible indicating 
strong interactions between the squeezed out material and the surface monolayer. 
The phase behavior of the depalmitoylated analogue, pSP-C17-pp, was similar to 
the one of pSP-C17+pp. Increasing peptide concentrations lead to a shift of the isotherms 
to larger molecular areas. Also a shoulder appeared, this time at 25 mN m-1. However, 
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at surface pressures above this value the compressibility of the lipid/peptide monolayers 
was identical to the ones of the pure DPPC:DPPG system. This is a sign for a pure 
squeeze-out of peptide without a simultaneous loss of lipids from the monolayer.  
 
 
 
                        a 
 
 
 
 
 
 
 
 
 
 
                         b  
 
 
 
 
 
 
 
 
 
 
Figure 3.1.15  Compression isotherms of DPPC:DPPG  (80:20, mol/mol) with and without 
different amounts of truncated porcine SP-Cs, pSP-C17+pp (a) and pSP-C17-pp (b), as shown in the 
inset.  The measurements were performed on a pure water subphase (pH 5.6) at 20°C. 
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 The typical characteristic parameters for the isotherms displayed in figure 3.1.15 
are summarized in table 3.1.5. 
 
Table 3.1.5  Data from the compression isotherms of DPPC:DPPG (80:20, mol/mol) with and 
without various concentrations of pSP-C17+pp and pSP-C17-pp (figure 3.1.15) on pure water (pH 
5.6) at 20 °C where A0= limiting molecular are and πs = squeeze-out surface pressure of peptide 
from lipid monolayer. 
 
Concentration of pSP-C17±  pp  A0 [Å2] πs [mN m-1] 
0.0 mol% 80 - 
+pp 75 20 
0.4 mol% 
-pp 80 - 
 
 
  
+pp 77 28 
2.5 mol% 
-pp 80 - 
 
 
  
+pp 80 35 
5.0 mol% 
-pp 88 25 
 
 
  
+pp 90 28 
10.0  mol% 
-pp 90 25 
 
 
  
 
 
3.1.5.5  Isotherms of DPPC:DPPG (4:1)  mixtures with SP-C13 ± pp 
 
The N-terminal peptides with 13 residues with and without palmitoylation were also 
investigated with a film balance using the same lipid mixture system and different 
concentrations of peptide. 
Monolayers containing the palmitoylated and truncated peptide pSP-C13+pp show 
a phase behavior, which is slightly different from the one typical for lipid films 
containing the SP-C peptide with 17 N-terminal residues. When 0.4 mol% pSP-C13+pp 
was present in the monolayer, no shift to smaller but to larger molecular areas is 
detectable (e.g. A0 = 90 Å2 for pSP-C13+pp and A0 = 75 Å2 for pSP-C17+pp). Unlike 
pSP-C17+pp, the shorter peptide does not decrease the compressibility of the film but 
increase it. Upon addition of increasing amounts of peptide (0.4 to 10 mol%) a 
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successive shift to larger molecular areas is observed (90-105 Å2). As was the case for 
pSP-C17+pp a shoulder becomes apparent at 10 mol% peptide concentration – only at a 
surface pressure of 10 mN m-1 instead of 20-25 mN m-1 – and the compressibility 
increases indicating a squeeze-out of the protein. Moreover the peptide with only 13 
amino acids did not show the SP-C specific plateau at 50-54 mN m-1. Successive 
compression/expansion cycles up to a pressure of 60 mN m-1 document the stability of 
lipid/pSP-C13+pp monolayers (data not shown). No irreversible material loss was 
observed during these cycles and only a small hysteresis was visible. 
The phase behavior of depalmitoylated pSP-C13-pp generally shows the same 
characteristics and tendencies as its palmitoylated analogue. No SP-C plateau is 
discernible and the monolayer displayed no irreversible material loss when 
compression/expansion isotherms were measured between 0 and 60 mN m-1 (data not 
shown). 
The typical characteristic parameters for the isotherms displayed in figure 3.1.16 
are summarized in table 3.1.6. 
 
Table 3.1.6  Data from the compression isotherms of DPPC:DPPG (80:20, mol/mol) with and 
without various concentrations of pSP-C13+pp and pSP-C13-pp (figure 3.1.16) on pure water (pH 
5.6) at 20 °C where A0= limiting molecular area and πs = squeezing out surface pressure of 
peptide from lipid monolayer. 
 
Concentration of pSP-C13± pp  A0 [Å2] πs [mN m-1] 
0.0 mol%  80 - 
+pp 90 - 
0.4 mol% 
-pp 80 - 
 
 
  
+pp 90 - 
2.5 mol% 
-pp 90 - 
 
 
  
+pp 100 48 
5.0 mol% 
-pp 105 55 
 
 
  
+pp 95 17 
10.0  mol% 
-pp 105 25 
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                        b 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.16  Compression isotherms of DPPC:DPPG  (80:20, mol/mol) with and without 
different amounts of truncated porcine SP-Cs, pSP-C13+pp (a) and pSP-C13-pp (b) as shown in the 
inset.  The measurements were performed on a pure water subphase (pH 5.6) at 20°C. 
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3.1.5.6  Isotherms of DPPC:DPPG (4:1)  mixtures with pSP-C13L1W 
 
The substituted truncated peptide with 13 residues where the first amino acid (Leu) was 
exchanged by Trp, was investigated again with the film balance technique using the 
same lipid mixture system with different concentrations of peptide. The results are 
shown in figure 3.1.17. 
The general isotherm course of lipid monolayers containing pSP-C13L1W was very 
similar to the one of the peptide with 13 residues and showed only two striking 
differences: First, the addition of 0.4 mol% pSP-C13L1W lead to a more significant shift 
to larger molecular areas – the area difference in the solid state was approximately 10 
Å2 whereas there was none for the SP-C13 analogues. Second, increasing the amount of 
peptide lead to a successive increase in compressibility. This is a hint for the 
consecutive squeeze-out of peptide. However, no loss of lipid material seems to occur 
because the final molecular area at the end of compression corresponds to the value of a 
pure lipid monolayer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.17  Compression isotherms of DPPC:DPPG  (80:20, mol/mol) with and without 
different amounts of pSP-C13L1W as shown in the inset.  The films were performed on pure water 
(pH 5.6) at 20°C. 
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The typical characteristic parameters for the isotherms displayed in figure 3.1.17 
are summarized in table 3.1.7. 
 
Table 3.1.7  Data from the compression isotherms of DPPC: DPPG (80:20, mol/mol) with and 
without various concentrations of pSP-C13L1W (figure 3.1.17) on a  water (pH 5.6) at 20 °C where 
A0= limiting molecular area and πs = squeeze-out surface pressure of peptide from the lipid 
monolayer. 
 
Concentration of pSP-C13L1W  A0 [Å2] πs  [mN m-1] 
0.0 mol% 80 - 
0.4 mol% 95 - 
2.5 mol% 91 13 
5.0 mol% 98 26 
10.0  mol% 100 24 
 
 
3.1.5.7    Discussion 
 
The aim of this set of experiments was to study the phase behavior of the presented SP-
C peptides in a mixture with DPPC and DPPG, the main lipid components of the native 
lung surfactant system. The standard system now frequently used is a monolayer of 
DPPC and DPPG in a molar ratio of 4:1 containing 0.4 mol% of native SP-C [78, 87, 
200-202].  In this study, starting from this normally used monolayer composition, also 
higher peptide concentrations were used in order to investigate the concentration effect 
in the lipid monolayer.  To elucidate the influence of the shorter SP-C analogues on the 
lipid mixture the different SP-Cs (SP-C34-pp, SP-C25+pp) have been synthesized and used 
in this study.  In addition, short peptides with only 13 and 17 residues (pSP-C13± pp, pSP-
C17± pp) were used in order to find out the intrinsic N-terminal effect of SP-C in lipid 
monolayer systems.  Furthermore, the effect of palmitoylation was investigated by using 
non-palmitoylated and palmitoylated SP-Cs in lipid mixtures. 
 Earlier studies of the lung surfactant model system (DPPC:DPPG: pSP-C35+pp in 
a molar of 80:20:0.4) showed the similar distinct plateau region at a surface pressure 
around 50-55 mN m-1
 
as was observed in this work  [29,87,91,196,102,200]. This 
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plateau is defined as a surface-confined reservoir, which is induced by SP-C and forms 
protrusions enriched with SP-C and specific lipids [196].  Fluorescence light 
microscopy (FLM) in conjunction with scanning force microscopy (SFM) images reveal 
that these protrusions, resulting in an increase of fluorescence intensity in FLM images 
and a formation of three-dimensional multilayer structure observed in SFM images, are 
due to a stacking of bilayers folded from the monolayer into the subphase at elevated 
pressure [87-88,200].  FLM and time-of-flight secondary ion mass spectrometry 
(TOF-SIMS) images showed that these protrusions originate exclusively from the 
protein-enriched domains, the former le phase of the low surface pressure region of the 
isotherm [86,102]. 
 
The orientation of the SP-C helix obviously changes from perpendicular (24°) in 
a lipid bilayer to a tilt angle of 70-72° in a monolayer with respect to the surface normal 
in lipid mixtures in order to obtain maximum interaction with the lipid acyl chains while 
simultaneously permitting the lipids to remain comformationally ordered [203]. 
Therefore an increase of the SP-C concentration leads to plateau regions at a lower 
surface pressure (figure 3.1.12) because of the high influence of the peptide resulting in 
a better ordered lipid orientation and triggering the formation of three-dimensional  
multilayers by lowering the required energy of this process.   
 
In lipid films with non-palmitoylated SP-C (SP-C34-pp) the plateau region was the 
same as in the native SP-C system (figure 3.1.13) and corresponded well to the one 
found in previous studies (~50 mN m-1) [204-206]. Using fluorescence labeled non-
palmitoylated SP-C/lipid film Kramer et al., 2000 [205] showed that in the plateau 
region the localization of lipid/protein protrusions is the same as found in native SP-C 
films.  At low concentration of SP-C34-pp a collapse of the lipid/protein films was 
discernible because not enough protein was present to stabilize the monolayer.  Also, 
due to the lack of the palmitoyl chains interactions between SP-C and phospholipids are 
reduced. Similar observations were made when the full spectrum of adsorption and 
dynamic surface behaviors was performed by Wang et al., 1996 [156].  Moreover, non-
palmitoylated SP-C has a different α-helical appearance compared to native SP-C [145], 
which causes a smaller tilt angle (maximum 29-38°) with respect to interface [207]) 
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than found in the native one, resulting in the required higher amount of peptide in 
lipid/protein monolayers to achieve the formation of surfactant-reservoirs at high 
surface pressure. Therefore the increase of the SP-C34-pp concentration in lipid/protein 
films also causes a lower plateau pressure due to the ordering effect of the peptides.  
 
In contrast to non-palmitoylated SP-C34-pp, truncated palmitoylated SP-C 
(SP-C25+pp) showed a lower required amount of peptide (less than 2.5 mol% SP-C25+pp) 
in lipid/protein films to achieve the plateau region at a surface pressure of ~50 mN m-1 
(figure 3.1.14).  This plateau region is also characterized by protrusions of lipid/protein 
multilayers as can be seen from the SFM results.  These structures, however, are not as 
high as the ones found in the native system. At low peptide concentrations a collapse of 
the lipid/protein film appeared. Nevertheless, increasing the peptide content in lipid 
films improved the appearance of the plateau region because of the better orientation of 
peptide and lipids in the monolayer.  It is possible that the shorter length of α-helical 
part of SP-C25+pp is the reason for a higher required amount of SP-C in lipid/protein 
mixtures to induce the formation of stacked multilayer structures. 
The results so far indicate that removing the palmitoyl chains or shortening the 
α-helix of SP-C reduces the potential of the peptide to form multilayers.  5 mol% of 
SP-C34-pp and 2.5 mol% of SP-C25+pp were necessary to obtain similar isotherms as the 
one formed for lipid monolayers with 0.4 mol% of native SP-C (see figure 3.1.18). 
Further investigations with e.g. fluorescence light microscopy and scanning force 
microscopy were therefore performed with monolayers containing these peptide 
concentrations. 
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Figure 3.1.18  Compression isotherms of DPPC: DPPG  (80:20, mol/mol) and native SP-C 
(pSP-C35+pp), non-palmitoylated SP-C (SP-C34-pp) or shorter palmitoylated SP-C (SP-C25+pp) with 
a concentration that provided similar plateau regions.  The films were performed on pure water 
(pH 5.6) at 20°C. 
 
It can be deduced that palmitoylation is more relevant for the physiological   
function of SP-C than the α-helical length.   
 
The further studies investigate the N-terminal effect of SP-C on lipid 
monolayers beased on truncated SP-C with only 17 or 13 residues which were mixed 
with the main surfactant lipids DPPC and DPPG in a molar ratio of 80:20 mol/mol. 
Varying concentrations of SP-C were also used from 0.4 to 10.0 mol%.  
Both palmitoylated pSP-C17+pp or non-palmitoylated pSP-C17-pp showed no 
plateau region at high surface pressure (even above 50 mN m-1) and showed a hase 
behavior like pure lipid films (figure 3.1.15). Interestingly, with palmitoylated SP-C 
(pSP-C17+pp), a squeeze-out of lipid and/or peptide from the monolayers even at a low 
peptide concentrations (0.4 mol%) was observed.  This material loss however did not 
seem to be dependent on the concentration of pSP-C17+pp because the isotherms did not 
change significantly when the monolayers were compressed above 30 mN m-1.  It can 
therefore be assumed that the peptide aggregates in the monolayer under formation of 
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peptide rich domains.  This aggregation is possibly mediated by the palmitoyl chains, a 
feature which would be in line with the results obtained for pure peptide monolayers 
(see chapter 3.1.4).  Also polar interactions between the phospholipid head-groups and 
the polar charged and non-charged residues of the N-terminal part of SP-C are possible 
[82-83].   
Films with non-palmitoylated pSP-C17-pp , on the other hand, only showed a loss 
of peptide from the monolayer interface.  From these film balance measurements, 
however, it is not possible to say if pSP-C17-pp equally aggregates as its palmitoylated 
analogue. Since there is no report about the biophysical behavior of these peptide in the 
literature except for one on the conformation of pSP-C17-pp in lipid micelles [146].  No 
far the information on their orientation in monolayers is available. 
 
SP-Cs containing only 13 residues with and without palmitoylation (pSP-C13± pp) 
were mixed with lipids (DPPC:DPPG in a molar ratio of 4:1) with varying peptide 
concentrations. Both peptides showed no observable plateau region and were therefore 
comparable to pSP-C17± pp films (figure 3.1.16).  The peptides are excluded from the 
lipid monolayers at high surface pressure especially at high pSP-C13± pp content (10.0 
mol%).  The same behavior was with pSP-C13L1W which showed no plateau region and 
an exclusion of the peptide from the monolayer.  Unlike the pSP-C13-pp films, 
monolayers with pSP-C13L1W are shifted to slightly higher molecular areas, especially at 
lowe peptide concentrations.   This is a sign for unfavorable interactions occurring 
between pSP-C13L1W and the lipids compared to pSP-C13± pp. The reason for this might be 
that in pSP-C13L1W a non-polar linear amino acid (leucine) is substituted by an aromatic 
ring (tryptophan), and might therefore have an expanding effect on the monolayer.  
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3.2 Fluorescence microscopy of truncated SP-C in lipid/peptide 
monolayers 
 
Isotherms provide thermodynamic information about the phase behavior of surface 
active substances at the air/water-interface, but it is not possible to determine the lateral 
organization of molecules. Therefore the technique of epifluorescence microscopy at the 
air/water-interface was developed [208-209].  Fluorescence microscopy techniques 
provide visual confirmation that films from surfactant lipids and pulmonary extracts 
undergo phase transitions during dynamic compression at an air-water interface 
[210-211].  In this work fluorescence microscopy was used to study the influence of 
different SP-C peptides on the phase behavior of DPPC/DPPG monolayers. 
 
 
3.2.1 Fluorescence 
 
The phenomenon of fluorescence became known by the middle of the 19th century. 
Stokes made the observation that the mineral fluorspar fluoresces when ultraviolet light 
is directed upon it and coined the word ‘fluorescence’ [212].  Stokes also observed that 
the fluorescing light has a longer wavelength than the excitation light. 
The fluorescence molecules absorb energy and are promoted into an excitated 
state, in which they suffer collisions with neighbouring molecules. Thereby they loose 
energy and drop down the ladder of vibrational energy niveaus. If the neighbouring 
molecules are not suitable to receive the energy difference corresponding to the 
transition of the fluorescence molecule into its fundamental electronic state these 
fluorescence molecules stay in the excitated state to emit the energy as radiation. This 
process is accompanied by a vertical electronic transition following the Franck-Condon 
principle. The fluorescence spectrum gets its characteristic vibrational structure, which 
is a reproduction of the electronic ground state.  
This mechanism also describes the shift of the emitted light to smaller 
frequencies compared to the absorbed radiation. The transition occurs after a part of the 
excitation energy was transferred to molecules of the environment, thus the difference 
to the electronic ground state becomes smaller. The intensity of fluorescence depends 
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on the ability of solvent molecules to absorb the eletronic and vibrational quantums of 
the fluorescence probe. If the vibrational niveaus of the solvent molecules are far apart 
(e.g. water), large quantums of electronic transitions can be absorbed and quenched. 
 
 
3.2.2 Fluorescence dye 
 
Due to the fact that most surface active substances do not show fluorescence, assistant 
molecules with fluorescence properties have been synthesized. The morphology of 
monolayers at the air/water-interface can hence be visualized by using fluorescence 
dyes. These fluorescence dyes facilitate to observe areas of different physical states in 
phospholipid monolayers. Many different fluorescence dyes have been developed either 
to increase the yield of emission light or to improve the suitability for the investigated 
probes. The use of fluorescence dyes increases the number of components of a 
monolayer. This necessitates to investigate the phase behavior of a n + 1 component 
system. To minimize the interactions between samples and fluorescence dyes, 
molecules have been synthesized, which are highly similar to phospholipids, to decrease 
the influence of these guest molecules on the observed monolayer. Additionally, the 
concentration of fluorescence dyes should be as small as possible to decrease their 
influence on the phase behavior of the investigated sample. The fluorescence dyes, 
Bodipy-PC, which is generally used to visualize the morphology of phospholipid 
monolayers, is depicted in figure 3.2.1. Due to its molecular architecture the interactions 
between Bodipy-PC and surrounding phospholipids in the liquid expanded phase are 
higher than the interactions of Bodipy-PC and phospholipids in the liquid crystalline 
phase. The closer package of hydrocarbon chains of the phospholipids in the liquid 
crystalline phase hinders guest molecules from an incorporation into this phase. 
Despite the fact that the addition of Bodipy-PC has a concentration dependent 
influence on the isotherms of pure lipids [213], no significant changes of the isotherms 
of the lipid/protein mixtures were observed when small amounts of these probes where 
used (~1 mol%).  Therefore, in this work, the labeled lipid Bodipy-PC was used in a 
concentration of 0.2 mol%. 
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Figure 3.2.1  Fluorescence dye used as assistant molecules in monolayers at the air/water-
interface. Due to their homogeneous distribution in only one physical state of the monolayer 
they show a high contrast between two different physical states. The fluorescence dye presented 
is Bodipy-PC (2-(4,4-difluoro-5-methyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl)-1-
hexadecanoyl-sn-glycero-3-phosphocholine, β-BODIPY 500/510 C12-HPC) [185]. 
 
 
3.2.3 Epifluorescence microscopy 
 
Epifluorescence microscopy is an excellent method for studying fluorescing materials 
either in their natural form (primary or autofluorescence) or when treated with 
chemicals capable of fluorescing (secondary fluorescence). The basic task of the 
fluorescence microscope is to permit excitation light to irradiate the specimen and then 
to separate the much weaker re-radiating fluorescent light from the brighter excitation 
light. Thus, only the emission light reaches the detector and the resulting fluorescing 
areas shine against a dark background with sufficient contrast to permit detection by a 
CCD camera connected to a microscope.   
Due to the inhomogeneous distribution of the fluorescence dyes in the different 
lipid phases high contrast maybe obtained between them. Thus the use of fluorescence 
dyes, which are soluble especially in the liquid expanded phase of phospholipids, makes 
it possible to distinguish between the liquid expanded phase, showing high intensity of 
emission light (bright areas), and the liquid crystalline phase, showing low intensity 
(dark areas).  The so-called “domains” have a diameter in the range of micrometers (ex. 
figure 3.2.4) and are therefore observable by using a light microscope.  Figure 3.2.2 
displays a compression isotherm of DPPC and fluorescence pictures, which are taken at 
different surface pressures indicating differences in surface morphology.   
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Figure 3.2.2   A compression isotherm of DPPC with fluorescence pictures that were taken at 
different surface pressures indicating gas, le/lc and solid phase. 
 
 
3.2.4 Experimental setup 
 
The fluorescence of the monolayer was excited and visualized by an epifluorescence 
microscope (Olympus STM5-MJS, Hamburg, FRG). The trough of the film balance was 
placed on a specially designed stage (Riegler and Kirstein, Mainz, FRG) for the 
microscope. With the help of the remote controlled stage, the trough could be moved 
independently in the three directions of the axes (x, y, z) of a Cartesian coordinate 
system where the x and y axes were oriented perpendicular to the optical axis, z, of the 
objective lens. For excitation, a high-pressure mercury lamp (URFL-T, Olympus) with a 
power of 50 Watt was used. The excitation light was passed through a filter and 
reflected down to the water surface via a dichroic mirror. The fluorescence from the 
surface was collected by an objective lens (50x, LMPlanFl, Olympus) and passed 
through the dichroic mirror and an additional barrier filter. Images of the monolayer 
were taken with a CCD camera (C4742-95, Hamamatsu), which is used to detect 
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differences in the emission light intensities, via a video relay lens. The images were 
viewed and stored on a computer. FLM images were converted to 256 × 255 pixels, a 
resolution of 254 × 254 dpi and decreased to a colour depth of 8 BPP. Care was taken to 
keep a constant gain during the experiments.  The experimental setup is schematically 
drawn in figure 3.2.3. 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 3.2.3  Schematic of Epifluorecence microscopy with film balance. 
 
All experiments were performed on pure water (Milli-Q quality, pH 5.6) at 20°C 
on a Riegler & Kirstein film balance. The barrier was moved with a velocity of 
5.81 cm2min−1. Prior to taking images the barrier was stopped at the requested lateral 
pressure and the monolayer was equilibrated for several minutes. 
 
 
Preparation of fluorescence phospholipid solutions 
 
The phospholipid solutions either with or without surfactant peptides were prepared as 
described in detail in section 3.1.3.  The mixture of DPPC:DPPG with a ratio of 80:20 
mol% and a varying concentration of native or truncated peptides have been prepared.  
The methanolic solution of Bodipy-PC was adjusted to a concentration of 25 µM. All 
solutions were stored at -20 °C and were stable for months. The fluorescence mixtures 
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were prepared directly before their measurement and contained 0.2 mol% of 
Bodipy-PC.  The mixture was shaken and spread directly onto the surface of the film 
balance. Milli-Q water was used as subphase in all experiments. 
 
 
Gathering images with the epifluorescence microscope 
 
The film balance was placed on a moveable table, which could be controlled by a 
joystick. This setup was used to take images at different positions at the air/water 
interface to control the homogeneity of the monolayer’s morphology. Series of five 
images were taken due to the fact that the monolayers show high mobility at the surface 
especially at low surface pressures. Sometimes a couple of series had to be taken to get 
a sharp image of the monolayer. During the photo-shooting the barrier of the film 
balance was stopped and the monolayer was equilibrated to the surface pressure for 
several minutes. 
 
 
3.2.5 Morphology of lipid/different SP-C systems 
 
As described in section 3.1.5 film balance measurements revealed a concentration-as 
well as SP-C-type dependent influence on the phase behavior of phospholipids at the 
air/water interface. Consequently, to characterize the different morphologies of 
lipid/peptide mixtures at various lateral pressures epifluorescence microscopy imaging 
was performed.  Each lipid/peptide system is illustrated in the following sections. 
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3.2.5.1 Morphology of DPPC:DPPG (4:1) mixtures with SP-Cnative (pSP-C35+pp) 
 
Different lung surfactant model systems with 0, 0.4 and 1.5 mol% SP-C were 
investigated to visualize the lateral lipid and protein distributions. The fluorescence 
light microscopy (FLM) images taken from the SP-C containing monolayers revealed 
that in the low surface pressure region the film demixed into two phases (figure 3.2.4). 
By comparison with pure lipid monolayers, the observed phases could be identified as 
an expanded (le) and a condensed phase (lc) discernible by the appearance of dark 
domains (lc phase) embedded in a bright domain (le phase) [87,101] (as already 
described in section 3.2.3).   
Considering the dye molecule used, fluorescence was observed in the regions of 
the le phase, which is the less dense phase. At 5 mN m-1 kidney shaped domains are 
visible in pure lipid monolayers as well as in the mixtures containing 0.4 and 1.5 mol% 
SP-C35+pp. The diameter of these domains depends on the amount of peptide present in 
the monolayer – it decreases when the SP-C concentration is higher (e.g. 15-25 µm at 0 
mol% SP-C, 10-20 µm at 0.4 mol% SP-C and 10-15 µm at 1.5 mol% SP-C).  On 
compression of pure lipid monolayers as well as of lipid/SP-C mixtures to a surface 
pressure beyond 10 mN m-1, fluorescence decreased due to quenching effects leading to 
a low contrast of the images. This contrast continuously decreased in the case of pure 
DPPC/DPPG films when compressing the monolayer further.  
In the case of lipid/protein mixtures, however, on compression in the collapse 
region at 55 mN m-1, an increase in contrast was clearly recognizable in the images. A 
detailed analysis of such images [87] showed that this effect could be explained by an 
increasing fluorescence intensity in the regions of the former le phase.  Another 
phenomenon was visible when higher amounts of peptide were used. The domain shape 
clearly changed from kidney to polygonal or flower shaped upon continuous 
compression.  However the re-increasing fluorescence intensity is also observed at high 
surface pressure in films with higher SP-C content. 
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Figure  3.2.4  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC in DPPC:DPPG (80:20 mol/mol) monolayers with different concentrations of 
pSP-C35+pp.  All films were measured on a pure water subphase (pH 5.6) at 20 °C.  The image 
size is 130x130µm2. 
 
 
3.2.5.2 Morphology of DPPC:DPPG (4:1) mixtures with non-palmitoylated SP-C 
(SP-C34-pp) and truncated SP-C (SP-C25+pp)  
 
In order to study the influence of non-palmitoylated SP-C34-pp and truncated SP-C25+pp 
on the morphology of lipid monolayers a peptide concentration was chosen, where a 
plateau was found that corresponds in length and height to the one found in monolayers 
with native SP-C (see figure 3.1.12). Therefore, FLM images were taken for lipid 
monolayers containing 5 mol% SP-C34-pp and 2.5 mol% SP-C25+pp at different surface 
pressures (figure 3.2.5).  
 
 
 
50 µm
Chapter 3: 3.2 FLM of truncated SP-C in lipid/peptide monolayers 91
Although the isotherms of the modified peptides display similar characteristics 
as the isotherms of the model system containing native SP-C the FLM images clearly 
differ from each other. At a surface pressure of 5 mN m-1 no round or kidney shaped 
domains are visible in the monolayers of the two modified peptides. Instead a dark 
meshwork of condensed material within a bright matrix of fluid lipids is observed which 
is more pronounced in the case of 2.5. mol% SP-C25+pp. Increasing the surface pressure 
leads to a clear reduction of contrast in FLM images of monolayers containing SP-C34-pp 
and SP-C25+pp. This contrast however intensifies when the plateau surface pressure of 
50-52 mN/m is reached. 
 
 
Surface pressure [mN m-1] 
DPPC:DPPG:  
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Figure  3.2.5  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC in DPPC:DPPG (80:20 mol/mol) monolayers with 5.0 mol% SP-C34-pp or 2.5 
mol% SP-C25+pp.  All films were measured on a pure water subphase (pH 5.6) at 20 °C.  The 
image size is 130x130µm2. 
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3.2.5.3 Morphology of DPPC:DPPG (4:1) mixtures with pSP-C17± pp 
 
Shorter SP-Cs have been synthesized in order to investigate the effect of α-helical 
length and palmitoylation on the domain formation at the air/water interface. SP-C with 
17 residues with and without palmitoylation (pSP-C17± pp) were added to a lipid mixture 
of DPPC:DPPG at a molar ratio of 4:1 with different peptide concentrations.  Figure 
3.2.6 illustrates the morphologies of lipid films with varying concentrations of 
pSP-C17+pp at different surface pressures.  The lc phase domains (diameter 5-15 µm) are 
smaller than the ones found in pure lipid mixtures. However, the films depict a good 
contrast especially at low surface pressure (5 mN m-1).  At the same surface pressure 
films containing 2.5 mol% of pSP-C17+pp showed a rather poor contrast because of the 
high fluidity of the monolayer.  
The absolute area occupied by the le phase becomes larger when increasing the 
peptide concentrations and is highest at 10.0 mol% pSP-C17+pp. In addition, the 
appearance of the lc phase domains changes from kidney-shaped at 0.4 mol% 
pSP-C17+pp to round and polygonal at higher pSP-C17+pp contents (5.0 and 10.0 mol%). 
On further compression these films lose their contrast i.e. fluorescence intensity 
decreases from 5 mN m-1 until it vanishes due to self-quenching of the accumulated 
fluorophors [200] at a surface pressure of 30 mN m-1.  After that the fluorescence 
intensity reappears at ~50 mN m-1 but not as clearly as found in native SP-C systems. At 
a peptide content of 10.0 mol% the film morphology strongly differs from the ones at 
law SP-C concentrations.  Increasing the pressure leads to a fusion of the small lc phase 
domains and the formation of a wide-stretched network.  
 Figure 3.2.7 depicts FLM images of films with various concentrations of 
pSP-C17-pp mixed with lipids at different surface pressures. The influence of mixing this 
peptide into lipid films causes a reduction in size and change in shape of the lc phase 
domains. The lc phase domain diameters are around 5-10 µm at 0.4 and 2.5 mol% 
pSP-C17-pp at 5 mN m-1. Increasing the peptide content results in an increase of the le 
phase area. This behavior corresponds to the one found in the pSP-C17-pp systems except 
that smaller lc domains (diameters less than 5 µm) are obtained. Interestingly, the 
general appearance of the monolayers with depalmitoylated pSP-C17-pp is characterized 
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by a higher fraction of fluid phase, i.e. bright regions, at all surface pressures compared 
to the palmitoylated system. 
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Figure  3.2.6  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC in DPPC:DPPG (80:20 mol/mol) monolayers with different concentrations of 
pSP-C17+pp.  All films were measured on a pure water subphase (pH 5.6) at 20 °C.  The image 
size is 130x130µm2. 
 
 
 
 
 
50 µm
Morphology of lipid/different SP-C systems 94
 
 
Surface pressure [mN m-1] DPPC:DPPG: 
[ x mol%] 
 pSP-C17-pp  5 15 30 ~50 
0.4 
 
   
2.5     
5.0     
10.0     
 
Figure  3.2.7  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC in DPPC:DPPG (80:20 mol/mol) monolayers with different concentrations of 
pSP-C17-pp.  All films were measured on a pure water subphase (pH 5.6) at 20 °C.  The image 
size is 130x130µm2. 
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3.2.5.4 Morphology of DPPC:DPPG (4:1) mixtures with pSP-C13 ± pp 
 
In order to investigate the influence of the N-terminal part of SP-C on the morphology 
of lipid mixtures, truncated pSP-C13± pp was used.  Figure 3.2.8 and 3.2.9 depict FLM 
images obtained from monolayers with various concentrations of pSP-C13+pp and 
pSP-C13-pp, respectively, in lipid mixture at different surface pressures. The 
palmitoylated peptide, pSP-C13+pp, shows the same behavior as pSP-C17+pp in decreasing 
the size of the lc phase domains. Interestingly, this effect is less pronounced than for 
pSP-C17+pp: the diameter of lc phase domains is around 10-15 µm for 0.4 mol% peptide 
in monolayers with
 pSP-C13+pp. Where as the ones found for pSP-C17+pp are 5-10 µm. 
The peptide truncated to 13 residues seems to have a less disturbing effect on the 
morphology of lipid monolayers.
  
At high peptide contents (5.0 and 10.0 mol% of pSP-C13+pp) the influence on the 
shape of lc phase becomes stronger and a change from round to polygonal patches is 
obvious. Also, at these concentrations, the fluidizing effect of this peptide, however, 
seems to be stronger than the one of pSP-C17+pp leading to smaller dark lc domains. 
Increasing the surface pressure leads in the case of monolayers with 0.4 mol% 
pSP-C13+pp to some very bright small le phase areas at 15 and 30 mN m-1 surface 
pressure, which vanish at 55mN m-1.This effect was not observed at other peptide 
concentrations.  
 pSP-C13-pp, too, had a less pronounced fluidizing effect than pSP-C17-pp at low 
peptide concentrations. This effect was again inverted at a pSP-C13-pp content higher 
than 5.0 mol%. In comparison to the palmitoylated analogue pSP-C13+pp, smaller and 
more aggregated lc domains were observable. Increasing the surface pressure at a 
defined peptide concentration leads to a strong decrease in contrast which doesn’t 
increase again at 55 mN m-1. Increasing the peptide concentration leads to more 
polygonal than round shaped lc domains which aggregate under the formation of an 
extended network-like structure. Interestingly, in monolayers containing 10.0 mol% 
pSP-C13-pp at 30 mN m-1surface pressure bright small le phase spots in the lc phase 
appear as domains, which turn to become more grey areas at ~55 mN m-1.  
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Figure  3.2.8  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC in DPPC:DPPG (80:20 mol/mol) monolayers with different concentrations of pSP-
C13+pp.  All films were measured on a pure water subphase (pH 5.6) at 20 °C.  The image size 
is 130x130µm2. 
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Figure  3.2.9  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC in DPPC:DPPG (80:20 mol/mol) monolayers with different concentrations of pSP-
C13-pp.  All films were measured on a pure water subphase (pH 5.6) at 20 °C.  The image size 
is 130x130µm2. 
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3.2.5.5 Morphology of DPPC:DPPG (4:1) mixtures with substituted truncated 
SP-C (pSP-C13L1W) 
 
Figure 3.2.11 illustrates the effect of the truncated peptide pSP-C13L1W on DPPC:DPPG 
(80:20 mol/mol) monolayers. The effect of this peptide caused a similar expansion of 
the isotherm as did pSP-C13-pp and was squeezed out from the interface, although at a 
somewhat higher surface pressure of 25 mN m-1.  FLM images, however, are different 
from those found for pSP-C13-pp systems even though the peptide molecules are very 
similar. The observed FLM images of monolayers containing low amounts of 
pSP-C13L1W rather resemble the ones of pure lipid films. Increasing the peptide 
concentration results in an increase of le phase and a change of the lc domain shape (at 
o.4 mol%) from round to polygonal (at 10 mol%).  Compression of either film to a 
higher surface pressure results in larger and more closely packed dark domains, which 
continue to grow at the expense of the brighter domains. A slight re-increasing 
fluorescence intensity is found at high surface pressure (~55 mN m-1) in monolayers 
with more than 5.0 mol% pSP-C13L1W, but this is not as obvious as in the native SP-C 
systems. 
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Figure  3.2.10  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC in DPPC:DPPG (80:20 mol/mol) monolayers with different concentrations of pSP-
C13L1W films.  All films were measured on a pure water subphase (pH 5.6) at 20 °C.  The 
image size is 130x130µm2. 
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3.2.6 Discussion 
 
By means of fluorescence light microscopy (FLM) the morphology of lung surfactant 
model systems containing DPPC:DPPG in a molar ratio of 80:20 and various types of 
SP-Cs were investigated. As a reference the standard model system for lung surfactant 
from previous studies [86-87,200,202], DPPC:DPPG: pSP-C35+pp (80:20:0.4 
mol/mol/mol), was used, as well as a pure lipid mixture consisting of DPPC:DPPG; 
80:20 mol/mol (as shown in figure 3.2.4).   
 According to the isotherms of pure lipid mixtures and pSP-C35+pp/lipid films, the 
compression characteristics of both films are quite similar at low surface pressures. In 
contrast to the pure lipid film, however, the lipid/pSP-C35+pp mixture exhibited a distinct 
plateau in the phase diagram at a surface pressure of about 50 mN m-1 which is 
attributed to a protrusion formation as mentioned before [87]. The FLM images 
confirmed the similarity between the surfactant model system and the lipid film in the 
region of low film pressures (5 mN m-1). At this pressure the le phase (bright area) is 
assumed to be enriched in dye molecules and protein, whereas the lc phase (dark area) 
probably is enriched in DPPC [214].  These films displayed a typical phase transition 
from the le phase to the lc phase [200] accompanied by a loss of fluorescence intensity 
at surface pressures higher than 10 mN m-1.  
On further compression lipid/protein films showed, in contrast to pure lipid 
monolayer, the re-appearance of fluorescence intensity. This rise in fluorescence 
intensity had to be due to the relaxation of the monolayer in distinct regions of the film 
but not because of an increasing emission of fluorescence light by single dye molecules 
[86].  This phenomenon was explained by the formation of three-dimensional 
protrusions on the film at the plateau region [87] which remain in contact with the 
monolayer at the surface at all stages of compression and expansion.  
Increasing the pSP-C35+pp concentration in lipid/protein films caused an increase 
in film fluidity resulting in more observable le phase domains in FLM images at low 
surface pressure.  Since the domain size and shape of the lc phase is known to depend 
on the type and concentration of incorporated protein [200] the size and shape of the lc 
phase was changed in monolayers with 1.5 mol% of pSP-C35+pp. However protrusions 
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were also observed in lipid/peptide films with higher concentration in pSP-C35+pp, as can 
be seen from the re-appearance of fluorescence intensity at high surface pressure. 
  
Non-palmitoylated native SP-C (SP-C34-pp) and truncated SP-C with 
palmitoylation (SP-C25+pp) showed different morphologies than the ones found in native 
SP-C systems.  At low surface pressure there is no clear contrast of fluorescence 
intensity in both films. The reason for this might be the high peptide concentration used 
resulting in highly fluid lipid/peptide films and significantly changed lc phase shapes. 
Despite the loss of fluorescence intensity at low surface pressure, the intensity of 
fluorescence subsequently reappears at high surface pressure. It is conceivable that the 
formed protrusions are considerably smaller or less extended if the reduced plateau 
lengths in the corresponding isotherms are considered (chapter 3.1.5).  This would be 
consistent with a previous study by Kramer et al., 2000 [205] that showed similar 
results, i.c. the appearance of small protrusions from monolayers with labeled 
non-palmitoylated SP-C. 
  
The truncated SP-Cs with 17 residues with or without palmitoylation 
(pSP-C17±pp) showed smaller lc phase domains than the ones found in native SP-C 
systems at low surface pressures (both for monolayers with pSP-C17+pp and pSP-C17-pp).  
Only a reduction in fluorescence intensity is observed upon further compression of the 
films.  According to the isotherms (figure 3.1.15), no plateau region at surface pressures 
higher than 50 mN m-1 is observed. No protrusion formation seems to occur at this 
pressure that would be correlated to the reappearance of fluorescence intensity.  The 
slight increase of fluorescence intensity in the le phase at this surface pressure is 
probably only due to an the aggregation of peptides in pSP-C17+pp containing films, 
especially in monolayers with 10.0 mol% peptide (figure 3.2.6).  
Interestingly at 0.4 mol% pSP-C17-pp there is a light grey border around the lc 
domains indicating a fluorescence dye accumulation, a feature which has already been 
observed in SP-B systems [200] at the same high surface pressure (~50 mN m-1). 
Increasing the peptide concentration of pSP-C17-pp has the same fluidizing effect on 
lipid/peptide films leading to a reduction in size and change of the shape of the lc phase 
as was observed in the previous peptide systems. It leads to the fact that depalmitoylated 
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peptide exhibits more fluid phase indicating a higher disturbing effect to monolayer. 
This depalmitoylated peptide showed a more homogenous distribution whereas 
palmitoylated peptide pSP-C17+pp seems to aggregate from the monolayer. Therefore it 
induces less fluid phase even with increasing peptide concentration. 
  
Although pSP-C13+pp and pSP-C13-pp both have a fluidizing effect on the 
monolayers compared to the native system, this effect is not as pronounced as with 
pSP-C17+pp or pSP-C17-pp at low peptide concentrations. This effect can be attributed to 
the smaller size of pSP-C13+pp or pSP-C13-pp and the less “disturbing” effect in the 
monolayer.  However, the situation is different when more than 5.0 mol% pSP-C13+pp or 
pSP-C13-pp are used.  They have a stronger fluidizing effect at these concentrations than 
pSP-C17+pp or pSP-C17-pp, which is rather surprising and can only be explained by 
different intermolecular interactions between the peptides and/or lipids.   
Interestingly, at higher surface pressures, the observed lc domains decrease in 
size and are surrounded by grey regions.  This could be explained by the squeeze-out of 
fluorescent dye and peptides from the monolayer, a result that would correlate with the 
already discussed isotherms (chapter 3.1.5) revealing the low stability of pSP-C13± pp 
monolayers. Such a squeeze-out has already been postulated by Bi et al. (2002) [173] 
from IRRAS measurements of pSP-C13+pp in DPPC or DPPG monolayers. Also 
Plasencia et al. (2001 and 2004) [172,215] found an aggregation of peptides with 
depalmitoylated 13 residues at higher surface pressures, which would explain first the 
grey boundaries and the squeeze-out.  
Furthermore, pSP-C13-pp has more fluidizing and disturbing effect on the lipid 
mixture than pSP-C13+pp.  This is obvious from the smaller lc phase domains found in 
lipid/pSP-C13-pp mixtures, especially at high concentration of peptide and high surface 
pressure.  The reason for this could be that pSP-C13+pp has a higher tendency to form 
peptide aggregates, a feature probably induced by the acyl chains.  Such peptide 
aggregates would disturb the monolayer less than homogenously distributed single 
molecules. 
The modified analogue pSP-C13L1W has a clearly different influence on lipid 
monolayers than the structurally familiar pSP-C13-pp.  It seems that this peptide almost 
does not effect the morphology of lipid films, especially at low concentrations. 
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Increasing the peptide content, however, induces the fluidization of the film and the 
change of size and shape of the lc phase. The substitution of tryptophan against leucine 
seems to have a significant effect on its interactions with lipids.  The tendency to form 
peptide aggregates must be higher than in pSP-C13-pp, a feature that is probably induced 
by strong hydrophobic interactions between the tryptophan of adjacent peptides. 
 
 
3.3 Topographical analysis of multilayer formation in lipid/peptide   
systems 
 
The topography of lung surfactant films can be investigated by using a technique that 
provides three-dimensional information about the sample surface: scanning force 
microscopy (SFM). It is a nondestructive technique to image the surface of biological 
samples in the nanometer scale. In recent years SFM has been developed as a powerful 
tool to investigate soft samples such as model membranes or even cellular surfaces 
under physiological conditions [216-223]. 
 
 
3.3.1 Scanning Force Microscopy 
 
In 1986 scanning force microscopy (SFM) or atomic force microscopy (AFM) was 
invented by Binnig, Quate and Gerber [224]. Like all other scanning probe microscopes, 
the SFM utilizes a sharp probe moving over the surface of a sample in a raster scan, 
while maintaining a constant applied force.  In the case of the SFM, the probe is a tip 
commonly made of silicon or silicon nitride closely positioned to the end of a flexible 
cantilevered bar. As the tip is moved over the material, it either continuously touches 
the surface and bends as it is repelled or attracted to the structure (contact mode) or 
periodically taps (tapping mode) the sample (figure 3.3.1 right).  In contrast to a 
scanning tunneling microscopy (STM), which detects the tunneling current between 
surface and tip, SFM can be used to image non-conductive materials. 
Since the cantilever obeys Hooke's Law for small deflections, the interaction 
force between the tip and the sample can be determined. The movement of the tip is 
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performed by an extremely precise positioning device made of piezo-electric 
ceramics, most often in the form of a tube scanner. The scanner is capable of sub-
angstrom resolution in x-, y- and z-directions. The z-axis is conventionally 
perpendicular to the sample (figure 3.3.1 left).  
 
 
Figure 3.3.1  (left) The basic SFM setup relies on a scanning tip and a detector. The tip, 
attached to the end of a cantilever, scans across the sample surface. The scanner is 
capable of sub-angstrom resolution in x-, y- and z-directions. A laser beam reflects from 
the top surface of the cantilever and is detected by a position-sensitive photodiode 
detector [225]. (right) The cantilever works as a spring, which converts a force into a 
deflection. The attractive or repulsive force between the tip and the sample causes a 
deflection of the cantilever towards or away from the sample. The deflection is 
measured by a laser beam focused on the back of the cantilever. As the cantilever 
deflects, the angle of the reflected beam changes, and the spot falls on a different part of 
the photodetector. The signals from the four quadrants of the detector are compared to 
calculate the deflection signal [226]. 
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3.3.1.1 Operation modes 
 
The two most commonly used modes of operation are contact mode and tapping mode, 
which can be operated in either air or liquid environments [178].  The forces between 
tip and sample are a function of their distance d, which can be described by the 
Lennard-Jones potential (figure 3.3.2). In case of large distances, attractive interactions, 
e.g. van-der-Waals interactions, cause an approach of the tip to the sample. By reducing 
the distance between tip and sample, repulsive forces appear. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.2  Forces between tip and sample during the approach of the SFM tip. The contact 
and tapping mode are indicated [185,227]. The contact mode is operated at distances almost 
predominating repulsive forces. Hence, the contact of tip and sample is maintained during the 
scan.  On the other hand, tapping mode is applied when attractive forces are deflectable at larger 
tip-sample distances.  Ideally the tip does not touch the sample surface. 
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I. Contact mode   
 
A SFM operating in the contact mode scans the probe across a sample surface, while 
monitoring the change in cantilever deflection with a 4-quadrant (4-Q) photodiode 
detector. A feedback loop maintains a constant cantilever deflection by vertical 
movement of the scanner to maintain a constant photo detector difference signal. The 
scanner moves vertically at each data point and the signal of the photodiode is recorded 
by the computer to form the topographic image of the sample surface (figure 3.3.3).  
If the tip were scanned at constant height, there would be a risk that the tip 
would collide with the surface and provoke surface damage. In most cases, a feedback 
mechanism is employed to adjust the tip-to-sample distance, which guarantees a 
constant force between the tip and the sample.  
 
Feedback operation 
 
The SFM can principally be operated with and without feedback modes. If the 
electronic feedback is switched on, the positioning piezo that is moving the tip up and 
down, responds to any detected changes in force and alters the tip-sample separation to 
restore the force to a pre-determined value. This mode of operation is known as 
constant force and usually enables a fairly faithful topographical image (or so called 
height mode). 
If the feedback drive is switched off, then the microscope is operated in constant 
height or deflection mode. This is particularly useful for imaging very flat samples at 
high resolution [228].  
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Figure 3.3.3  AFM: Contact mode. The sharp tip is in contact with the surface of the sample. It 
scans line by line over the surface. (left) The surface and the cantilever with tip are sketched. 
(right) The obtained profiles are plotted. A three-dimensional profile of every line is stored and 
stitched together to get a real three-dimensional image [229]. 
 
 
Force-distance curve 
 
Recording the cantilever deflection as a function of distance from contact yields a force-
distance curve at a single point of the surface (figure 3.3.4). The surface forces cause a 
deflection of the cantilever. Force-distance curves convey valuable information on the 
nature and strength of surface forces, the cleavage of a single molecular bond (single 
molecule force spectroscopy) and the folding and unfolding of proteins by confining the 
molecules between the SFM tip and a surface. 
 
 
 
 
 
 
Scanning force microscopy 108
 
 
 
 
 
 
 
 
 
Figure 3.3.4  Example of a force-distance curve: The cycle starts at position (1): the tip is far 
away from the surface, and no attractive and repulsive forces act on the tip (equilibrium; free 
cantilever regime). (2) As the tip approaches, it enters the range of surface forces and is 
deflected (in this case downwards by an attractive force). Finally, the tip touches the surface. (3) 
The tip still moves down onto the surface and now exerts pressure on the surface until retraction 
starts. (4) Adhesion forces may keep the tip attached to the surface until the spring force exerted 
by the cantilever can overcome adhesion. Then, the tip snaps back into the free cantilever 
regime and the cycle starts again. 
 
 
II.  Tapping mode  
 
Tapping mode is the next most common mode used in AFM. The sample can be 
measured under physiological conditions; in ambient air or in a liquid.  In operation the 
cantilever is oscillated at its resonant frequency (~300 kHz) and positioned above the 
surface so that it only taps the surface for a very small fraction of its oscillation period, 
but ideally no contact occurs. Lateral forces are dramatically reduced as the tip scans 
over the surface. The laser deflection method is used to detect the root-mean square 
amplitude of cantilever oscillation. The feedback loop maintains constant oscillation 
amplitude by moving the scanner vertically at every data point, until the set amplitude is 
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adjusted. The topographic image is generated of the recorded data of this piezo 
movement and the feedback signal respectively [178] (figure 3.3.6).  
The tapping mode is an adequate operating mode in comparison to contact mode 
because of less contact between tip and sample resulting in a preservation of the probe, 
in less lateral forces [230] and in a gentle treatment conserving the integrity of the 
sample. 
Other methods of obtaining image contrast are also possible. An image 
originates from the amplitude signal, as there are small variations in the amplitude due 
to the control electronics being unable to respond instantaneously to changes of the 
specimen surface [228].  The resulting phase image (also called a contrast image) 
contains information about the chemical composition, adhesive properties and 
viscoelasticity of the sample. Phase images are obtained side-by-side with the height 
images to reveal surface features that would not show up in either image alone [225]. 
Another option in order to obtain the same configuration as phase image is using 
derivative image.  It is a derived height image to distinguish different surface 
compositions.  Moreover, the important caution of a height analysis is that it has 
generally an error of 1-2 nm. 
In this study the tapping mode SFM in ambient air is the main technique to 
investigate the topographical information of various lipid/peptide films because of its 
wide advantages compared to contact mode. 
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Figure 3.3.5  In tapping mode 1) the oscillating tip delineates the drive amplitude in this 
operating mode (A0 and A1 in case of approach). The top image shows the free oscillating 
cantilever far away from the surface; the amplitude is A0. The next image shows the tip in 
measuring position; the amplitude has decreased to the value A1. The amplitude A1 varies due to 
differences in height and material of the specimen. The feedback signal regulates A1 according 
to the set drive amplitude A0 and the gains [229]. 
 
 
3.3.2 Langmuir-Blodgett-Transfer (LB-Transfer) 
 
The preparation of solid supported monomolecular films was introduced by Blodgett 
and Langmuir in 1935 [183]. The LB-transfer is based on the use of a film balance. A 
lipid monolayer is spread on the air/water-interface and a mica sheet is dipped into or 
pulled out of the subphase through the lipid monolayer, which is thereby transferred to 
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the mica sheet. The repetition of this procedure allows the formation of lipid 
multilayers. The use of cleaved mica sheets provide an atomic plane surface for SFM 
images. 
 
 
3.3.2.1 Hydrophilic transfer 
 
Phospholipid monolayers or mixtures of lipid and peptides are transferred from the 
air/water-interface to a hydrophilic substrate with a plane surface (mica sheets). The 
mica sheet is pulled out of the subphase and the monolayer is transferred to the solid 
support by physisorption. The hydrophilic headgroups of the lipids interact with the 
hydrophilic surface of the mica and the fatty acid chains point to the air. This procedure 
can also be used to hydrophobize the surface of the mica sheets and to transfer a second 
monolayer in a hydrophilic transfer to generate a solid supported lipid bilayer (figure 
3.3.9). AFM measurements on hydrophilic transferred monolayers are performed in air 
in tapping mode. 
 
 
3.3.2.2 Hydrophobic transfer 
 
The investigations of lipid bilayers or protein-lipid-films are performed in aqueous 
solutions because bilayers are stabilized by water molecules. Therefore, the lipid 
monolayer has to be transferred with the hydrocarbon chains oriented to the mica sheet 
and the headgroups oriented to the aqueous solution. The hydrophobic transfer is an 
excellent technique to construct a model of lipid bilayers mimicking the attitude of 
biological membranes. This monolayer arrangement is achieved by an additional 
hydrophilic transfer of a lipid film in the solid state as the first monolayer (usually 
DPPC at a lateral pressure of 45 mN m-1) and a subsequent transfer of the second 
required monolayer (phospholipid or lipid/peptide mixture). Therefore, after the 
hydrophillic transfer, the mica sheet is dried. Then that mica sheet with the first lipid 
monolayer is dipped through the second monolayer at the air/water-interface into the 
subphase. The monolayer is transferred to the mica sheet in the fashion that the 
hydrocarbon chains interact with the fatty acid chains of the previously transferred 
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monolayer (first lipid monolayer) by hydrophobic interactions and the hydrophilic 
headgroups are oriented to the subphase (figure 3.3.9). Thus, the prepared phospholipid 
or lipid/peptide bilayers are only stable in an aqueous medium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.6 Langmuir-Blodgett-Transfer. (upper) Hydrophilic transfer illustrating the 
preparation of a hydrophobic surface and (lower) hydrophobic transfer forming a lipid bilayer. 
 
 
3.3.2.3 Preparation of membranes for the SFM 
 
The samples for scanning force microscopy were prepared by using a film balance with 
an area of 38.5 cm2 and a subphase volume of 25ml.  In the center of the film balance 
trough there is a hole of 1.5 cm diameter to place mica sheets in the subphase by 
dipping through the air/water interface or pulling them out of it. All transfers were 
performed in pure water (MilliQ quality) as subphase. 
For the transfer to a hydrophilic substrate the mica sheet was fixed to a lift and 
dipped into the subphase. Afterwards the mixture of phospholipid or/and various 
peptides (DPPC:DPPG with a ratio of 80:20 mol% and with or without different types 
and various concentrations of peptide) solution was spread to the surface and 
mica  
barrier 
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equilibrated for half an hour. Then the monolayer was then compressed with a velocity 
of 1.79 cm2min−1 to a final lateral surface pressure of 45-60 mN m-1, depending on the 
lipid film preparation and equilibrated again for half an hour.  
The mica sheet was pulled out of the subphase with a velocity of 0.7 mm min-1 
at a constant required lateral pressure (of 45-60 mN m-1 depending on the film). Finally 
the lipid film was dried for several hours. This constant surface pressure was guaranteed 
by reducing the surface area of the film balance during the transfer. Consequently, the 
monolayer was compressed about the same area that was transferred to the mica sheet. 
 
 
3.3.2.4 Experimental setup 
 
Surface images of the LB films were obtained at ambient conditions (20°C) applying a 
Bio-Scope/Nanoscope IIIa Dimension 3000 microscope controller from Digital 
Instruments (Santa Barbara, CA, USA) operating in tapping mode, using silicon 
NanoProbe tips (BS-Tap 300, Nanoscience Instruments Inc., Phoenix, AZ, USA) with a 
resonance frequency in air of 250–300 kHz.  
 
 
3.3.3 Topography and multilayer formation of lipid/peptide systems 
 
By means of film balance measurements the phase behavior of lipids and their mixtures 
with different peptides was analyzed. With epifluorescence microscopy the lateral 
organization of mixed lipid monolayers and the domain structures in the micrometer 
scale were visible. Scanning probe microscopy offers the unique possibility of obtaining 
a large variety of material parameters, especially information of topography, at high 
lateral resolution.  
 The films contained lipid mixtures and different types of peptides transferred 
onto mica sheets at different surface pressures (45-60 mN m-1).  After LB transfer the 
obtained solid supported layers were investigated by SFM imaging to obtain height 
information. 
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3.3.3.1 Influence of different pressures on the topography of lipid systems 
 
Figures 3.3.7A-C show SFM height images and height profiles obtained for LB films 
transferred at different surface pressures. The phospholipid mixture contained 
DPPC:DPPG in a ratio of 80:20 (mol/mol). The topographical images of monolayers 
transferred at the lowest pressure of 45 mN m-1 show no differences in height (figure 
3.3.7A).  Only some protrusions are visible in the height profile from the cross section 
(corresponding to the blue line in the topographical image) with around 6 ± 2 nm in 
height and 100 nm width (figure 3.3.7a).  In contrast to this, SFM images obtained at 
higher transfer pressures (55 and 65 mN m-1) displayed many holes (identified by dark 
spots in the image) with a depth of 6 nm and a diameter of 250 nm.  Increasing the 
surface pressure lead to a larger number of holes present in the LB film (figure 3.3.7B 
and C respectively).  Also more bright spots were visible at the highest pressure of 65 
mN m-1 with the same height and a somewhat increased cross sectional area compared 
to the bright spots obtained at a pressure of 45 mN m-1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.7  SFM height images and height profiles of DPPC:DPPG (80:20, mol/mol) 
monolayers transferred onto mica at 45 mN m-1 (A), 55 mN m-1 (B) and 65 mN m-1 (C). The 
image size is 10 x 10 µm2.  The scale of the topographical images is 10 nm for (A) and (B) and 35 
nm for (C). 
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3.3.3.2  SFM images of native SP-C systems 
 
Figure 3.3.8A and B show SFM images of lipid mixtures with 0.4 mol% or 10.0 mol% 
of native SP-C (pSP-C35+pp) transferred from the air/water interface to mica at a plateau 
pressure of ~50 mN m-1. The inset of each figure represents a high resolution image of 
the blue squared area (10 x 10 µm2 in size). The height profiles in figure 3.3.8a and b 
depict the height differences along the line drown in the insets. The derivative images 
corresponded to each high resolution image and are represented in the figure 3.3.8C and 
D. These derivative images are phase images, which are better suited to distinguish 
different surface compositions, than in the height images where different colors 
symbolize the height differences. 
The low resolution topographical image (figure 3.3.8A) of a DPPC:DPPG: 
pSP-C35+pp film (molar ratio of 80:20:0.4) shows large, flat and polygonal patches 
surrounded by a rim of protrusions which can be attributed to multilayers. These 
protrusions display distinct steps of 10 nm height difference as can be seen by the 
arrows in the height profile analysis. 
 Monolayers containing higher pSP-C35+pp contents (e.g. 10.0 mol%), as shown 
in figure 3.3.8B, depict much more groups of bright domains with higher protrusions 
and less steps than there are present in a film with 0.4 mol% pSP-C35+pp (figure 3.3.8A). 
In addition, the dark domains do not have the same shape as the polygonal patches 
found in samples containing 0.4 mol% SP-C but rather show no pattern at all.  
Moreover, those bright domains do not have a filamentous area around the dark patches 
as films containing 0.4 mol% SP-C.  In contrast, it shows more bright clusters that can 
be seen in the high resolution derivative images  (figure 3.3.8C and D). 
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3.3.3.3 Effect of SP-C34-pp and SP-C25+pp on the topography of phospholipid/ 
peptide films 
 
In order to investigate the effect of palmitoylation and truncation of the α-helical part of 
the native SP-C molecule, non-palmitoylated SP-C (SP-C34-pp) and truncated SP-C 
(SP-C25+pp) have been used. 
A mixture of phospholipids (DPPC:DPPG in a molar ratio of 80:20 mol/mol) 
containing 5.0 mol% SP-C34-pp was transferred onto a mica sheet at a plateau pressure of 
~50 mN m-1.  This sample was investigated by applying tapping mode (figure 3.3.9A).  
Disc-like clusters of flat dark areas are discernible forming polygonal domains.  These 
domains are surrounded by a network of brighter domains.  There are also some large 
and high bright domains observable in the middle of the image (figure 3.3.9A), which 
are located in the area of the network.  These domains develop a height of around 
60-160 nm and a width of 1-2 µm as is illustrated in the height profile image (figure 
3.3.9a).  The contrast image 3.3.9A (right) shows the dark areas and brighter domains 
more clearly. 
The topography image (figure 3.3.9B) of a phospholipid film containing 
DPPC:DPPG in a ratio of 80:20 (mol/mol) and 2.5 mol% of SP-C25+pp, which was 
transferred at the plateau pressure of ~50 mN m-1, depicts different bright domains and 
dark areas compared to the ones from SP-C34-pp-containing film.  There is a larger 
amount of bright domain clusters, which are irregularly distributed and do not extend to 
form a network structure. The derivative image (figure 3.3.9B) of this system shows a 
good contrast between bright and dark areas, that is between higher and flatter regions. 
The bright domains in this system are round, very small and do not have several steps of 
multilayers as can be seen in the height profile (figure 3.3.9b). 
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Figure 3.3.8  SFM height images of lipid films containing DPPC:DPPG with a molar ratio of 80:20 
and supplemented with 0.4 mol% (A) or 10.0 mol% pSP-C35+pp (B). The monolayers were transferred 
onto mica at a plateau surface pressure of ~ 50 mN m-1. The inset shows a magnification image of the 
blue square area with a size of 10 x 10 µm2. The topography derivative image reveals the phase 
differences and corresponds to the magnification images shown in figure C and D. The height profile 
depicts the height differences along the blue line in each of the insets. The image size of A and B is 50 
x 50 µm2 and the ones of the derivative image are 10 x 10 µm2. The scale of the topographical images 
is 90 nm. The height steps of stacked layers are labeled by arrows. 
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Figure 3.3.9  SFM height images (left), topography derivatives (middle) and height profiles (right) 
of lipid films containing DPPC:DPPG with a ratio of 80:20 (mol/mol) and supplemented with 5.0 
mol% SP-C34-pp (A) or 2.5 mol% SP-C25+pp (B). The monolayers were transferred onto mica at a 
plateau surface pressure of ~ 50 mN m-1. The image size is 50 x 50 µm2.  The scale of the 
topographical images is 90 nm.  The blue square areas are magnified in figure 3.3.10. 
 
The blue squared areas in both topographical images (figure 3.3.9A and B) 
represent areas with higher resolution and are used for the now following detailed 
comparison with native SP-C (pSP-C35+pp, figure 3.3.8A). 
A thorough examination of the high resolution SFM images of monolayers 
containing differently modified SP-C peptides in concentrations that lead to very similar 
isotherms clearly reveals that the topographies, however, differ from each other. The 
most obvious difference is the profile of the protrusions surrounding the polygonally 
shaped flat domains, which have in all three cases a diameter of 1.7-1.8 µm. In the case 
of native SP-C the observed multilayers reach a height of approximately 25 nm (figure 
3.3.10 A) whereas the protrusions found in the monolayers with depalmitoylated 
SP-C34-pp and the truncated SP-C25+pp only have a height of 7-10 nm. In addition, in LB 
films with native SP-C the rims of the flat domains consist of round spots whereas 
monolayers with SP-C34-pp form filamentous structures. SP-C25+pp, however, also 
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induces the formation of spot-like protrusions which are somewhat larger than the ones 
found in the native systems and which are not in such a close contact to each other 
(figure 3.3.10 C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.10  SFM height images and height profiles of lipid films containing DPPC:DPPG 
with a ratio of 80:20 (mol/mol)  and supplemented with 0.4 mol% pSP-C35+pp (A), 5.0 mol% 
SP-C34-pp (B) or 2.5 mol% SP-C25+pp (C). The monolayers were transferred onto mica at a 
plateau surface pressure of ~ 50 mN m-1. The image size is 10 x 10 µm2.  The scale of the 
topographical images is 90 nm.   
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3.3.3.4 Topography of films containing pSP-C17+pp or pSP-C17-pp   
 
Film balance measurements performed with monolayers containing either palmitoylated 
SP-C17+pp or depalmitoylated SP-C17-pp revealed that these truncated peptides did not 
induce the formation of the characteristic SP-C plateau. In order to obtain three 
dimensional information on the structures formed at the air/water interface at high 
surface pressures, LB-films of these model systems were analyzed with the SFM 
technique. Figure 3.3.11A-D show the high resolution topographical images of LB films 
composed of DPPC:DPPG 80:20 (mol/mol) and 0.4 or 10.0 mol% of pSP-C17+pp or 
pSP-C17-pp.  The monolayers were transferred on mica at ~60 mN m-1.  
The images taken of films containing 0.4 and 10.0 mol% pSP-C17+pp are shown 
in figure 3.3.11A and B.  The right parts of these images are derivative images and 
figure 3.3.11a and b are the corresponding height profiles of both topographical images.  
Small bright domains or knobs are present in monolayers with 0.4 mol% and 10.0 mol% 
of pSP-C17+pp.  At low concentration of pSP-C17+pp higher and wider knobs with 10 nm 
height and 200 nm width are found whereas smaller knobs (5 nm height and ~100 nm 
width) are present in films with high concentration of pSP-C17+pp. Increasing the 
pSP-C17+pp amount also causes an increase in the amount of knobs occurring in the 
LB-film. Interestingly, all knobs found in monolayers with 0.4 mol% pSP-C17+pp are 
distributed in a filamentous boundary line that is located around flatter areas as can be 
seen more clearly in the phase images (figure 3.3.11A, right). However, in films with 10 
mol% pSP-C17+pp no such boundary lines are visible (figure 3.3.11B right).  
In figure 3.3.11C topographical images (left) and derivative images (right) of 
LB-films containing 0.4 and 10.0 mol% pSP-C17-pp are shown. There are knobs in both 
films with 12-16 nm height and ~200 nm width.  Increasing the concentration of peptide 
had the same effect as in pSP-C17+pp films and leads to increasing amount of knobs.  In 
contrast there are obviously more knobs present in films with 10.0 mol% of pSP-C17-pp 
than in monolayers containing 10.0 mol% of the palmitoylated pSP-C17+pp.  Moreover, a 
filamentous boundary line is also observed in LB-films with low concentrations of non-
palmitoylated peptide as can be seen in the derivative images (figure 3.3.11C right).   
However, the filamentous network is more pronounced in pSP-C17+pp films than in the 
ones with pSP-C17-pp.  
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Figure 3.3.11  SFM height images (left), topography derivatives (middle) and height profiles (right) 
of lipid films containing DPPC:DPPG with a ratio of 80:20 (mol/mol) and supplemented with 0.4 
mol% (A) or 10.0 mol% (B) pSP-C17+pp or with 0.4 mol% (C) or 10.0 mol% (D) pSP-C17-pp. The 
monolayers were transferred onto mica at lateral surface pressure ~ 50 mN m-1. The image size of A 
and B is 10 x 10 µm2 and the ones of C and D is 5 x 5 µm2.  The scale of the topographical images is 
10 nm. 
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3.3.3.5 Topography of films containing pSP-C13± pp or pSP-C13L1W 
 
To further study the influence of the N-terminal part of SP-C on the phase behavior of 
surfactant model systems at the air/water interface truncated peptides with 13 
N-terminal amino acid residues with and without two palmitoyl chains (pSP-C13± pp) 
were used. In order to investigate the effect of the amino acid composition in the first 
position the peptide with a substitution of tryptophan against leucine was also analyzed 
(pSP-C13L1W). The SFM images of monolayers with these truncated SP-C peptides are 
shown in figure 3.3.12A-G together with the height profile analysis of each image 
(figure 3.3.12a-h).  
 Figure 3.3.12A and B represent topographical images of LB-films containing 0.4 
and 10.0 mol% pSP-C13+pp. A lot of holes with ~ 6 nm depth and knobs with 6 nm height 
are observable in the monolayer with 0.4 mol% pSP-C13+pp.  The pattern of holes 
resembles the one found in a pure lipid monolayer transferred at a surface pressure of 
60 mNm-1(figure 3.3.7c). Increasing the pSP-C13+pp concentration resulted in a 
disappearance of the holes and an increase in the amount of bright domains (figure 
3.3.12B).  These knobs also have a height of ~6 nm. 
In the case of LB-films containing 0.4 mol% of depalmitoylated pSP-C13-pp 
figure 3.3.12 C the holes are a bit smaller than the ones observed in pSP-C13+pp films at 
same concentration but have the same depth (figure 3.3.12c).  At this concentration 
there are more and higher domains than in the presense of pSP-C13+pp.  LB-films 
containing 10.0 mol% pSP-C13+pp do not have any observable holes. There are only little 
bright domains present with a height of ~6 nm and a width of ~100 nm figure 3.3.12D. 
On the other hand, LB-films containing 0.4 mol% of substituted SP-C 
(pSP-C13L1W) have smaller and less holes as the ones presented in figure 3.3.12E.  
Interestingly, more huge knobs are found with a height of ~45 nm and a width of ~1000 
nm (figure 3.3.12e).  In contrast to LB-films containing low concentration pSP-C13L1W, 
the holes vanish in 10.0 mol% pSP-C13L1W containing films (figure 3.3.12F).  There are 
some little knobs with a height of ~7 nm and a width of ~200 nm instead.  
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Figure 3.3.12  SFM height images and height profiles of lipid films containing DPPC:DPPG 
with a ratio of 80:20 (mol/mol) and supplemented with 0.4 mol% (A) or 10.0 mol% pSP-C13+pp 
(B), with 0.4 mol% (C) or 10.0 mol% pSP-C13-pp (D) or with 0.4 mol% (E) or 10.0 mol% 
pSP-C13L1W (F). The monolayers were transferred onto mica at lateral surface pressure ~ 60 mN 
m-1. The image size is 10 x 10 µm2.  The scale of the topographical images is 20 nm. 
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3.3.4 Discussion 
 
The aim of this SFM study was to verify the multilayer formation in 
DPPC:DPPG surfactant model systems containing differently modified SP-C peptides 
and to obtain information on the importance of the α-helix and the palmitoyl chains for 
this process.  
First, a pure lipid mixture containing DPPC:DPPG in a molar ratio of 80:20 was 
transferred onto a mica sheet and analysed with tapping mode. Interestingly, the transfer 
pressure had a considerable effect on the topography of the examined LB films. 
Increasing the transfer pressure from 45 mNm-1 to 55 or 65 mNm-1 lead to an increasing 
amount of defects with a depth of 6 nm (figure 3.3.10). Taking into account that the 
accuracy of the height analysis with SFM is 1-2 nm and that tapping mode provides 
height data which are not as exact as the ones obtained from contact mode the actual 
depth of the defects found in the LB-film is 3-4 nm. This value corresponds well to the 
thickness of a DPPC monolayer in the condensed phase of ~2.5-3.0 nm [231-234].  Not 
only defect structures are observable in pure DPPC:DPPG films but also knobs with a 
height of 6 nm and a width of 100-250 nm. Schief and et al., 2000 [235] showed 
topographic instabilities in phospholipid (DPPC) monolayers at the air/water interface 
at a surface pressure near the film collapse pressure by using light scattering microscopy 
and scanning force microscopy (tapping mode). Knobs or round islands with a height of 
5-20 nm and a width of 50-150 nm are found in these DPPC monolayers at a transfer 
pressure higher than 30 mN m-1. Moreover, the amount of knobs found by SFM at a 
surface pressure of 65 mN m-1 was considerably higher than the one at a surface 
pressure of 30 mN m-1 [235]. It was indicated that these knobs originate from packing 
defects created where adjacent domain edges with conflicting molecular orientations 
grow together during the le to lc phase transition. Therefore the spatial distribution of 
these defects can be recorded in the fully condensed monolayer, and the defects can 
serve as a source of precollapse instabilities upon compression far below the collapse 
pressure. 
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 In case of DPPC:DPPG monolayers with native SP-C transferred at the plateau 
pressure characteristic protrusions occur (figure 3.3.8).  The structures formed by SP-C 
correspond to those previously characterized by means of scanning force microscopy, 
fluorescence microscopy and scanning near-field optical microscopy [85,87-
88,196,200,205]. The composition of the squeeze out-material was also spatially 
analyzed by time of flight secondary ion mass spectrometry [86,102] and revealed that 
the ternary mixture DPPC:DPPG:SP-C transferred from the plateau region exhibited 
SP-C-rich domains surrounding pure lipid areas. All findings confirmed the formation 
of stacked bilayers in the plateau region as observed in this study. The excluded 
material contained mainly DPPG and SP-C and originated from the le phase observed in 
FLM images. The remaining monolayer was enriched in DPPC and corresponded to the 
lc phase of the monolayers [102].   The protrusions have distinct steps of ~6 nm or 
multiples of 6 nm (see in figure 3.3.8a) that fit with the ones of all previous studies 
(6.0-6.5 nm [86] and 5.5-6.5 nm [85,88]).  Increasing the SP-C content to 10.0 mol% 
resulted in an increase of the number of protrusions, probably due to the fluidization of 
material in the film as previously observed in a study by Nag et al., 1997 [236].  
 Depalmitoylation of SP-C (SP-C34-pp) had a significant effect on the formation of 
SP-C characteristic protrusions as was visualized in figure 3.3.9 and 3.3.10. The 
observed protrusions did not reach a maximum height of ~50 nm as was typical for 
systems with native SP-C but only 6 nm.  Also did the protrusions form a more densely 
connected network surrounding the polygonal shaped domains. The network formation, 
however, is probably as pronounced since 5.0 mol% of SP-C34-pp were used in this 
model system.  ATR-IR results from Dluhy et al., 2003 [207] showed that 
depalmitoylated SP-C34-pp was not strongly membrane-associated especially when 
increasing the monolayer lateral surface pressure to 60 mN m-1. This pressure was 
sufficient to exclude all the remaining protein from the membrane interface probably 
due the absence of the palmitoyl chains that serve to anchor acylated SP-C to the 
monolayers.  In addition, it is also possible that increasing the lateral surface pressure 
drives non-palmitoylated SP-C from a metastable α-helical into a β-strand 
conformation, thereby increasing the solubility of the protein and eliminating it from the 
membrane surface [207].  Besides, protein acylation is thought of enhancing protein-
membrane interaction (interaction with phospholipid acyl chains [237] by increasing the 
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hydrophobicity of a protein [157].  Consequently, the lack of palmitoyl chains in SP-C 
might induce the reduction in lipid-protein interaction resulting in a squeeze-out of 
depalmitoylated SP-C from monolayers into the subphase and protrusion formation at 
high surface pressures. In a lipid bilayer depalmitoylated SP-C is orientated parallel to 
the lipid acyl chains [81,84,238] whereas the peptide has a tile angle of 70-80° in lipid 
monolayers [157]. These orientations assure a maximum hydrophobic matching 
between the lipid acyl chains and the helical length of SP-C and thus stabilizing the 
mixed lipid/peptide layers.  On the other hand, results form more dynamic surface 
tension measurements [204] indicated that acylation does appear to have an important 
role in the formation of a surface associated surfactant rich reservoir [157]. Therefore 
the palmitoylated part of SP-C has a considerable effect on the three-dimensional 
structures and the stability of the films. 
 The length of SP-C also affects the characteristic protrusion formation.  The 
shortening of SP-C to 25 residues (SP-C25+pp) displayed similar protrusions as found in 
native SP-C systems.  One difference however is that the domain boundaries are not as 
clear as in the native system, even though a higher peptide concentration was used.  
Truncating the peptide therefore also leads to a significant reduction of its multilayer 
formation capacity. 
 
 The other truncated SP-Cs used in this study with only 17 residues showed a 
clearly different influence on the formation of protrusions in lipid/peptide films than the 
longer peptides. Some knobs were observed in a delicate filamentous structure at low 
concentrations of pSP-C17+pp.  These knobs are located in the region, which was 
identified in FLM images as a fluid phase. It therefore seems as if the peptide is located 
in this region.  Although no plateau region was observable in the isotherm of 
lipid/peptide films with pSP-C17+pp, the general processes occurring in monolayers with 
native SP-C also seem to take place in the films with this truncated peptide, especially 
at higher concentrations. During compression, DPPC and DPPG form lc domains from 
which the peptide obviously is excluded especially at a high surface pressures (>50 mN 
m
-1).  This results in the appearance of a filamentous network, which is barely visible in 
the images. This might be due to the smaller dimensions of the peptide and, most 
importantly, to its reduced functionality.  In addition, increasing the pSP-C17+pp 
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concentration in the films leads to a stronger disturbance of the monolayer and the 
formation of smaller lc phase domains. This was also observed in FLM images of 
monolayer films containing 10.0 mol% pSP-C17+pp at high surface pressures (figure 
3.2.6). Interestingly, the number of knobs does not increase when more peptide was 
added to the lipid mixture. This is an evidence for the self-aggregation of the 
palmitoylated peptide and also fits with the isotherms of pSP-C17+pp films (figure 
3.1.15a), which already indicated a non-concentration dependent squeeze-out of the 
peptide. 
SFM images of the depalmitoylated peptide pSP-C17-pp reveal a different 
filamentous network, probably because this peptide does not seem to aggregate as 
pSP-C17+pp does. This can be seen from the increase in the number of knobs with 
increasing peptide concentration. From this SFM study it can be concluded that the 
palmitoyl chains seem to mediate peptide-peptide or peptide-lipid interactions and act as 
adhesive moieties. The helix, however, seems to be important for the formation of 
pronounced multilayer structures since no protrusions were detected in monolayers with 
strongly truncated SP-C. It can be assumed that the hydrophobic helix is too short to 
adapt to the hydrophobic core of the lipids and trigger the formation of bilayer 
structures in which the helix is oriented parallel to the lipid acyl chains. Therefore, only 
the length of the α-helix of native SP-C is optimally suited for interacting with DPPC 
bilayers in the lc phase [80]. If the peptide is significantly shorter than the thickness of a 
lipid bilayer, it might induce the formation of phase separation between peptide and 
lipid [239]. This is also supported by a previous fluorescence energy-transfer study 
[104], which showed that gel phase phospholipid bilayers induce aggregation of SP-C 
polypeptides.  
 
Further decreasing the helical part (using pSP-C13+pp, pSP-C13+pp or pSP-C13L1W) 
destabilizes the lipid/peptide mixtures. At low concentrations of peptides, material is 
lost during the compression and the LB-films with these peptides are similar to those of 
pure lipid films. This material loss is more pronounced in systems with palmitoylated 
peptide (pSP-C13+pp). It can be assumed that lipid material is also lost into the subphase 
with palmitoylated peptide due to the interactions between the acyl chains of the lipids 
and the peptide. Interestingly, increasing the concentration leads to the disappearance of 
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the holes in the LB film perhaps due to protein rich patches stabilized by hydrophobic 
interactions between the peptides and/or lipids.  Also electrostatic interactions between 
the positively charged N-terminus and DPPG are possible which would become more 
pronounced with increasing peptide concentration.  
Since the substituted tryptophan probably has a higher area requirement or leads 
to different intermolecular interactions not only the isotherms differ from the ones 
observed for pSP-C13-pp but also the SFM images. The substituted peptide (pSP-C13L1W) 
exhibited bigger and higher knobs than pSP-C13-pp. 
 
 
 
 
 
 
 
 
  
   
 
  
 
 
 
Chapter 4 
 
 
Biophysical properties 
of SP-B analogues 
 
 
Synthetic surfactant peptides based on defined structural patterns or amino acid charge 
distribution found in human SP-B or SP-C appears to mimic some of the structural and 
functional properties of the native proteins. Thus they may offer a useful basis for the 
design of synthetic agents for therapeutic intervention. Towards this end, Cochrane and 
co-workers [168] suggested that the simple peptide KLLLLKLLLLKLLLLKLLLLK 
(KL4) with its pattern of five positively charged lysine residues interspaced with four 
leucines would be an effective therapeutic agent. It may mimic some characteristic 
features of SP-B, i.e. the positive charge and hydrophobic residue distribution [169]. To 
date, it is used as a medical treatment in ARDS patients. In this chapter, SP-B as well as 
its mimic KL4 are investigated by means of film balance technique, fluorescence 
microscopy and scanning force microscopy. 
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4.1 Biophysical properties of SP-B 
 
In order to investigate the biophysical properties of SP-B in phospholipid monolayers 
film balance, fluorescence light microscopy and scanning force microscopy have been 
used. The experiments were set up as described previously in chapter 3. Main lung 
surfactant phospholipid components like DPPC:DPPG with a ratio of  4:1 are used as a 
model of lipid surfactant system. SP-B was added to a concentration of 0.2 mol% to the 
lipid system. All experiments were performed on pure water (pH 5.6) at 20 °C. 
 
 
4.1.1 Phase behavior of lipid/SP-B monolayers 
 
The results of the film balance measurements of the standard system containing 
DPPC:DPPG:SP-B with a molar ratio of 80:20:0.2 are displayed in figure 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Compression isotherms of DPPC:DPPG (80:20, mol/mol) with and without 0.2 mol% 
SP-B as shown in the inset. The measurements were performed on a pure water subphase (pH 
5.6) at 20°C.  
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The SP-B/lipid film has a limiting molecular area (A0) of 82 Å2 and a little 
plateau at ~15 mN m-1 with a length of 5 Å2. Beyond this plateau region the isotherms 
of pure lipid films and the lipid/SP-B monolayers are superimposed displaying a very 
similar compressibility.  
 
 
4.1.2 Morphology of DPPC:DPPG (4:1) mixture with 0.2 mol% SP-B 
 
Monolayers containing DPPC:DPPG:SP-B in a molar ratio of 80:20:0.2 were 
investigated with fluorescence microscopy. The obtained FLM images are displayed in 
figure 4.2.  
 
Surface pressure [mN m-1] 
DPPC:DPPG:  
5 15 30 ~50 
0.2 mol%SP-B  
 
   
 
Figure  4.2  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC of DPPC:DPPG:SP-B (80:20:0.2, mol/mol) film.  The film was measured on a 
pure water subphase (pH 5.6) at 20 °C.  The image size is 130x130µm2  
 
At a low surface pressure of 5 mN m-1, the SP-B containing DPPC:DPPG film 
exhibits round-shaped lc domains, i.e. dark domains as previously described in section 
3.2.5.1. The diameter of these domains is 5-20 µm. There is a light gray border around 
each domain, which is indicative of a significant fluorescence dye accumulation. 
Similar observations were already reported by Krol et al., 2000 [200]. Interestingly, the 
fluorescence arising from the accumulated dyes is preserved at elevated pressure. 
Upon further compression the SP-B film reveals a decrease of the lc domain size 
to about 5 µm and the loss of image contrast. At ~50 mN m-1 a reappearance of 
fluorescence intensity is observed but not as pronounced as in the standard SP-C 
50 µm
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system. The domain size is the same as observed at lower pressures and the domains are 
more closely packed. Interestingly the light grey border is still existent even at this high 
pressure. 
 
 
4.1.3 Topography of DPPC:DPPG:SP-B monolayers 
 
Extensive SFM studies have been performed by Krol et al. (2000) [200] and are briefly 
summarized here to round off the biophysical properties of SP-B in lipid mixtures. 
SFM images of LB films transferred at ~50 mN m-1 display flat hexagonal 
domains with an average diameter of 50 nm which are surrounded by filamentous 
borderlines with a height of ~10 nm. Zooming into the SFM image reveals that the 
structures surrounding the flat areas are composed of individual knobs or rather disc-
like structures arranged like a string of pearls.  
 
 
 
 
 
 
 
 
Figure 4.3 SFM height image of lipid films containing DPPC:DPPG with a ratio of 80:20 
(mol/mol) and 0.2 mol% SP-B.
 
The monolayers were transferred onto mica at lateral surface 
pressure of ~ 50 mN m-1. The height image size is 10 x 10 µm2.  The scale of the topographical 
images is 30 nm [200]. 
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4.2 Biophysical properties of KL4 
 
The investigations of the biophysical properties of KL4 and its influence on 
phospholipid monolayers were again performed with film balance, fluorescence light 
microscopy and scanning force microscopy. Different concentrations of KL4 were 
added to a lipid mixture consisting of DPPC:DPPG in a molar ratio of 4:1. All 
experiments were performed on pure water (pH 5.6) at 20 °C. 
 
 
4.2.1 Phase behavior of DPPC:DPPG (4:1) mixtures with KL4 monolayers 
 
First, mixtures of DPPC and DPPG (molar ratio of 4:1) supplemented with different 
concentrations of KL4 were investigated by film balance measurements. The obtained 
compression isotherms are depicted in figure 4.4 and compared to the one of pure lipid 
films. 
 The lipid/peptide films containing low concentrations of KL4 (0.2 or 0.4 mol%) 
behave as pure lipid monolayers of DPPC:DPPG (molar ratio of 4:1) but are shifted to 
larger molecular areas (limiting area A0 = 90 Å2 for these KL4 concentrations compared 
to 80 Å2 for pure lipids). Even at higher surface pressures no plateau region is 
discernible in both lipid/peptide monolayers, a feature which is clearly different from 
the behavior of the native SP-B/lipid system. At a surface pressure of 48 mN m-1 the 
mean molecular areas of the monolayers containing 0.2 or 0.4 mol% KL4 both are 42 
Å2, which corresponds to the molecular area of a pure DPPC:DPPG  monolayer in the 
solid state. 
At 1.0 mol% KL4 the isotherm progression corresponds to these found by 
monolayers with lower peptide concentration up to an area of 60 Å2. However, at a 
surface pressure above 4 mN m-1 the compressibility of the 1.0 mol% KL4 film is 
suddenly significantly lower leading to an isotherm course which is shifted by 10 Å2 to 
higher molecular areas. Again, no plateau is observable at surface pressures up to 48 
mN m-1. 
Increasing the KL4 content to 5.0 and 10.0 mol% leads to clearly larger limiting 
molecular areas of 111 Å2 and 135 Å2, respectively. Also a significantly increased
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compressibility up to 40 mN m-1 is observable. Interestingly, monolayers containing 
more than 5 mol% KL4 display one or two plateaus at a surface pressure above 30 mN 
m
-1
. The lipid film containing 5.0 mol% KL4 reveals a plateau at 36 mN m-1 with a 
length of 8 Å2. 10 mol% KL4 films, however, exhibit two plateau regions. The first one 
is at 31 mN m-1 with a length of 5 Å2 and the second one is at 37 mN m-1 with a length 
of 8 Å2. At maximum surface pressure of 48 mN m-1 (indicated by an arrow in figure 
4.4), the mean molecular areas are ~43 Å2 for 5.0 mol% KL4 and 48 Å2 for 10.0 mol% 
KL4 films.  
 
 
The various constants describing the characteristics of the lipid/peptide 
isotherms depicted in figure 4.1 and 4.4 are summarized in table 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4  Compression isotherms of DPPC:DPPG (80:20, mol/mol) with and without different 
amounts of KL4 shown in the inset. The arrow indicates the transfer pressure of these films onto 
mica sheet for SFM measurements. The measurements were performed on a pure water 
subphase (pH 5.6) at 20°C.  
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Table 4.1 Data from the compression isotherms of DPPC:DPPG (80:20, mol/mol) displayed in 
figure 4.3.1 with various concentrations of KL4 on pure water (pH 5.6) at 20 °C where A0 = 
limiting molecular area, Ap1 = molecular area of the beginning plateau region, πp1 = beginning 
surface pressure at plateau region and Lp = length of plateau region. 
 
Concentration of KL4 A0 [Å2] Ap1 [Å2] πp1 [mN m-1] Lp [Å2] 
0.0 mol% 
0.2 mol% 
0.4 mol% 
1.0 mol% 
5.0 mol% 
10.0 mol% 
Standard SP-B system 
80 
90 
90 
90 
111 
135 
82 
- 
- 
- 
- 
53 
70/60* 
53 
- 
- 
- 
- 
36 
31/37* 
15 
- 
- 
- 
- 
8 
6/8* 
5 
* this value is corresponding to the second plateau region 
  
 
4.2.2 Morphology of DPPC:DPPG (4:1) mixtures with different 
concentrations of KL4 monolayers 
 
In order to investigate the lateral organization of the molecules in KL4/lipid films 
epifluorescence microscopy was used.  Figure 4.5 depicts the FLM images of different 
monolayers containing various concentrations of KL4. 
The addition of 0.2, 0.4 or 1.0 mol% KL4 to lipid mixtures results in a 
considerate decrease of the lc domain-size diameter (less than 5 µm) compared to the 
domains found in pure lipid films (10-20 µm) or in lipid/SP-B monolayers (5-15 µm).  
Upon further compression the lc domain size and the image contrast are significantly 
decreased.  
Interestingly, in monolayers containing higher KL4 contents, a completely 
different behavior is observable. Instead of a continuous decrease of the lc domain 
diameter with increasing peptide concentration an increase of the domain size is 
discernible. Also a disruption of the domain borderlines is observed which, however, 
can also be the result of the very diffuse appearance of the lc domains. 
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Figure  4.5  Fluorescence microscopy images at different surface pressures with 0.2 mol% 
Bodipy-PC of DPPC:DPPG (80:20, mol/mol) monolayers and different concentrations of KL4.  
All films were measured on a pure water subphase (pH 5.6) at 20 °C.  The image size is 
130x130µm2. 
 
 
 
50 µm
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At 5.0 mol% KL4 these non-defined lc domains have a diameter ranging from 10 
to 20 µm. Increasing the surface pressure, however, leads to sharper FLM images 
maybe due to the solidification of the lipid/peptide monolayer. More or less round 
domains with a diameter of 5-15 µm are visible.  
In films containing 10.0 mol% KL4, again, vague dark domains are visible. 
Because of the bad contrast no satisfactory domains size quantification is possible – not 
even at higher surface pressures.  
   
 
4.2.3 Topography of lipid films containing KL4 
 
For further investigation lipid/KL4 films were compressed to a defined surface pressure 
of ~48 mN m-1) and deposited on mica. The topography of the LB films was 
subsequently visualized by scanning force microscopy in tapping mode. 
Figure 4.6 shows the high resolution images of lipid monolayers containing KL4 
at various concentrations. At increasing KL4 contents up to 1.0 mol% the lipid films 
reveal only a few knobs with a height of 14-30 nm and a width of ~150-200 nm. 
However, the amount of knobs is not changed with increasing peptide concentration. 
The phase images shown in figure 4.6 (middle image) give more detailed topographical 
information about the surface. In the films containing 0.2 to 1.0 mol% KL4 weak 
filamentous boundary lines are observed. These lines, however, do not seem to have a 
distinct height. Increasing the KL4 content to 1.0 mol % leads to an increase of the 
density of these filamentous structures. 
LB-films containing 5.0 mol% KL4 display a somewhat increased amount of 
knobs. Interestingly, size and height are the same as the ones observed in monolayers 
with lower peptide contents. However, the filamentous boundary lines vanish when the 
concentration of KL4 in lipid films is 5.0 mol%. 
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Figure 4.6  SFM height (left), phase (middle) images and height profiles (right) of lipid films 
containing DPPC:DPPG with a ratio of 80:20 (mol/mol) and supplemented with 0.2 mol% (A), 0.4 
mol% (B), 1.0 mol% (C) or 5.0 mol% (D) KL4. The monolayers were transferred onto mica at a 
lateral surface pressure of ~ 48 mN m-1. The height image size is 10 x 10 µm2 and the phase image 
size is 10 x 10 µm2 for A. The magnified images according to grey square area of B, C and D is 3 x 3 
and 5 x 5 µm2, respectively.  The scale of the topographical images is 10 nm.  
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4.2.4 Discussion 
 
Detailed knowledge about the biophysical activity of synthetic surfactant peptides and 
their interactions with lipids is required for clinical application of model surfactants. 
Therefore, the biophysical properties of KL4 have been intensively examined with 
different techniques and compared to the ones of native SP-B. Especially the phase 
behavior, lateral orientation and topography of these peptides in lipid monolayers were 
in the focus of this study.  
 
SP-B/lipid films investigated with the film balance technique displayed a small 
plateau region at a surface pressure of 15-25 mN m-1. It is assumed that a phase 
separation of a lipid-enriched and protein-enriched phase occurs [78]. Upon further 
compression of this film SP-B/lipid aggregates are most likely squeezed out of the 
monolayer into a third dimension at ~25 mN m-1. This is concluded from the feature that 
the molecular area at this point is the same as for pure lipid films [78]. Similar 
assumptions were made by Pastrana-Rios et al., 1995 [240] who deduced from external 
reflection absorption infrared spectroscopy that SP-B is excluded from the monolayer at 
40 mN m-1. This process was irreversible for DPPC-containing films but reversible in 
the case of POPG:DPPC [240]. 
Fluorescence microscopy revealed that SP-B is most likely located in the le 
phase and influence the fluidity of the lipid monolayer. This is in agreement with the 
results obtained by Lee et al., 1997 [241] where the use of fluorescently labeled SP-B as 
well as labeled lipid confirmed that SP-B is dissolved in the fluid phase.  
The SFM measurements performed by Krol et al., 2000 [200] have contributed 
significant information about the topographical characteristics of SP-B containing LB 
films and revealed significant differences compared to lipid/SP-C systems. Instead of 
forming extended sheets of bilayers filamentous structures consisting of little round 
knobs (disc-like structures) were identified. TOF-SIMS measurements from 
Breitenstein et al., 2005 (submitted) [242] furnished further information on the chemical 
structure of this filamentous boundary lines. LB films transferred onto mica from an 
aqueous subphase displayed a high concentration of DPPC and SP-B in these 
filamentous structures. This distribution can be attributed to a demixing of the 
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lipid/monolayer already at low surface pressures and an enrichment of DPPC and SP-B 
in the le phase. Compressing the film to higher surface pressure leads to the squeeze-out 
of the peptide with probably some DPPC molecules and an enrichment in the knobs 
found in SFM images.    
 
Compression isotherms of monolayers containing DPPC:DPPG (80:20 molar 
ratio) with different concentrations of KL4 displayed a similar phase behavior to that of 
lipid/SP-B films [78]. At low KL4 concentrations (0.2-1.0 mol%) the isotherms were 
similar to the ones of pure lipid mixtures and showed no SP-B specific plateau. It can be 
suggested that KL4 still remains attached to the monolayer even at high surface 
pressures of about 50 mN m-1. However, increasing the KL4 content results in a more 
pronounced fluidizing effect on the lipid molecules in the monolayer leading to higher 
molecular areas of the isotherms.  
In addition, at high concentrations of KL4 (5.0 and 10.0 mol%), lipid/peptide 
films exhibit a plateau at a surface pressure of ~36 mN m-1. This observed plateau is 
similar to the one of DPPC:DPPG films containing high contents of a monomeric SP-B 
analogue with 1-25 residues [243]. It is possible that KL4 is squeezed out from the lipid 
monolayer as reported in a previous study [3].  These reports show that KL4 can form a 
single-phase monolayer, which is stable up to defined surface pressures. Therefore, at 5 
mol% KL4 the peptide seems to be excluded from the monolayer surface leading to an 
increase in compressibility and the formation of a plateau. However, at 10.0 mol% KL4 
the film exhibited a second plateau at 31 mN m-1. This plateau might be due to a 
rearrangement or conformational change of KL4 in the lipid monolayer. Further 
compression of the lipid/peptide film would then lead to the above explained squeeze-
out of the peptide at 36 mN m-1.  
Interestingly, the observed molecular area at 48 mN m-1 of films with 5.0 mol% 
KL4 had the same value as films containing 1.0 mol% KL4. These results would indicate 
that not all of the peptide molecules are squeezed out from monolayers with 5 mol% 
KL4. A certain amount of the peptide seems to remain in the film. This behavior also 
seems to hold true for monolayers with 10 mol% KL4. However, at this higher peptide 
concentration more KL4 remains localized in the lipid film as can be seen from the 
significant shift of the corresponding isotherm to higher molecular areas.  
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As can be seen from these film balance results KL4 seems to unfold its influence 
on the DPPC:DPPG mixtures at peptide concentrations higher than 5 mol%. 
Interestingly, infrared reflection-absorption spectroscopy (IRRAS) performed with 
either DPPC:KL4 or DPPC:DPPG:KL4 mixtures furnish interesting information on the 
structural and conformational changes occurring on a buffered subphase (pH 7) [169]. 
In DPPC monolayers the peptide obviously adapts a β-sheet conformation during 
continuous compression of the film (> 5mN m-1). However, when DPPG is present in 
the monolayer, the dominant conformation of KL4 was the α-helix over the entire 
pressure range. This conformational change is attributed to enhance electrostatic 
interactions between the negatively charged DPPG and the positive residues of KL4. 
Although the lipid/peptide system in this work was investigated on a pure water 
subphase with a pH of 5.6 similar ionic interactions have to be expected. 
 
The FLM images of lipid monolayers with different concentrations of KL4 
reveal a typical phase transition from the le phase to the lc phase which is comparable to 
the one found in the SP-B system. Also, the images obtained at low surface pressure are 
very similar with respect to the le/lc distributions indicating that KL4 is most likely 
located in the le phase. Increasing the surface pressure in these lipid/peptide films only 
leads to a decrease of contrast. No reappearance of fluorescence intensity like in SP-C 
containing films and also less pronounced as in lipid/SP-B monolayer is observed. This 
may be explained by the reduced capability of forming extended multilayer structures 
beneath the monolayer. Here, the fluorescence dye is in a less dense environment. In 
contrast to SP-B and especially SP-C, KL4 is not able to form stacked bilayers at all as 
can be seen from the SFM results. 
However, one interesting aspect has to be discussed when looking at the FLM 
images of monolayers with 0.2 – 1.0 mol% KL4. These images clearly show that the lc 
domains in KL4 containing monolayers are smaller than in SP-B containing films. This 
could indicate a less fluidizing effect of this peptide on the monolayer or rather a 
smaller tendency to form peptide aggregates within the monolayer due to its high 
amount of positive charges. It is also possible, that the charge distribution of the peptide 
leads to specific interactions with the negatively charged DPPG. Consequently, this 
could lead to smaller lc domains, which are probably mainly composed of DPPG under 
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the chosen experimental conditions (water subphase, pH 5.6, 20 °C). Such a behavior 
would also be consistent with the findings of Ma et al., 1998 [3] who reported ionic 
interactions between oppositely charged PA and KL4 appearing in 
DPPC:POPG:PA:KL4 monolayers as well as the IRRAS results of Cai et al., 2003 
[169]. 
If specific interactions between DPPG and KL4 are assumed it is also possible to 
explain the sudden increase of fluid phase at KL4 concentrations above 5 mol%. It is 
very likely that KL4 inhibits the formation of DPPG-rich lc domains at low surface 
pressures due to the formation of stable DPPG-KL4 aggregates separated from a DPPC-
rich phase. It is possible that the dark domains observed in monolayers with 5 and 10 
mol% mainly consist of DPPC – a hypothesis which finally can only be proven by 
future TOF-SIMS measurements on LB monolayers with high KL4 contents.  
 
SFM measurements performed with LB films containing different KL4 contents 
lead to topographic images, which are strongly related to the morphologies of 
lipid/peptide monolayers observed with fluorescence microscopy.  
In contrast to lipid/SP-B monolayers, the KL4/lipid films only revealed the 
formation of little knobs more or less statistically distributed on the surface. But no 
extended network of disc-like structures that form boundary lines around flat hexagonal 
areas could be observed. However, when the phase images of the KL4 films are 
considered, the general existence of weak boundary lines is shown. These structures are 
of no considerate height and most interestingly disappear when the KL4 concentration is 
increased to 5 mol%.  If again ionic interactions between DPPG and KL4 are assumed, 
following processes in the monolayer are conceivable when increasing the peptide 
concentration: At low KL4 contents, the amount of peptide is too low to disrupt the 
DPPG-rich lc domains completely. Only a few peptide/DPPG aggregates would then be 
present in the surrounding fluid phase leading to a weak boundary line when the 
monolayer is transferred onto mica and analyzed with SFM. Increasing the KL4 
concentration would finally result in the disappearance of the DPPG-rich domains and 
the formation of statistically distributed peptide/DPPG aggregates. Again this theory 
can only be supported with TOF-SIMS experiments, which remain to be performed.  
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As was frequently mentioned so far, a KL4 exclusion of the monolayer is the 
most probable explanation for the interpretation of the film balance and fluorescence 
microscopy results. Such a behavior is also expected in the literatures [3,169]. Therefore 
the question arises why no three-dimensional structures can be detected in the SFM 
images, especially at high KL4 concentrations where a plateau region is discernible. One 
has to consider that the peptide addressed in this study contains so many charges lys 
residues around the circumference of the helix. Therefore, it is most likely not to insert 
neither in the hydrophobic interior of the monolayer nor in the core of a lipid bilayer. It 
is more conceivable that the peptide is oriented preferentially parallel to the aqueous 
surface as proposed in a model from Cai et al., 2003 [169]. Due to its high positive 
charge the peptide will be statistically distributed in the monolayer. Taking into account 
a helical structure, the peptide would have a rod like structure with a length of 
approximately 3 nm. Peptides lying flat beneath the monolayer would not be detectable 
with the SFM tip scanning over the surface after transfer on mica. This would be the 
reason for the rather flat appearance of the lipid/KL4 LB films. The rare knobs found in 
the SFM images ware probably general preparation artifacts, especially since they were 
also found in pure lipid LB films.  
 
   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter 5 
 
 
General conclusion and perspective 
 
 
The two hydrophobic proteins SP-B and SP-C are known to be essential for proper lung 
function. They stabilize the surfactant film at the air/liquid interface of the alveoli, 
induce the formation of multilayer stacks and enhance the material exchange between 
the hypophase and the monolayer. 
SP-C acts as an anchor between the monolayer and the surfactant reservoir 
formed during exhalation. Thereby, the two cystein linked palmitic acid chains remain 
in the surface film, while the α-helix is thought to penetrate two of the excluded 
adjacent monolayers. The aim of this study was to elucidate the minimal structural 
requirements of these two moieties for a proper interaction between the protein and the 
lipid components. Therefore, the biophysical properties of either unpalmitoylated and/or 
in the α-helical sequence shortened SP-C have been investigated by film balance, 
fluorescence microscopy and scanning force microscopy. 
SP-B is thought to considerably enhance the material exchange in the lung 
surfactant monolayer. By conformational changes of its two positively charged 
α-helices the edges of squeezed out discoidal bilayer structures are presumably 
stabilized by this protein. In therapeutic agents against RDS and ARDS SP-B is often 
replaced by a synthetic peptide called KL4. In this thesis the influence of this 
structurally simple model peptide on lipid monolayers was investigated in order to 
understand the way KL4 mimics the physiological function of SP-B. 
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5.1  Native SP-C and its analogues  
 
Either native or synthetic SP-C fragments have been investigated by film balance 
measurements. Isotherms containing native human and porcine SP-C (SP-C35+pp or 
pSPC35+pp) displayed a similar phase behavior. Only the limiting molecular area was 
different, maybe because of differences in the amino acid sequence and thereby changes 
in secondary and tertiary structure. The phase behavior, however, was not affected by 
these structural differences. 
When depalmitoylated or significantly shortened SP-C analogues such as 
SP-C34-pp and SP-C25+pp were investigated a phase behavior clearly different from that of 
native SP-C was observed. These differences became especially apparent when 
hysteresis measurements were performed. The lack of the two palmitic chains lead, in 
the case of SP-C34-pp, to a smaller hysteresis curve than the one of native SP-C. Such a 
behavior generally indicates decreased attractive forces between the molecules of a 
monolayer. The acyl chains therefore seem to mediate intermolecular interactions that 
stabilize the surface film during expansion. Since depalmitoylated SP-C has no adhesive 
modules anymore a less compressible monolayer displaying a smaller hysteresis is 
formed.  
Hysteresis curves containing palmitoylated SP-C25+pp with a shorter α-helix 
compared to the native SP-C protein revealed a significant material loss upon 
consecutive compression/expansion cycles. Therefore the length of the α-helix not only 
influences the phase behavior of peptide monolayer but also their stability.   
Interestingly, the palmitoylated truncated SP-C with 17 residues (pSP-C17+pp) 
displayed high reversibility during successive compression/expansion cycles, which 
confirms the assumption of the palmitoyl chains acting as adhesive modules in the 
peptide and thus stabilize the monolayer. If the α-helix is too short, however, this 
stabilizing effect is lost, as was observed in systems with pSP-C13+pp, pSP-C13-pp and 
pSP-C13L1W.  
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The obtained results indicate that the α-helix not only influences the phase 
behavior but also the stability of pure peptide monolayers. Apparently, the α-helical 
part has to comprise more than 13 amino acids for the palmitoyl chains to properly 
function as stabilizing moieties. Over all, the hydrophobic interactions between the acyl 
chains and the α-helix seem to be essential for this stabilizing effect. It is possible that 
the palmitoyl residues orient parallel to the helix. Therefore reducing the length of the 
helical part strongly influences the hydrophobic interactions with the palmitoyl chains. 
In the case of pSP-C17+pp monolayers the length of the α-helix and its hydrophobicity are 
still sufficient to permit stabilizing interactions between the helical part and the acyl 
chains. In peptides with only 13 residues, however, the α-helix is too short – the 
stability of the monolayers is considerably decreased.  
 
When lipid/peptide mixtures were investigated at the air/water interface other 
interesting aspects concerning the influence of α-helix and palmitoylation on the phase 
behavior of lipids became apparent. The distinct plateau region found in native 
SP-C/lipid films could not be found to such an extend with the other modified SP-C 
analogues. Non-palmitoylated SP-C (SP-C34-pp) and shortened palmitoylated SP-C 
(SP-C25+pp) still show a defined plateau but require a higher amount of peptide in the 
lipid/peptide monolayers (5.0 mol% for SP-C34-pp and 2.5 mol% for SP-C25+pp). The 
strongly truncated SP-C peptides with 17 or 13 residues (with or without 
palmitoylation), however, did not show any plateau at all at high surface pressures. 
Therefore a removing the palmitoyl chains or shortening the α-helix of SP-C reduces 
the ability of the peptide to form multilayers. Interestingly, the removal of the palmitic 
acids had a stronger influence than the reduction of the helical part which again 
emphasizes their stabilizing role in monolayers.  
Increasing the peptide concentration increased the monolayer fluidity in all 
lipid/peptide mixtures, which can be explained by a higher disturbance of the lipids by 
the peptide. In the case of films containing longer SP-Cs (pSP-C35+pp, SP-C34-pp and 
SP-C25+pp) increasing the peptide concentration decreased the plateau pressure height. 
This effect might be due to the peptides inducing a better ordering. It is also possible 
that the peptides trigger the formation of three-dimensional multilayers by lowering the 
required energy of this process.  
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Fluorescence light microscopy was used to show the lateral domain formation in 
lipid/peptide films. In accordance with previous studies the standard lung surfactant 
system exhibited a typical behavior like the reappearance of fluorescence intensity at 
high surface pressure. This phenomenon is interpreted as indicator of protrusion 
formation [85]. Lipid/peptide monolayers containing SP-C34-pp or SP-C25+pp displayed 
different lateral domain formation than the native system. Less pronounced and 
differently shaped domains were visible which might be due to the high peptide 
concentrations used in these FLM studies. 
The monolayers containing considerably truncated SP-Cs (pSP-C17±pp and 
pSP-C13±pp) exhibited no fluorescence intensity reappearance at high surface pressure 
and did not show any sign of protrusion formation. Moreover, a pronounced 
accumulation of the fluorescence dye around the lc domains was observed at high 
surface pressure leading to the appearance of grey borders. Probably, the fluorescence 
dye is enriched in the le phase during the le/lc phase transition of the monolayer. At 
higher surface pressures the dye is then squeezed out of the monolayer together with a 
certain amount of peptides. This effect was even more pronounced in monolayers 
containing pSP-C17+pp and pSP-C13+pp perhaps because palmitoylated peptides aggregate 
more easily. FLM images of substituted SP-C (pSP-C13L1W) showed a stronger 
aggregation of the peptide than pSP-C13-pp, which is probably induced by strong 
hydrophobic interactions between the tryptophan of adjacent peptides. Moreover, polar 
interactions between the phospholipid head-groups and the charged or polar residues of 
the N-terminal part of SP-C are possible [75,82].  
 
The topographies of the peptide/lipid films at high surface pressure were 
investigated by means of SFM. According to previous studies, the standard model 
system containing native SP-C formed extended multilayers with distinct steps of 6 nm. 
In contrast, filamentous structures around flat polygonal domains were observed in 
films containing non-palmitoylated pSP-C34-pp with peak heights of 6 nm. Consequently, 
the lack of palmitoyl chains in SP-C seems to induce the reduction of lipid-protein 
interactions. Monolayers containing depalmitoylated SP-C therefore show decreased 
capability to form a pronounced lung surfactant reservoir.  
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When the shorter peptide with 25 residues was investigated, also round 
protrusions with 6 nm height were observed.  However, the domain boundaries were 
significantly less clearly visible than in the case of pSP-C34-pp. Therefore the length of 
SP-C also affects the characteristic protrusion formation. Shortening the α-helix also 
inhibits the formation of the multilayer stacks which are characteristic for the native SP-
C system. 
In contrast to the long length SP-C systems, the strongly truncated SP-C 
analogues (pSP-C17± pp, pSP-C13± pp and pSP-C13L1W) revealed different topographical 
images with small knobs (with a height of 6 nm and a width of 100 nm) and holes. 
Interestingly, the number of knobs did not increase when more pSP-C17± pp was added to 
the lipid mixture. Therefore, a self-aggregation of the palmitoylated peptide can be 
assumed leading to a non-concentration dependent squeeze-out of the peptide. The very 
short SP-C analogues (pSP-C13± pp and pSP-C13L1W) revealed the great impact of α-helix 
reduction resulting in a significant material loss and hole formation at low peptide 
concentrations. This effect underlines the importance of the helical length for multilayer 
formation. The substituted first amino acid SP-C (pSP-C13L1W) showed higher 
intermolecular interactions resulting in bigger knobs than the ones of non-substituted 
SP-C (pSP-C13-pp).  
 
The performed biophysical investigations on the phase behavior of differently 
modified SP-C peptides lead to interesting conclusions on the relevance of the palmitoyl 
chains and the α-helix. Palmitoylation of SP-C influences hydrophobic interactions 
between SP-C and lipid molecules as well as other peptides leading to peptide 
aggregates within the monolayer. The length of the α-helix is important for the dynamic 
biophysical properties of lung surfactant proteins. Decreasing the α-helix length 
interferes with the packing of lipid monolayers and inhibits protrusion formation. 
However, it can be deduced that palmitoylation is more relevant for the physiological 
function of SP-C than the α-helical length.   
 
Figure 5.1 shows the assumed orientations of palmitoylated and unpalmitoylated 
SP-C in DPPC:DPPG monolayers at low and high surface pressures (le and lc phase, 
respectively) on pure water (pH 5.6) at 20 °C. Both SP-C types are located in the le 
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phase of the lipid monolayer and are surrounded by disordered lipids. Further 
compression leads to a higher organizationof the lipid/protein film. SP-C is excluded 
first from the lc domains and later from the monolayer under formation of a multilayer 
reservoir. 
Palmitoylated SP-C is probably located in the monolayer as well as in the 
multilayer. The non-palmitoylated SP-Cs, however, are most possibly excluded from 
the monolayer and form bilayers in the subphase. A similar behavior is expected with 
SP-C25+pp and SP-C34-pp, which are still functional despite their modifications. However, 
the depalmitoylated peptide will not be connected to the monolayer via the palmitoyl 
chains. 
 
 
Figure 5.1  Schematic diagram of the lung surfactant model system containing long α-helix 
(longer than 17 amino acid residues) SP-C with and without palmitoylation and DPPC:DPPG. 
In the le phase both SP-C types are located in the lipid monolayer. Upon further compression 
lipid/protein aggregates are excluded from the monolayer and form a surfaced-confined 
reservoir. Palmitoylated SP-C is located in the monolayer and/or the multilayers whereas the 
depalmitoylated peptide is directed to the multilayers and is not attached to the monolayer 
anymore. 
 
 For strongly truncated SP-Cs (shorter than 17 amino acid residues) with and 
without palmitoylation an aggregation model of lipid/peptide films at low and high 
surface pressure is proposed (figure 5.2). In the le phase both SP-C types are located in 
the DPPC:DPPG monolayer. The peptide molecules are highly and show no preference 
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for a distinct secondary structure (here only the α-helical form is presented). Further 
compression leads to a higher organization of the lipid/protein film. SP-C aggregates are 
excluded from the monolayer under formation of lipid/protein micelles instead of 
extended surfaced-confined reservoirs. Palmitoylated SP-C most possibly aggregates 
because of the more pronounced interactions of acyl chains and α-helices than in non-
palmitoylated films. 
 
 
Figure 5.2  Schematic diagram of the lung surfactant model system containing short α-helix 
(shorter than 17 amino acid residues) SP-C with and without palmitoylation and DPPC:DPPG.  
In the le phase both SP-C types are located in the lipid monolayer with a disordered secondary 
structure (here only the α-helical form is presented). Upon further compression lipid/protein 
film aggregates are excluded from the monolayer to lipid/protein micelles. 
 
Finally, a model for the LB-films with truncated SP-Cs transferred onto mica sheet is 
presented in figure 5.3. This models offers an explanation for the observed heights in 
LB films containing strongly shortened SP-C (sections 3.3.3.5 and 3.3.3.6 of the SFM 
results). Transferring the monolayer and the micellar structures attached to it on to a 
solid substrate would lead to the appearance of knobs with a height of 6 nm. Reason for 
this is the monolayer covering the associated micelles like a carpet which would be 
detected by the SFM tip as little round knobs with a constant height. 
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5.2  SP-B and its mimic KL4 
 
The phase behavior of the hydrophobic surfactant protein SP-B at the air/water interface 
is characterized by a considerate squeeze-out of the protein at relatively low surface 
pressures compared to SP-C (15-25 mN m-1 instead of 52 mN m-1). This exclusion from 
the monolayer is obviously correlated with structural features of the protein – it is much 
larger than SP-C and also contains more polar and positively charged residues, 
rendering the protein less hydrophobic. The results available on the phase behavior of 
SP-B so far suggest that SP-B hardly penetrates into the acyl chains region of the lipid 
film and that it is located rather superficially in bilayers [75,98,100]. Together with the 
FLM and SFM results obtained for SP-B [200] it becomes clear that it may have a role 
opposite to that of SP-C in modulating the properties of surfactant films at high surface 
pressures. In contrast to SP-C, lipid monolayers containing SP-B displayed only distinct 
protrusions consisting of bilayer patches which are limited in size and exhibit a globular 
disk-like structure. SP-B is therefore most possibly not meant to induce the formation of 
extended multilayer sheets beneath the lipid monolayer but rather to stabilize the 
boundaries of the formed 3D patches [200]. A balance between the action of SP-B and 
SP-C could then lead to surfactant films stably compressible to high surface pressures 
but still flexible enough to work under the dynamic conditions imposed by the lung.  
 
 
 
 
 
 
 
 
Figure 5.3  Schematic diagram of the LB-films containing truncated SP-C explaining the knob 
formation in SFM images.  
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The peptide KL4 seems to be an effective mimic of SP-B since it is reported to 
be very successful in the clinical treatment of animal and human RDS [115,167]. 
Therefore, it appears that such a peptide behaves very similarly to SP-B and provides a 
means of substituting for SP-B in reconstituted surfactant systems. However, the 
molecular mechanisms by which SP-B and KL4 perform their actions in the native lung 
system are not known yet. The study of the surface properties of this peptide in lipid 
mixtures, especially the topographical features of LB films, should broaden our 
understanding of the role of this peptide, and in turn, provide a better mechanistic model 
for lung surfactant function in general.  
The evaluation of film balance experiments indeed reveals a phase behavior of 
KL4 which is similar to that of native SP-B. The peptide clearly fluidizes the monolayer 
and is squeezed out from films containing higher amounts of KL4 at higher surface 
pressures. However, FLM images reveal that the fluidizing effect of the protein is less 
pronounced than SP-B at low KL4 concentrations. On the contrary, the peptide seems to 
lead to a more condensed monolayer in which smaller and more lc domains are visible. 
Because of the conditions chosen (water subphase, pH 5.6, 20 °C) it is very likely that 
these domains mainly contain DPPG. Interestingly, increasing the peptide concentration 
to more than 5 mol% KL4 leads to a surprising disruption of the observed solid 
domains. It is possible that this highly charged peptide exerts pronounced attractive 
electrostatic forces on DPPG leading to a decomposition of the DPPG-rich domains. If 
this behavior would prove to be true, i.e. by prospective TOF-SIMS measurements, then 
KL4 would be more effective than its native counterpart SP-B in promoting a substantial 
refinement of surfactant composition via a mechanism of surface phase separation.  
When SFM measurements were performed with solid supported KL4/lipid 
monolayers it became clear that this peptide was not able to induce the formation of any 
kind of 3D structure. Only faint boundary lines were distinguishable at low peptide 
concentrations which, however, vanished when the KL4 content was increased to 5 
mol%. The reason for this might be the significantly smaller molecular dimensions of 
this peptide compared to SP-B. KL4 is probably too small to assemble along the edges 
of excluded surfactant material and to stabilize these boundaries. Therefore only 
isolated peptides distributed over the monolayer surface are presumably present, but 
cannot be visualized with SFM.  
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In summary, the SP-B mimic KL4 seems to be more potent in inducing a phase 
separation of the main surfactant lipids DPPC and DPPG, probably due to its high 
density in positive lysine residues. Since KL4 is smaller in size than SP-B, however, it 
does not lead to the formation of protrusions at higher surface pressures.  
 
 
5.3  Perspectives 
 
The results of this study lead to the conclusion that both the α-helix and the palmitoyl 
chains influence the stability of SP-C/lipid monolayers at the air/water interface and are 
necessary for an effective formation of a surfactant reservoir. Thereby palmitoylation 
seemed to be more important for proper surfactant function than the length of the 
α−helical part.  
One still unanswered question however is the exact location of truncated SP-Cs 
at high surface pressures. This problem can be addressed by time of flight secondary ion 
mass spectroscopy (TOF-SIMS). This technique can be used to identify the composition 
of the knobs found in SFM images of differently modified SP-C peptides. Furthermore, 
the use of fluorescently labeled truncated SP-C is another possibility to estimate the 
location of the peptide in the monolayer. Also infrared reflection-absorption 
spectroscopy (IRRAS) can be used for the determination of peptide orientation in 
lipid/protein systems. This technique will additionally provide molecular information 
about the secondary structure of the SP-C analogues as well as the conformational order 
of the lipid acyl chains.  
 
The biophysical study of SP-B and its analogue KL4 lead to interesting aspects 
on the molecular mechanism by which these peptides influence the phase behavior of 
lipid monolayers. Especially the lysine residues as well as the molecular structure seem 
to play an important role for surfactant function. However, it remains to be elucidated 
whether KL4 is more effective than SP-B in interacting with the oppositely charged 
DPPG. TOF-SIMS experiments with the native SP-B/lipid system under similar 
conditions (water subphase, pH 5.6, 20 °C) did not show any specific interactions 
between SP-B and DPPG [171]. It would be therefore extremely interesting to verify the 
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chemical distribution of DPPC, DPPG and KL4 in LB films with the TOF-SIMS 
technique. Since SP-B, and thus Kl4, are assumed to play a crucial role in dynamic lung 
surfactant processes it would be a great challenge to study the relevance of KL4 for 
kinetic processes. 
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Appendix A 
 
Abbreviations 
 
ACM acetamidomethyl 
ala alanine (A) 
ARDS acute respiratory distress syndrome 
arg arginine (R) 
ATR-FTIR attenuated total reflection fourier transform infrared spectroscopy 
BOC tert-butyloxycarbonyl 
BSA   bovine serum albumin 
CD circular dichroism spectroscopy 
DAB 1,3-diaminobutyric acid residues 
DIEA diisopropylethylamine 
DMF dimethyl formamide 
DPPC   dipalmitoyl-sn-glycero-phosphatidylcholine  
DPPG  dipalmitoyl-sn-glycero-phosphatidylglycerol 
DTNB dithio-bis-nitrobenzoic acid 
EDT ethanedithiol 
EDTA   ethylendiamine- tetraacetic acid 
ESI-MS  electrospray ionization mass spectrometry 
FLM fluorescence light microscopy 
FM film balance 
Fmoc 9-fluorenylmethoxycarbonyl 
FPLC  fast performance liquid chromatography 
g  gravity (9.81 m/s2) 
HPLC  high performance liquid chromatography 
ile isoleucine (I) 
IRRAS infrared reflection-absorption spectroscopy 
KL4 KLLLLKLLLLKLLLLKLLLLK 
LB Langmuir-Blodgett 
lc phase  liquid-condensed phase 
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le phase liquid-expanded phase 
leu leucine (L) 
LPS lipopolysaccharide 
lys lysine (K) 
MALDI-MS  matrix assisted laser desorption ionization mass spectrometry 
MALDI-TOF matrix-assisted laser desorption time-of-flight mass spectrometry 
MBHA methylbenzhydrylamine 
mRNA messenger ribonucleic acid 
PA palmitic acid 
PBS phosphate buffered saline 
PC  phosphatidylcholine 
PE phosphatidylethanolamine 
phe phenylalanine (F) 
PI phosphatidylinositol 
PL phospholipid 
PMC 2,2,5,7,8-penthamethyl chroman-6 sulfonyl 
POPG palmitoyl-oleoyl-phosphatidylglycerol 
PxB polymyxin B  
PyBop (benzotriazolyl)N-oxy-pyrrolidinium phosphonium 
hexafluorophosphate 
RDS respiratory distress syndrome 
SDS sodium dodecyl sulfate 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SFM  scanning force microscopy 
SP-A surfactant (associated) protein A 
SP-B surfactant (associated) protein B 
SP-C surfactant (associated) protein C 
SP-C35+pp  human native surfactant protein C with two palmitoylation 
pSP-C35+pp  porcine native surfactant protein C with two palmitoylation 
SP-C34-pp  recombinant human 34 residues surfactant protein C without 
palmitoylation 
SP-C25+pp  recombinant human 25 residues surfactant protein C with two 
palmitoylation 
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pSP-C17+pp  porcine 17 residues surfactant protein C with two palmitoylation 
pSP-C17-pp  porcine 17 residues surfactant protein C without palmitoylation 
pSP-C13+pp  porcine 13 residues surfactant protein C with two palmitoylation 
pSP-C13-pp  porcine 13 residues surfactant protein C without palmitoylation  
pSP-C13L1W  porcine 13 residues surfactant protein C without palmitoylation  
SP-D surfactant (associated) protein D 
TBTU O-(benzotriazol-1-yl)-N,N,N´-tert-tetramethyluronium 
tetrafluoroborate 
TFA trifluoroacetic acid 
TOF-SIMS time-of-flight secondary ion mass spectrometry 
trp tryptophan (W) 
TRT trityl 
val valine (V) 
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Appendix B 
 
Chemicals 
ammonium molybdate (VI)·4H2O Fluka (Neu-Ulm, D) 
ascorbic acid  Sigma-Aldrich (Taufkirchen, D) 
BODIPY-PC® Avanti Polar Lipids, Pelham, USA 
BSA  Sigma, Deisenhof, D 
chloroform  Merck (Darmstadt, D) 
Dichlormethan  Merck, Frankfurt, D 
disodium hydrogen phosphate  Merck (Darmstadt, D) 
DPPC, DPPG Avanti Polar Lipids (Alabaster, USA) 
EDTA  Sigma-Aldrich (Taufkirchen, D) 
ethanol  Fluka (Neu-Ulm, D) 
fluorescamine  Sigma, Deisenhof, D 
methanol Merck (Darmstadt, D) 
MucasolTM  Merck (Darmstadt, D) 
perchloric acid  Merck (Darmstadt, D) 
sodium dihydrogen phosphate Merck (Darmstadt, D) 
sodium hydroxide Merck (Darmstadt, D) 
SDS  Merck (Darmstadt, D) 
 
Materials  
cantilever   Nanoscience Instruments, Phoenix, USA 
filter paper   Sartorius (Göttingen, D) 
mica sheets   Provac AG (CH) 
microliter syringe   Hamilton (Bonaduz, CH) 
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Technical Equipments 
MilliQ RO 10 Plus and MilliQ plus 185 Millipore (Eschborn, D) 
balance  Sartorius (Göttingen, D) 
pH meter  Knick 761 Calimatic Knick (Berlin, D) 
UV/Vis photometer  UV-1601 PC Shimadzu (Gieβen, USA) 
evaporation apparatus  Willi Fischer (Frankfurt, D) 
vortex mixer  IKA-Vibrax VXR Janke & Kunkel 
 IKA-Labortechnik (Staufen, D) 
Fluorescence spectrometer  LS 2b Perkin Elmer (Wellesley, Ma, USA) 
 
Film Balance 
Thermostat F3  Haake (Karlsruhe, D) 
Wilhelmy film balance  Riegler & Kirstein (Mainz, D) 
 
Fluorescence Microscopy 
CCD camera  C4742-95 Hamamatsu(Hamamatsu, Japan) 
fluorescence microscope  STM5-MJS Olympus (Hamburg, D) 
 
Scanning Force Microscope 
BioScope with NanoScope IIIA Controller  Digital Instruments (Santa Barbara, USA) 
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